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 Summary 
The global rise in microbial resistance, ranging from the agricultural industry to the medical 
sector, has created the urgent need for novel or supplementary antibiotics. Antimicrobial 
peptides or “nature’s antibiotics” may be the answer to this major problem. In this study a group 
of antimicrobial peptides, cyclic decapeptides named tyrocidines, produced by the soil bacterium 
Bacillus aneurinolyticus, was investigated for their antifungal activity, possible mode of 
antifungal action and potential applications.  
The study illustrated that the tyrocidines have significant antifungal activity against a range of 
phytopathogens, including Fusarium solani and Botrytis cinerea, as well as the human pathogen 
Candida albicans. The activity of the tyrocidines is influenced by the identity of both the target 
organism and the media environment. Further evidence was obtained in support of the 
hypothesis that the tyrocidines are extremely sensitive to their environmental conditions and that 
they tend to self-assemble to form oligomers. The assessment of a small tyrocidine library and 
analogues, comprised of eight peptides, revealed no overt structure-activity relationships against 
fungal pathogens, except for the importance of a tyrosine residue. This indicated an important 
role for the conserved sequence of the tyrocidines, NQYVOLfP, together with the tendency of 
the tyrocidines to oligomerise into higher-order active structures in their antifungal activity. 
The tyrocidines were found to be membrane active toward the fungal pathogens. However, 
supporting evidence was also obtained for additional mode(s) of antifungal action for the 
tyrocidines which inter alia induces morphological abnormalities in filamentous fungal target 
cells. Furthermore, the results also indicated that the membrane activity of the tyrocidines may 
be influenced by additional factors to that of the composition of the target cell membrane, for 
instance components of the fungal cell wall. 
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This investigation also indicated the significant potential of the tyrocidines to be developed for 
the commercial sector. The potent activity of the tyrocidines against agronomically important 
phytopathogens (significantly higher than the commercial fungicide bifonazole) together with 
their relative salt stability bodes well for their development as bio-fungicides for the agricultural 
sector. The tyrocidines also exhibited an overt sinergistic effect on the in vitro candidacidal 
activity of two key antifungal drugs, caspofungin and amphotericin B. Furthermore, tyrocidine A 
and caspofungin exhibited synergistic activity in vivo which had a significant positive effect on 
the survival of C. albicans infected Caenorhabditis elegans. Latter results highlighted their 
potential to serve as candidates for combinatorial treatment in the medical industry. 
. 
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Opsomming 
 
Die globale verskynsel van mikrobiese weerstand, wat strek vanaf die landbou sektor tot in die 
mediese bedryf, het ’n dringende behoefte vir die ontwikkeling van nuwe antmikrobiese middels 
geskep. Antimikrobiese peptiede of “die natuur se antibiotika”, kan moontlik die antwoord op 
hierdie ernstige problem wees. Tydens hierdie studie is ‘n groep sikliese antimikrobiese 
peptiede, naamlik die tirosidiene wat deur die grondbakterium Bacillus aneurinolyticus 
geproduseer word, vir hulle antifungiese aktiwiteit, hulle moontlike meganisme(s) van 
antifungiese werking en hulle potensiёle aanwendings bestudeer. 
Hierdie studie het getoon dat die tirosidiene uitsonderlike antifungiese aktiwiteit teen ‘n reeks 
fitopatogene, insluitend Fusarium solani en Botrytis cinerea, asook teen die mens patogeen 
Candida albicans het. Die aktiwiteit van die tirosidiene is deur beide die identiteit van die 
teikenorganisme sowel as die mediumomgewing beїnvloed. Daar is ook verdere bewyse verkry 
wat die hipotese dat tirosidiene uiters sensitief is tot hulle omgewing en dat hulle neig om te 
oligomeriseer, ondersteun. Die studie van die klein tirosidien-biblioteek, saamgestel uit agt 
tirosidiene en analoё, het geen ooglopende struktuur-aktiwiteit verwantskappe opgelewer nie, 
behalwe vir die oёnskynlike invloed van die tirosien-residu. Laasgenoemde het die belangrikheid 
van die gekonserveerde aminosuurvolgorde van die tirosidiene, NQYVOLfP, asook die neiging 
van tirosidiene om hoё-orde aktiewe strukture te vorm deur self-verpakking, beklemtoon.  
Tydens die studie is daar gevind dat die tirosidiene membraan-aktiewiteit toon teenoor fungiese 
patogene. Daar is egter ook goeie bewyse vir alternatiewe meganisme(s) van antifungiese 
werking, wat ondermeer tot morfologiese abnormaliteite in filamentagtige fungi-teikenselle lei, 
vir die tirosidiene verkry. Die resultate het verder ook daarop gewys dat die membraan-aktiwiteit 
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van die tirosidiene ook deur ander faktore, soos deur komponente van die fungiese selwand, en 
nie net deur die samestelling van die fungiese membraan beїnvloed word nie. 
Hierdie ondersoek het ook die aansienlike potensiaal van die tirosidiene vir kommersiёle 
ontwikkeling en gebruik uitgelig. Die merkwaardige aktiwiteit van die tirosidiene teen 
fitopatogene van agronomiese belang (wat selfs beter as diè van die kommersiёle swamdoder 
bifonazole was) tesame met die relatiewe sout stabiliteit van die tirosidiene, is belowende tekens 
om die tirosidiene as bio-swamdoders vir die landbou sektor te ontwikkel. Die tirosidiene het 
ook ‘n uitgesproke sinergistiese effek op die in vitro candidasidiese aktiwiteit van twee sleutel 
antifungiese middels, caspofungin en amphotericin B, getoon. Verder is daar in vivo sinergistiese 
aktiwiteit gewys deur die kombinasie van tirosidien A en caspofungin wat ’n beduidende 
positiewe effek op die oorlewing van C. albicans geïnfekteerde Caenorhabditis elegans gehad 
het. Laasgenoemde dui op die potensiaal van die tirosidiene om in die mediese bedryf as 
kandidate vir kombinasie-behandeling te dien. 
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Preface 
 
In recent years the steady increase in resistance against conventional chemical fungicides has led 
to significant problems in both the agricultural and medical sector creating an urgent need for the 
development of novel antifungal compounds. Antimicrobial peptides, with their wide range of 
activity and swift antimicrobial action, may potentially serve as alternative and/or supplementary 
antifungals. Tyrocidines, a group of cyclic decapeptides produced by Bacillus aneurinolyticus, 
have been illustrated to have significant antibacterial and antiplasmodium activity; however, 
information regarding their antifungal activity is limited. The tyrocidines may therefore be 
potential candidates to be developed as novel antifungals. 
The objective of this study was to increase our knowledge regarding the antifungal activity of the 
tyrocidines and to investigate their possible mode(s) of antifungal action. Furthermore, the 
potential of the tyrocidines to be developed into commercial bio-fungicides in the agricultural 
sector, as well as antifungal agents for the treatment of Candida albicans infections in the 
medical industry was explored.  
An overview regarding the problem of microbial resistance in both the agricultural and medical 
sector as well as a summary on antimicrobial peptides, their characteristics and antimicrobial 
activity and their potential to be the answer to the problem of microbial resistance is given in 
Chapter 1. In the five experimental chapters (Chapters 2-6) we address some of these 
themes/challenges and in Chapter 7 the outcomes of this project is discussed with 
recommendations for future studies. 
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The goal of this study was therefore to determine the antifungal activity of the tyrocidines, the 
structural and environmental modulators of tyrocidine antifungal activity and possible mode(s) 
of tyrocidine antifungal action. The aims to meet this goal were: 
1. The purification and analysis of tyrocidines from the tyrothricin complex of Bacillus 
aneurinolyticus and the culture medium of Brevibacillus parabrevis ATCC 8185 (study 
presented in Chapter 2); 
2. Development and optimisation of antifungal assays for optimum tyrocidine activity 
(study presented in Chapter 3);  
3. Determine the antifungal activity of the tyrocidines against a range of phytopathogens 
and the influence of environmental composition on their antifungal activity (study 
presented in Chapter 4);  
4. Investigate the possible mode(s) of antifungal action employed by the tyrocidines (study 
presented in Chapter 5); and 
5. Investigate the activity of the tyrocidines against Candida albicans and its biofilms 
(Chapter 6). 
The experimental chapters 2-6 in this thesis were, to some extent, written as independent units so 
as to facilitate future publication. Although this led to some repetition, every attempt was made 
to keep this to a minimum.  
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Chapter 1 
Literature Review: Antifungal Peptides 
1.1 Introduction 
In recent years a disturbing trend of fungal pathogen resistance against conventional antifungal 
compounds has been observed. This phenomenon has been reported for both the agricultural (1, 
2) and medical (3-6) industries. The agricultural sector is afflicted by various fungal plant 
pathogens that infect a wide spectrum of crops which ultimately leads to significant losses in 
annual food yields. The medical industry is also plagued by mainly opportunistic fungal 
pathogens, which target immune-compromised individuals. The widespread use of broad 
spectrum antibiotics is the main culprit behind the rise in microbial resistance (1, 2, 7, 8). The 
development of novel antimicrobials, with novel modes of action, is therefore essential in both 
the agricultural and medical sector. 
A natural, bio-degradable group of antibiotics is omnipresent in nature. These antibiotics 
comprise predominantly of antimicrobial peptides (AMPs) which are produced in almost every 
organism and tissue providing first line of defence against various infections and competing 
microorganisms such as bacteria, fungi, parasites and viruses (9-11). The structures of AMPs are 
just as diverse as their origins: AMPs can be divided into linear peptides which form 
amphipathic and hydrophobic helices, -sheet peptides, peptides with a mixture of -helices and 
-sheets, modified peptides, cyclic peptides, lipopeptides and peptides rich in certain amino 
acids (12). Even though membrane interaction is integral to antimicrobial activity, 
additional/alternative modes of action for microbial inhibition have been illustrated (13). With 
the escalating problem of microorganisms exhibiting resistance against conventional antibiotics, 
there is increasing interest in the potential of antimicrobial peptides to serve as novel antibiotics 
(12). As a result of the wide range of inhibitory mechanisms exhibited by AMPs, they have less 
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likelihood of inducing de novo resistance in target microorganisms (9). Their selectivity, rapid 
action and low likelihood of inducing resistance make AMPs ideal candidates for 
novel/templates for novel antimicrobials (14). 
Bacillus aneurinolyticus produces a complex of potent antibiotic peptides called the tyrothricin 
complex. Tyrothricin was one of the first clinically utilised antibiotic preparations (15). 
Tyrothricin can be separated into two fractions. The one fraction contains neutral, linear 
pentapeptides the gramicidins (unrelated to the cyclic gramicidin S). The other fraction contains 
the tyrocidines, basic cyclic decapeptides (16, 17). Since their discovery in 1939 (18) the 
tyrocidines have been shown to be active against various microorganisms including bacteria (17-
19) and the parasite responsible for malaria, Plasmodium falciparum (20). Except for one study 
that has been conducted on the activity of tyrothricin (the tyrocidine-gramicidin metabolite 
complex of B. aneurinolyticus) against Candida albicans (21) and one report on the activity of 
tyrocidines against Neurospora crassa (22) the antifungal activity of tyrocidines has not yet been 
fully explored. 
1.2 Fungal pathogens 
1.2.1 Fungal pathogens of fruits in agriculture 
According to the United Nations (UN) Populations Division we have a population of around 7.16 
billion people. In the UN Food and Agriculture Organisation’s State of Food Insecurity in the 
World (SOFI) report of 2013 it was revealed that the basic income of 0.84 billion people lie 
under the breadline which in essence means that approximately 12 % of the world population is 
starving. Furthermore, around a third of the annual global food production is wasted (SOFI 
2013). Microorganisms, including fungal pathogens, are partly responsible for this wastage 
causing a loss of up to 16 % of the annual food production (23). 
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Furthermore, some fungal species secrete mycotoxins which can be toxic, as well as mutagenic 
with long term exposure, when ingested by humans and animals (24, 25). For example, the 
mycotoxin ochratoxin A is a nephrotoxin and possibly also a human carcinogen with neurotoxic 
and genotoxic properties (26). 
Various plant species, including vegetables and fruits, are affected by the necrotrophic fungus 
Botrytis cinerea (27). Grapes, one of South Africa’s most prized commodities, are a well-known 
target of B. cinerea (28, 29). Various factors make the control of B. cinerea a challenge. B. 
cinerea has a diverse host range, mechanisms of attack and it also has an astonishing capacity for 
survival (27). Penicillium spp. (30-32) and Aspergillus spp. (33) are further examples of post-
harvest fungal infections that are a big problem in especially the grape and fruit industry (34). 
Aspergillus and Penicillium strains are believed to be the main culprits in the production of 
ochratoxin A in especially wine and red grape juice (26). 
Fusarium species are predominantly soil fungi. They can survive in various climates ranging 
from tropical to arctic regions (35). Accordingly they infect a wide range of crops, in some 
instances opportunistic human pathogens have even been isolated (36), and resultantly lead to 
significant losses in yields and concurrent economic damages (37). Fungal spores can survive in 
contaminated soil for years infecting plants through their roots and vascular wounds (38). 
Fusarium species also secrete harmful mycotoxins (39, 40). These fusaric acids have numerous 
pharmacological implications in that they influence the functioning of both the brain and pineal 
neurotransmitters and metabolites (41). 
Cylindrocarpon species are another group of economically significant fungal pathogens. They 
induce black foot disease in grape vines that lead to necrotic root lesions and necrosis of wood 
tissue. These pathogens are notably a problem in grapevine nurseries and young vineyards (42). 
Black foot disease is responsible for the reduction or loss in yield and the decline or death of 
young infected vines. Stunting phenotype and an incapability to carry fruit are symptoms of 
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older vines that have been infected with black foot disease. The incapability of infected vines to 
deliver yields leaves farmers with no choice but to replant the vines which entail further financial 
and production loss. However, the chance of the new vines also being infected is substantial as 
the major source of the problem is contaminated nurseries. Less than 50% of the cultivated plant 
material from nurseries leads to the production of healthy replantable vines (43). 
Conventionally these pathogens are controlled with chemical fungicides. However, this 
widespread, prolonged and frequently excessive use of chemical fungicides often results in the 
target pathogens developing resistance against the chemicals (1, 2, 44). For example, B. cinerea 
that infects cyclamen developed resistance to benomyl, methyl-thiophanate and furidazol (45). A 
study on B. cinerea isolated from vegetable crops showed 61.8% frequency resistance against 
bezimidazole, 18% against dicarboximide, 49.1% against pyrimethanil and 57.4% against 
cyprodinil (46). Grape isolates of B. cinerea also show resistance to fenhexamid (47, 48), 
anilinopyrimidines (48, 49), fludioxonil (48), hydoxyanilides and phenylpyrrole derivates (49). 
Resistant strains of Fusarium against benomyl and thiophanate-methyl have been isolated (50).  
Fungicide resistance in Penicillium strains have also been observed. For instance Penicillium 
digitatum, cause of citrus green mould, resistant to imazalil, thiabendazole and sodium ortho-
phenylphenate have been isolated (44). 
Of even greater concern is the increasing evidence of the detrimental effect these chemicals have 
on the biosphere (2, 51). Furthermore, regulatory standards are progressively decreasing the 
acceptable amount for chemical residues in/on crops and their products. Additionally, importing 
markets and consumers are also increasingly demanding products with lower pesticide levels (2). 
Therefore there is a growing need for novel fungicides which will not only protect precious 
agricultural produce, but which will also have reduced risks of inducing target cell resistance 
and, most important of all, will not have harmful effects on the environment and consumers. 
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1.2.2 Human fungal pathogens 
An alarming escalation in fungal infections has been observed in the past two decades. Not only 
was there a rise in the frequency of infections, but also in variety of fungal isolates from 
infections (3). Furthermore, the widespread use of broad spectrum antibiotics (52) together with 
the growth in immune compromised individuals such as AIDS and cancer patients and recipients 
of organ transplants or medical devices (3-5, 52-54) immune-suppression, chemotherapy and 
radiotherapy (3, 6) has inter alia led to growing resistance against conventional antifungal drugs 
(3-6). Aspergillus spp. (55, 56), such as A. terreus, A. niger, A. flavus (55) and A. fumigates,- the 
most commonly isolated specie from aspergilloses (55, 56), are frequently the culprits behind 
these infections. Invasive Aspergillus infections, which usually result from solid organ 
transplants, are quite serious and are associated with a 100% mortality rate (7, 57). Candida spp., 
of which C. parapsilosis accounts for 20-40% (of all Candida specie infections), C. tropicalis 
(10-30%), C. krusei (10-35%) and C. glabrata (5-40%) (58) and C. albicans (50%) (7, 55), in 
particular lead to serious infections and is recognised as one of the major causative agents of 
nosocomial infections (59, 60) and, with a mortality rate of approximately 40%, invasive 
Candida infections, such infections are a serious medical concern (7, 52, 61, 62). In recent years 
there has also been a rise in Fusarium spp. as new opportunistic human pathogens (63). After 
Aspergillus spp., Fusraium spp. are the most frequent filamentous pathogens in high risk 
patients. Fusarium solani is the most commonly isolated from infections contributing to almost 
50% of Fusarium infections. Other opportunistic Fusarium species include F. oxysporum, F. 
moniliforme and F. verticilloides (64).  
The focus of this study will be on Candida albicans and its biofilms as human pathogen. C. 
albicans is the most commonly isolated species from Candida infections and is able to 
efficiently infect various sites in humans, from cutaneous sites such as the skin to deep tissue and 
organs (52, 65).  The ability of C. albicans to form biofilms on especially medical implants and 
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indwelling medical devices increases the seriousness/significance of their infections (52, 66) and 
is usually the culprit behind the instigation of candidiasis (59, 67, 68). 
The ability of fungi and bacteria to form biofilms, a microbial community embedded in a 
polymeric matrix (6, 59, 60, 69), increases their resistance to antibacterial treatments (66). The 
exopolymeric matrix (EPM) that are secreted and formed by biofilms acts as a protective barrier 
against antifungal compounds, host immune factors (70), phagocytosis (71) and physical 
disruptions (52). The composition of the EPM depends on the species involved, but 
polysaccharides, chitins and proteins have been identified as general constituents of EPM’s (52, 
72, 73). Planktonic cells are therefore more vulnerable to antifungal action than their biofilm 
counterparts. Although the degree of resistance vary among clinical isolates, Candida biofilms 
can be 30 to 2000 times more resistant than planktonic cells against antifungal compounds such 
as fluconazole, ketoconazole and amphotericin B (52). The increased resistance of biofilms has 
been ascribed to various factors including decreased growth and/or altered metabolic activity of 
biofilm cells, physical barriers preventing the penetration of antifungal compounds and the 
existence of persisters (52, 74). These microbial communities can grow on various surfaces from 
biotic (mammalian tissues) to abiotic (synthetic polymers and indwelling medical devices) (75-
77). A mature biofilm can serve as an inexhaustible source of detaching yeast cells that can cause 
fungemia and systemic infection in an individual (52). Biofilms result in significant hygiene 
problems in both the food industry and medical field (78). 
Treatment of fungal infections is complicated since among the currently available antimycotics 
some are associated with harmful side-effects, can only be administered intravenously and/or 
pathogens have developed resistance against them (7, 54). Azole-derived antifungals are 
predominantly used in the treatment of aspergilloses (79, 80). However, the first resistant strain 
was isolated in 1999 and since then of resistance has increased drastically. In a study of 
itraconazole resistant A. fumigates strains cross-resistance to voriconazole and posaconazole was 
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observed (79). In addition to azoles being used for the treatment of chronic aspergilloses and 
over long periods, they are also used in agriculture. Azole-resistant Aspergillus strains have been 
isolated azole naïve patients, in azole exposed patients and in the environment (80). Azole 
resistance and cross-resistance is therefore a growing concern in the treatment of aspergilloses 
(79). Azole resistance in C. albicans is also a major concern. Fluconazole, with relatively low 
toxicity and with bio- availability greater than 90% after oral administration, has also been used 
extensively to treat a wide range of Candida infections. However, resistance or total failure of 
fluconazole treatment has been reported on several occasions (81). Mechanisms for fluconazole 
resistance include multidrug efflux pumps (82) and changes in phospholipids and the membrane 
sterol composition (83). C. albicans resistance to amphotericin B is acquired through mutations 
in ERG3, which lowers the concentration of ergosterol in the cell membrane. This mutation can 
also confer resistance to azoles and vice versa (83, 84). Thus far limited clinical resistance to the 
echinocandins has been reported. This may either be the result of limited use to date, or that 
resistance events are rare. However, the echinocandin-resistant C. albicans isolates that have 
been isolated have point mutations in their (1,3)-β-glucan synthase subunit Gsc1p (84). 
The seriousness of fungal resistance is augmented by the fact that there is a limited variety of 
antifungal drugs classes available for treatment (84). Unfortunately numerous attempts to 
identify and develop novel antifungal compounds have been impeded by the fact that the 
majority of compounds that exhibit antifungal activity concurrently exhibit toxicity to 
mammalian cells (85). It has also been observed that under certain circumstances  antifungal 
compounds and biofilm-specific antibodies act antagonistically (86).  
It is therefore crucial that novel antifungal compounds with especially anti-biofilm action and 
low mammalian toxicity, be developed. 
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1.3 Antifungal peptides 
Within the large family of AMPs, there are peptides with the ability for antifungal activity. 
Antifungal peptides come from various sources, including humans, insects and bacteria, and 
have diverse structural motifs (Table 1.1). This trend of diversity continues through to the 
antifungal peptides’ mode of action. Their activity may either be membrane active, disrupting the 
outer membrane, or they may bind to a specific intracellular target (87). 
1.3.1 Sources of antifungal peptides 
As is the case with AMPs as a group, antifungal peptides can be found in diverse sources which 
include mammals, amphibians, insects, plants, bacteria and other fungi. The iturin and 
bacillomycin families, produced by the soil bacterium Bacillus subtilis, were among the earliest 
antifungal peptides to be discovered (87, 88). Gramicidin S, a cyclic decapepide produced by 
Brevibacillus brevis and polymyxin B, produced by Bacillus polymyxa, were illustrated to have 
significant activity against B. cinerea (89). Another Bacillus specie, B. licheniformis, produces 
the chitin binding peptide CB-1 which exhibits activity against F. oxysporum (90). Members of 
the Pseudomonas syringae pv. syringae also produces small cyclic lipodepsipeptides known as 
syringomycins (87, 91). Other antifungal peptides produced by bacteria include the powerful 
nikkomycins produced by Streptomyces tendae, which inhibit chitin biosynthesis (87, 92), the 
cepacidines, glycopeptides from Burkholderia cepacia (87, 93) and surfactin, also produced by 
B. subtilis (94).  
Antifungal peptides produced by fungi are some of the most potent fungicides. Unfortunately 
these peptides are predominantly haemolytic (87). Selected peptides produced by fungi have 
been chemically modified to decrease their harmful side-effects (95). Work has been done on the 
echinocandins, peptides produced by A. nidulans and A. rugulosus, and pneumocandins, peptides 
from Zalerion arboicola, in order to decrease their haemolytic effect and increase their 
fungicidal properties (87).  
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Table 1.1 Examples of antifungal peptides from various sources, their structures and their antifungal activity. 
Producer/Source Peptides Structure Selected target organisms Mode of action 
Bacterial peptides         
Bacillus subtilis Iturin A lipopeptide Saccharomyces cerevisiae lytic 
 
Bacillomycin F lipopeptide Aspergillus niger lytic 
Pseudomonas syringae Syringomycin E lipodepsipeptide 
Aspergillus fumigatus, A. niger, Fusarium 
moniliforme, F. oxysporum 
lytic 
 
Syringostatin A lipodepsipeptide Candida albicans, A. fumigatus lytic  
 
Syringotoxin B lipodepsipeptide Candida albicans, A. fumigatus lytic  
Burkholderia cepacia Cepacidines glycopeptides A. niger, F. oxysporum unknown 
Streptomyces tendae Nikkomycin X peptidyl nucleoside 
Coccidiodes immitis, Blastomyces 
dermatitidis 
chitin synthesis 
 
Nikkomycin Z peptidyl nucleoside 
Coccidiodes immitis, Blastomyces 
dermatitidis 
chitin synthesis 
Bacillus brevis Gramicidin S cyclodecapeptide C. albicans lytic 
Lactococcus lactis Nisin lantibiotic   
 Mersacidin    
Fungal peptides 
Aspergillus rugulosus Echinocandin B cyclic lipopeptide C. albicans glucan synthesis 
Zalerion arboicola Pneumocandins lipopeptide Pneumocystis carnii glucan synthesis 
Aspergillus aculeatus Aculeacin lipopeptide C. albicans glucan synthesis 
Aspergillus syndowi var. mulundensis Mulundocandins lipopeptides A. niger glycan synthesis 
Coleophoma empetri WF11899 A, B and C lipopeptides C. albicans glucan synthesis 
Aureobasidium pullulans Aureobasidin A cyclic depsipeptide C. albicans actin assembly 
Plant peptides 
Zea mays Zeamatin 
 
C. albicans 
membrane 
permeabilisation 
Nicotiana alata NaD1 
 
F. oxysporum unknown 
Dahlia merckii DmAMP1  S. cerevisiae membrane 
Raphanus sativus RsAFP2  C. albicans apoptosis 
Pisum sativum Psd1  Neurospora crassa cyclin F 
Phaseolus vulgaris PvD1  C. albicans, F. oxysporum 
membrane, 
apoptosis 
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Producer/Source Peptides Structure Selected target organisms Mode of action 
Insect peptides 
Hyalopora cecropia Cecropin A and B linear peptides F. oxysporum, A. fumigatus lytic 
Drosophila melanogaster Drosomycin 
44 amino acid 
cysteine rich peptide 
F. oxysporum lytic 
Podisus maculiveris Thanatin 
21 amino acid 
cysteine rich peptide 
F. oxysporum, A. fumigatus unknown 
Bee Melittin α-helix C. albicans permeabilisation 
Amphibian peptides 
Phyllomedusa sauvagii Dermaseptins β-sheet F. oxysporum, A. fumigatus lytic 
Xenopus laevis Magainin 2 α-helical C. albicans lytic 
 Buforin, buforin II    
Mammalian peptides 
Human neutrophils HNP-1 
30 amino acid 
cysteine rich peptide 
C. albicans lytic 
 
HNP-2 
29 amino acid 
cysteine rich peptide 
C. albicans lytic 
 
HNP-3 
30 amino acid 
cysteine rich peptide 
C. albicans, C. neoformans lytic 
Rabbit neutrophils Np-1 
33 amino acid 
cysteine rich peptide 
A. fumigatus lytic 
 
NP-2 
33 amino acid 
cysteine rich peptide 
A. fumigatus lytic 
 
NP-3a 
24 amino acid 
cysteine rich peptide 
A. fumigatus lytic 
Bovine epithelial cells 
Tracheal antimicrobial 
peptide 
38 amino acid 
cysteine rich peptide 
C. albicans lytic 
Chicken leukocytes 
Gallinacin-1, 
gallinacin-1α 
39 amino acid lysine 
and arginine rich 
peptide 
C. albicans lytic 
Human LL-37 (hCAP18) α-helix C. albicans lytic 
Bovine BMAP-28    
Human hBD-1    
 Brevinin-1 α-helix Batrachochytrium dendrobatidis lytic 
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V-echinocandin (LY303366), with a substitution of its cyclic peptide ring, and caspofungin (MK-
0991), with a long akyl N-acyl substitution, have both undergone successful clinical trials and were 
effective against esophageal candidiasis (87). 
Plants are also rich sources of antifungal peptides that inhibit both plant and human fungal 
pathogens (96). RsAFP2 and HsAFP1, respectively isolated from Raphanus sativus and Heuchera 
sanguinea, are both peptides active against C. albicans (97, 98). Dahlia merckii produces the plant 
defensin DmAMP1 which inhibits Saccharomyces cerevisiae (96). A potent plant defensin from the 
ornamental tobacco Nicotiana alata, NaD1, inhibits 50% of Fusarium oxysporum and F. 
graminearum growth at a concentration of 2.5 µM (99). 
The mammalian immune system also produces potent antifungal peptides. The α-defensins are 
produced by neutrophils and intestinal Paneth’s cells. HNP-1 and HNP-2, produced by human 
neutrophils (100), and NP-1, NP-2 and NP-3, produced by rabbit neutrophils (101), are deadly to C. 
albicans. Epithelial cells are mainly responsible for the production of β-defensins. Tracheal 
antimicrobial peptide (TAP), a cysteine rich β-defensin, were active against C. albicans (MIC of 25 
µg/mL) (87). The epithelial cells, together with neutrophils and macrophages, also produce the 
cathelicidin peptides (102). The human cathelicidin LL-37 and mouse cathelicidin mCRAMP 
exhibited activity against C. albicans (103). 
Antifungal peptides have also been isolated from insects and amphibians. The giant silk moth, 
Hyalopora cecropia, produces linear lytic peptides the cecropins (104). These cecropins were able 
to kill 95% of F. oxysporum and Aspergillus fumigates at concentrations of respectively 12 and 9.5 
µg/mL (87). Brevinin-1BYa, a peptide isolated from the skin of the yellow-legged frog Rana boylii, 
exhibited significant activity against C. albicans characterised by a MIC of 3 µM. Unfortunately 
this peptide is also quite haemolytic (HC50 = 4 µM) (105). 
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1.3.2 Antifungal peptide activity 
Previously antifungal peptides were divided into two broudgroups based on their effect on fungal 
morphology. If the peptides induce changes in the morphology, e.g. induce hyperbranching, they 
were classified as morphogenic, while non-morphogenic peptides do not lead to any significant 
morphological changes in the fungi even though they inhibit fungal growth (106). Although this 
classification is very broad it is still useful to classify new peptide candidates into one of the broad 
catogories.  
The inhibition of fungal growth can be achieved via various mechanisms of action. There are three 
targets for AMP interaction with the target organism, namely external cell wall 
components/structures, the cell membrane and intracellular targets (2). The major or common mode 
of action for antifungal peptides is believed to be the disruption of the fungal membrane integrity 
resulting in the leakage of ions and other molecules (87). Various models have been proposed for 
the disruption of membrane integrity: the barrel-stave model, the aggregate model, the carpet model 
and the toroidal pore model (9, 14). There are also peptides that target specific non-membrane 
targets. They may influence the synthesis of important cellular components, such as cell wall 
synthesis or  chitin synthesis, they can interact with the nuclear components (87) or induce 
depolymerisation of the actin cytoskeleton (11) or interfere with cell division (9). Certain AMPs 
may also utilise various modes of action instead of just one, thereby decreasing  the possibility of 
inducing microbial resistance against them (2). 
Iturins, the small cyclic peptidolipids produced by Bacillus subtilis, affects membrane surface 
tension, which leads to pore formation with resultant ion leakage and cell death (107). Lipids that 
are predominantly found in eukaryotic membranes are phosphoglycerolipids, glycoglycerolipids, 
sphingolipids and sterols (108). A family of lipopeptides, the iturins produced by B. subtilis, form 
ionic pores in target cell membranes. These pores are believed to be the result of the formation of 
lipopeptide-sterol aggregates (109). The syringomycins, cyclic peptides produced by P. syringe, 
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interact with ergosterol in the membranes of yeast cells (87). An antifungal plant defensin from 
Dahlia merckii, DmAMP1, was shown to interact with the sphingolipid 
mannosyldiinositolphosphorylceramide (M(IP)2C) from S. cerevisiae and subsequently 
permeabilise the membrane. Mutant S. cerevisiae, lacking the gene that encodes for M(IP)2C, were 
resistant to DmAMP1. The presence of ergosterol together with M(IP)2C enhanced DmAMP1 
activity (96). RsAFP2, a defensin produced by the radish plant (Raphanus sativus), targets fungal 
sphingolipid glucosylceramide (GlcCer) as part of their action against Pichia pastoris and S. 
cerevisiae (110). Subsequent to initial interaction with GlcCer, downstream signalling pathways 
leads to the induction of reactive oxygen species (ROS) and cellular apoptosis (97, 111). The 
defensin from Nicotiana alata, NaD1, appears to use a cell wall dependant mechanism to enter 
fungal cells. Van der Weerden et al. (99) observed that NaD1 lost antifungal activity against 
proteinase K treated hyphae, pointing to the possibility that a cell wall protein is the target for NaD1 
(99).  
Pisum sativum defensin 1 (Psd1) is an example of an antifungal peptide with an intracellular target. 
Psd1 interacts with cyclin F of Neurospora crassa, a protein involved in cell cycle control. Psd1 
induces endo-reduplication, i.e. the conidial DNA increases in the presence of the antifungal peptide 
but the entire process of cell division is not completed (112). 
The activity of certain antifungal peptides have been linked to the formation of ROS (10). Certain 
antifungal compounds, such as the plant defensin RsAFP2, have been shown to inhibit C. albicans 
through the induction of endogenous ROS. In the presence of the antioxidant ascorbic acid, a 
significant loss in fungicidal activity could be observed linking the involvement of ROS induction 
to their activity against C. albicans (7, 97).  
The induction of ROS triggers programmed cell death in yeast (113) and therefore the accumulation 
of endogenous ROS in yeast cells is a phenotypical marker of the initiation of the apoptotic process 
(113, 114) and has been linked to fungicidal activity in C. albicans (114). PvD1, a defensin from 
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Phaseolus vulgaris, permeabilises fungal membranes and causes apoptosis in C. albicans and F. 
oxysporum. Disorganisation in the cytoplasm and plasma membrane of C. albicans were observed 
following treatment with PvD1. It was further illustrated that PvD1 induces the formation of ROS in 
C. albicans and F. oxysporum, and nitric oxide (NO) in C. albicans (115). The peptide histatin-5 
leads to mitochondrion depletion in C. albicans and concurrent induction of ROS (116).  
The cyclic depsipeptide aureobasidin A, produced by Aureobasidium pullulans, disrupt actin 
assembly and resulted in chitin delocalisation and loss of membrane integrity in S. cerevisiae. 
Inhibition of normal cell budding was also observed as a result of aureobasidin A action (117). 
The action of certain antifungal peptides, previously classified as morpogenic, can lead to 
hyperbranching of filamentous hyphae. This is probably due to interruption/interference with the 
fungal cell’s ability to germinate and propagate the normal growth of hyphae since similar 
symptoms of hyperbranching has been observed for fungal mutants with alterations in their ability 
to establish and maintain polar growth (118). Not every aspect of spore germination, hyphal 
elongation and lateral branching is known and understood. However, a few factors/regulators have 
been identified as probably being involved in these processes. The establishment of a polar axis, 
essential for asymmetrical growth during germination (119), is believed to be regulated by Rho-type 
GTPases (119) and cAMP signalling (120, 121). Subsequent to establishing the polar cite, hyphal 
elongation is controlled by various factors such as GTPases (119, 122), formins and septins (120, 
122), the Spitzenkorper, the microtubule cytoskeleton (122, 123) as well as actin polymerisation 
(123). Likewise the process of hyphal branching is not completely understood, but this process is 
also believed to be similarly complex. There are two proposed models for how a branching site is 
formed in hyphae. The first model is associated with septa where the septum possibly acts as an 
indicator of the region where branch formation should advance. In the second model, the “random 
pattern” model, there is evidence that GTPases (122), localised spikes in calcium (124, 125), ROS, 
as well as localised nuclear division, plays a role in temporal and spatial regulation of branch 
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formation (122). The cell cycle also seems to have a regulatory influence in some fungi on 
branching (122, 126).  
Retarded germination and hyperbranching as a result of AMP activity can be the result of 
interference with any one of the above mentioned processes or their regulators. For example 
Thevissen et al. (127) hypothesised that RsAFP2-induced septin mislocalisation results in altered 
morphology and hyperbranching of the filamentous fungus Fusarium culmorum (127). The peptide 
PAF26’s activity on Penicillium digitatum results in altered polar growth, hyperbranching and 
abnormal chitin deposition (118).  
1.3.3 The tyrocidines and analogues as potential antifungal peptides 
The tyrocidines and analogues, β-sheet cyclic decapeptides produced by B. aneurinolyticus as part 
of its secondary metabolite complex namely tyrothricin (tyrocidine-gramicidin complex) are the 
focus of this study. (16, 17). The primary structure of 28 natural tyrocidines has been determined by 
Tang et al. (16) (Table 1.2). The tyrocidines that principally compose the tyrocidine mixture, 
tyrocidine A1, A, B1, B, C1 and C, are referred to as the major tyrocidines. The tyrocidine analogues 
are those peptides that are present in lower quantities when naturally produced by B. 
aneurinolyticus  (16). Phenycidine A (PhcA) and tryptocidine C (TpcC) are the two analogues 
selected for this study. The tyrocidines and their analogues are highly conserved in their amino acid 
sequence. With the basic sequence of cyclo[f1P2X3x4N5Q6Y7V8X9L10] the major tyrocidines 
relevant to this study only vary in the amino acid residue positions Trp3,4/Phe3,4 or Lys9/Orn9 and 
the analogues in the amino acid residue position Tyr7/Phe7/Trp7 (also refer to Figure 1.1). 
Tyrocidine A has been illustrated to have an antiparallel β-sheet structure (128). Gramicidin S (GS), 
with the sequence cyclo[VOLfPVOLfP], share 50 % sequence homology with some of the 
tyrocidines. Similar to the tyrocidines, GS is a β-sheet cyclic decapeptide which assumes similar 
backbone conformations/molecular topologies to the tyrocidines (129). GS has been illustrated to 
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have significant antifungal activity (130-132) and also to disrupt the integrity of membranes (130, 
133-135). GS was therefore also included in this study for comparison purposes.  
Subsequent to the discovery of the tyrocidine containing tyrothricin more than 70 years ago, Dubos 
and Hotchkiss (17) demonstrated that the tyrocidines possess noteworthy antibacterial activity. 
Since then the tyrocidines have been illustrated to exhibit activity against various other organisms. 
Spathelf and Rautenbach (19) explored tyrocidines’ potential to serve as therapeutic agents and bio-
preservatives. The six major tyrocidines, tyrocidine A1, A, B1, B, C1 and C exhibited inhibitory and 
membranolytic activity toward the Gram-positive bacteria, Micrococcus luteus and Listeria 
monocytogenes. This significant activity was not, however, observed for Escherichia coli, the 
Gram-negative representative. 
 
Figure 1.1: The primary structure of tyrocidine A (TrcA). The amino acid residues in variable 
positions 3, 4, 7 and 9 are indicated. Details on the primary structures of the different 
tyrocidines are given in Table 1.2. 
Rautenbach et al. (20) established that the tyrocidines exhibit significant antimalarial activity. The 
six major tyrocidines also exhibited significant activity against P. falciparum with IC50’s (peptide 
concentration resulting in 50% inhibition) < 500 nM. The concentrations where haemolysis was 
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observed were considerably higher and less variable than the IC50’s. This high activity and 
selectivity of the tyrocidines make them potential templates for anti-malarial drug design (20). 
Except for a study illustrating the ability of the tyrocidines to inhibit Neurospora crassa (22) and a 
study on the activity of tyrothricin (the tyrocidine-gramicidin complex produced by B. 
aneurinolyticus) against C. albicans (21), limited research has been conducted on the antifungal 
activity of the tyrocidines and their analogues. 
Even though there is abundant evidence that the tyrocidines are membrane active (19, 136), there 
has also been results hinting/suggesting that the tyrocidines have additional/alternative mode(s) of 
action. Dubos (18) showed that even though the tyrocidines caused lysis of bacterial cells, this lysis 
was a secondary process as a result of a primary action, presumably inactivation of the glucose 
dehydrogenase system of the bacterial cell (18). Spathelf and Rautenbach (19) illustrated in 2009 
that the antilisterial activity of the tyrocidines are, to a certain extent, as a result of a membranolytic 
mechanism of action. However, since the individual peptides had differing degrees of growth 
inhibition, even though their lytic rates were comparable, they proposed that there are additional 
factors(s) to membrane lysis that leads to cell death (19). This hypothesis is supported by the results 
of Spathelf (129) and Leussa (137) which indicates that the presence of Ca2+ promotes a non-lytic 
mode of antibacterial action in the tyrocidines. During their investigation of the tyrocidines’ 
antimalarial activity, Rautenbach et al. (20) discovered, that despite their significant antimalarial 
activity, the tyrocidines did not induce noteworthy cell leakage. Nonetheless, prominent 
modifications/alterations of the parasite development could be observed after incubation with the 
tyrocidines. Definite conclusions on the mode of action employed by the tyrocidines against P. 
falciparum could not be made, but the investigators did suggest the disruption of the parasite cell-
cycle development by the tyrocidines (20). Furthermore, the tyrocidines have also been shown to 
act as repressors of transcription through the interaction with the DNA of B. brevis (138-140) and to 
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inhibit β-galactosidase and acetylcholinesterase activity (141). Therefore the possibility exists that 
the tyrocidines may have additional/alternative mode(s) of action to that of membrane interaction. 
Table 1.2: Structures and abundance of 28 tyrocidine and analogous peptides identified by Tang et 
al. (16).  
Nr Identity Abbreviation Sequence Mr Abundance 
1 Tyrocidine D* TrcD VOLfPYwNQY 1324.7 2.1 
2 Tyrocidine D1* TrcD1 VKLfPYwNQY 1338.7 1.7 
3 – – VOLyPWwNQY 1363.7 <1 
4 Tyrocidine E'* TrcE VOLfPFyNQY 1285.7 <1 
5 Tyrocidine E1'* TrcE1 VKLfPFyNQY 1299.7 <1 
6 Tyrocidine C TrcC VOLfPWwNQY 1347.7 100 
7 Tyrocidine C1 TrcC1 VKLfPWwNQY 1361.7 30 
8 Tryptocidine C TpcC VOLfPWwNQW 1370.7 23 
9 Tryptocidine C1* TpcC1 VKLfPWwNQW 1384.7 2.3 
10 Tyrocidine B'* TrcB' VOLfPFwNQY 1308.7 14 
11 Tyrocidine B1'* TrcB1' VKLfPFwNQY 1322.7 5.8 
12 Tyrocidine B TrcB VOLfPWfNQY 1308.7 109 
13 Tyrocidine B1 TrcB1 VKLfPWfNQY 1322.7 44 
14 Tryptocidine B TpcB VOLfPWfNQW 1331.7 26 
15 Tryptocidine B1* TpcB1 VKLfPWfNQW 1345.7 13 
16 Tyrocidine A TrcA VOLfPFfNQY 1269.7 88 
17 Tyrocidine A1 TrcA1 VKLfPFfNQY 1283.7 39 
18 Tryptocidine A TpcA VOLfPFfNQW 1292.7 15 
19 Phenycidine A** PhcA VOLfPFfNQF 1253.7 3.1 
20 Tyrocidine E* TrcE VOLfPYfNQY 1285.7 2.2 
21 Tyrocidine E1* TrcE1 VKLfPYfNQY 1299.7 1.1 
22 – – VOLfPF(?)NQY 1336.7 4.5 
23 – – VKLfPF(?)NQY 1350.7 9.4 
24 Phenycidine B* PhcB VOLfPWfNQF 1292.7 3.7 
25 – – (L/I)OLfPWfNQY 1322.7 1.9 
26 – – (L/I)KLfPWfNQY 1336.7 2.6 
27 – – VOLfP(L/I)fNQY 1325.7 1.2 
28 – – VKLfP(L/I)fNQY 1249.7 <1 
Conventional one letter abbreviations are used to depict peptide sequences [from Tang et al. (16)], except for ornithine 
that is represented by O. D-amino acid residues are indicated by lower case abbreviations.  
The abundance of the tyrocidines is expressed relative to that of tyrocidine C.  
Peptides marked with * were named by our group; ** renamed from tyrocidine E.  
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1.4 Factors influencing peptide activity 
1.4.1 Target cell properties 
As was mentioned in section 1.3.2, AMPs may have additional targets to that of membrane 
disruption or may even have multiple modes of action. However, these AMPs must still interact 
with the cell membrane and in some cases the cell wall, to gain access to the cell interior and to act 
on intracellular targets. AMPs have the ability, to some degree, to distinguish between different 
cells on the basis of differences in their cell membranes. For example, AMPs may be able to 
distinguish between differences in the membrane architecture and composition (142-146). Although 
all bio-membranes have the lipid bilayer as foundation, bio-membranes may differ extensively in 
their structure, composition and complexity.  Different strains and growth conditions may also lead 
to diverse phospholipid compositions. Some of these membrane components may serve as targets 
for certain peptides (144-146) and can play part in microorganism specificity (144, 145, 147). 
The interaction of cationic peptides with their target cells are influenced by inter alia the following 
characteristics: 
 the lipid composition of, and the presence of sterols in, the target membrane (111, 148, 
149); 
 non-lipid components of target membrane, i.e. proteins (111); 
 the metabolic state of the target cell (150), and  
 the electrochemical potential of the membrane (151). 
However, the complexity of the membrane makes the task of pinpointing peptide binding affinity to 
one component, and the effect on the membrane as a whole, a challenging task. Nevertheless, the 
importance of characteristic lipid composition of cell membranes for individual organisms are 
acknowledged (152). The preference some peptides have for certain membrane components could 
also influence their secondary structure (144-146). 
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Furthermore, the environment/culture conditions of the fungi may influence these target cell 
properties. The nutrient and oxygen availability can influence the metabolic state of the cell. The 
water potential and salt composition of their surroundings may influence the lipid composition of 
the fungal cell membrane and the electrochemical potential. Culture and assay conditions therefore 
influence the characteristics of the target cell and consequently peptide activity. 
1.4.2 Environmental factors 
AMP activity, selectivity and their modes of antimicrobial action are influenced by their 
environment (153-156). The presence of monovalent and divalent cations, proteases and polyvalent 
anions, such as glycosaminoglycans, influence peptide antimicrobial action (10). Cations, for 
example Na+, Mg2+ and Ca2+, decrease the activity of the majority of AMPs (100, 153, 157-163). 
Various reasons have been proposed for this phenomenon. The number of available active peptides 
may decrease as a result of peptide aggregation (160), or/and the electrostatic pull between 
negatively charged target membranes and cationic peptides can be hampered (158, 160). Another 
explanation for the decrease in AMP activity is that their mode(s) of action are dependant on cation 
concentrations or that the presence of cations interfere with their target interaction (164). For 
instance certain cell processes, such as hyphal elongation, are believed to be dependant on Ca2+ 
gradients and some AMPs are thought to interfere with this Ca2+ signalling as part of their 
antimicrobial action. Evidently the environment must be taken into account when determining the 
antimicrobial/antifungal action of a peptide.  
Marques et al. (165) showed that the in vitro activity  of TrcA, one of the cyclic antifungal peptides 
investigated in our studies, was decreased in the presence of calcium (165). However, our group 
observed that the critical concentration of 7.5 mM CaCl2, increased the tyrocidines’ activity against 
L. monocytogenes. The presence of Ca2+ not only increased the antilisterial activity of tyrocidines, 
but also changed the mode of action from lytic to an alternative non-lytic mode of action (129, 137). 
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It was proposed that in the presence of 7.5 mM CaCl2 the tyrocidines form active/higher order 
structures which influences their degree of antilisterial activity as well as their mode of action (129).  
1.5 Peptide application 
1.5.1 Peptide application in the agricultural sector 
Of late there has been a trend in agricultural research to use microorganisms as an eco-friendly 
method for controlling pathogens. Microorganisms that produce AMPs have been shown to 
successfully control plant diseases, for example Bacillus subtilis B-3 and B. subtilis RB14, that 
respectively produce iturin A and iturin A and surfactin, were successful in controlling Monilinia 
fructicola (166) and Rhizoctonia solani (167). Bacillus cereus UW85 cultures and culture extracts 
inhibits damping-off (caused by Phytophthora medicaginis) of alfalfa (168). B. subtilis, with trade 
name Kodiak (Gustafson Inc) is used, in combination with chemical fungicides, to control seedling 
and root diseases. Another biofungicide, MYCOSTOP®, was developed from the antibiotic 
producing Streptomyces griseoviridis for the protection of potatoes against scab (caused by 
Streptomyces scabies) (169). Products containing Pseudomonas syringae Van Hall that is active 
against Botrytis, Penicillium, Mucor and Geotrichum species;  and Candida oleophila Montrocher, 
active against Botrytis and Penicillium spp., are also available (1). However, it is not always ideal to 
use live organisms. The growth conditions can be such that by the time the producer has reached the 
ideal growth condition for secreting AMPs, the pathogens could already have reached a growth 
state where they are strong enough to resist the AMPs and/or the pathogens have already caused a 
sufficient amount of harm to the crops. Furthermore, the inhibitory activity observed may not 
necessarily be the result of peptide production and release into the environment, but the result of 
other MOA including microbial competition (170, 171) and therefore not sufficiently reliable for 
consistent results.  In addition, a live organism can change the character of the harvest and the 
products thereof (172). Another approach is to genetically modify plants to express antimicrobial 
peptides and thereby increasing their resistance against pathogens. However, consumers’ resistance 
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to genetically manipulated (GM) products renders this strategy currently unfavourable. A solution 
to the problem is to utilise the naturally produced AMPs themselves. Cyclic peptides - primarily 
produced by ground dwelling bacteria - are, as a result of their stable nature, especially promising 
candidates. Even though they are bio-degradable, they have inherent resistance to degradation by 
proteases.  
1.5.2 Peptide application in medicine 
The pharmacologic application of AMPs has been hindered by various barriers. A large number of 
AMPs are unfortunately also toxic to human cells or they are haemolytic. Furthermore, as was 
discussed in section 1.4.2, AMP activity is influenced by their environment and therefore 
physiologic salt, pH and serum conditions may negatively influence their activity. The majority of 
peptides are also susceptible to proteolytic degradation in vivo (10, 14, 173). However, there is a 
large body of research being conducted on developing AMPs for medical/pharmaceutical 
applications with a number of peptides in advanced clinical trials and already approved for clinical 
use (Table 1.3). 
One research approach is to modify the AMP structure in order to gain a molecule with more 
favourable properties. For example the lipopeptide echinocandin B produced by A. nidulans and A. 
rugulosus inhibits the synthesis of 1,3-β-glucan and has significant activity against Candida spp. 
(MIC of 0.20-0.35 µg/mL). Unfortunately echinocandin B is also quite haemolytic and could 
therefore not be developed as a clinical antifungal agent (174). Subsequent to modifications and 
numerous screenings, cilofungin (LY121019) was selected as an echinocandin analogue with 
significantly lower haemolysis activity, but retained activity against Candida spp. and A. fumigates 
(174, 175). Unfortunately, as a result of side effects, the clinical trials of cilofungin were 
discontinued (174, 176). 
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Table 1.3: Selected examples of antimicrobial peptides in development for clinical treatment 
Company Peptide Source Clinical trial stage Application 
AM-Pharma 
hLF1-11 (based on 
Lactoferrin) 
human Phase IIa 
Systemic; transplant 
infection 
Migenix 
Omiganan (MX-
226/MBI-226) (based on 
indolicidin) 
bovine Phase III & II 
Topical; prevention 
of catheter 
infections 
Pacgen 
Biopharmaceuticals 
Corp. 
PAC-113 (based on 
histatin) 
human Phase IIb 
Oral;  
candidiasis, 
antifungal 
Pfizer 
Pharmaceuticals 
Anidulafungin 
(echinocandin B) 
Coleophoma 
empetri 
FDA and EMEA 
approved 
Systemic; 
candidemia and 
candidiasis 
Astellas 
Pharmaceuticals 
Micafungin (FR901379) 
Aspergillus 
nidulans 
FDA and EMEA 
approved 
Systemic; 
candidemia and 
candidiasis 
Merck and Co 
Caspofungin 
(pneumocandin B0) 
Glarea 
lozoyensis 
FDA and EMEA 
approved 
Systemic; 
candidemia and 
candidiasis 
MacroChem 
Pexiganan acetate (MSI-
78) (based on magainin) 
Xenopus 
laevis 
Phase III Topical; antibiotic 
Zengen 
CZEN-002 (based α-
melanocyte-stimulating 
hormone) 
human Phase IIb 
Topical; 
vulvovaginal 
candidiasis 
 
An alternative tactic to increase the therapeutic applicability and systemic uptake of AMPs is to 
apply them in formulation or delivery substrate. AMPs in a lipid-based formulation have been 
shown to exhibit increased stability and solubility, increased plasma half-life and decreased toxicity. 
Furthermore the liposomal formulation allows for measured peptide release (173). Polymyxin E 
(177) and indolicidin (178) in a liposomal formulation exhibited significant reduced toxicity 
compared to unencapsulated peptides  (177). Human serum albumin (HSA) has also been illustrated 
to be a successful carrier for AMPs, decreasing toxicity and increasing systemic distribution (173, 
179). 
Another approach is combinatorial treatment which is considered as a solution to the development 
of resistance against an individual compound. Other benefits from combinatorial treatment includes 
synergy, which not only makes lower drug dosage possible with concurrent decrease in toxicity, but 
also a wider range of activity and speedier antifungal effect (60). 
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Using the above mentioned research approaches there are a few success stories regarding AMP 
application in medicine. Micafungin (Mycamine, Astellas Pharmaceuticals), anidulafungin (Eraxis, 
Pfizer Pharmaceuticals) and caspofungin (Cancidas, Merck and Co.), semisynthetic cyclic 
lipopeptides based on echinocandins, have been clinically approved and are effective against 
Candida sp. and Aspergillus sp. infections (180). 
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Chapter 2 
Purification and analysis of the six major tyrocidines and their 
analogues 
2.1 Introduction 
The steady increase in microbial resistance against conventional chemical fungicides has created 
an urgent need for the development of novel antifungal compounds. A group of antimicrobial 
peptides, the tyrocidines, have been illustrated to have significant antibacterial and 
antiplasmodium activity; however, information regarding their antifungal activity is limited. 
Therefore the aim of this study is to investigate the tyrocidines for potential antifungal activity 
and their potential to act as novel antifungal compounds. 
The tyrocidines and analogues selected for this study are part of the secondary metabolite 
peptide complex, namely tyrothricin, produced by Bacillus aneurinolyticus. It must be noted that 
there is controversy surrounding the nomenclature of the tyrocidine producers. Upon their 
discovery the tyrocidine producers were originally referred to as the Dubos strain of Bacillus 
brevis (1). Afterwards it was illustrated that B. aneurinolyticus is a distinct group with 
comparable phenotype (2) and phylogenetics (3) to the B. brevis group. Since the taxonomical 
descriptions of B. aneurinolyticus relied on only few strains (4) the name was not included in the 
“Approved lists of bacterial names” (5). However, Shida et al. (6) have proposed a revival of the 
name B. aneurinolyticus,  but later suggested that the B. brevis cluster of bacteria be referred to 
as Brevibacillus gen. nov. and that bacteria of the  B. aneurinolyticus cluster be referred to as 
Aneurinibacillus gen. Nov (7).  For simplicity the tyrothricin/tyrocidine producers will be 
referred to as B. aneurinolyticus during the rest of this study.  
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The tyrothricin complex, which is commercially available, consists of linear gramicidins and the 
cyclic tyrocidines. In order to purify the tyrocidines, they must be extracted from the tyrothricin 
complex and separated from each other, a challenging task as a result of their highly conserved 
sequences (8). Producer strains of B. aneurinolyticus (denoted by ATCC as Brevibacillus 
parabrevis 8185) can also be induced to produce tyrothricin  (9).  
 Our group developed improved methods of culturing and supplementing the growth medium of 
B. aneurinolyticus to increase the peptide yield and also, depending on growth medium 
supplementation,  to produce only selected tyrocidines of interest (10). These advanced methods 
greatly simplified the process of peptide purification. 
In general compounds are separated from each other using their characteristic differences i.e. 
size, charge, physicochemical properties and hydrophobicity. An effective way of separating 
peptides from each other on the basis of their variances in hydrophobicity is through reverse-
phase high-performance liquid chromatography (RP-HPLC). Even though RP-HPLC is one of 
the most efficient techniques for separating peptides, the similarity of some antimicrobial 
peptides in their amphipathicity and hydrophobicity may complicate their separation. Therefore 
all aspects of the RP-HPLC setup must be taken into account. With the characteristics of the 
peptides of interest in mind the matrix, column dimensions, eluant compositions, gradient profile 
and temperature must be fine-tuned in order to separate analogous peptides (11). 
Subsequent to the production, extraction, separation and purification of the peptides, their 
identities and purities must be confirmed. Mass spectrometry is an effective analytical technique 
for determination of the identity, the elemental composition and purity of a sample based on 
molecular mass. Time-of-flight electrospray mass spectrometry (TOF-ESMS) is an extremely 
sensitive technique that has high accuracy in molecular mass determination by the generation 
and detection of multiply charged species. Ultra performance liquid chromatography (UPLC) is a 
powerful method with high resolution for separating most if not all the components in a sample. 
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UPLC-linked electrospray mass spectrometry (ESMS) provides a combination of these two 
powerful methods to determine the identity of a sample with high accuracy. 
In order to evaluate the antifungal activity of the tyrocidines, to determine any structure-function 
relationships and to investigate possible modes of action, high purity peptide preparations are 
essential. An optimised high-performance liquid chromatography (HPLC) purification method, 
developed by our group (11, 12), was utilised to separate these highly analogue peptides. The 
purity of the obtained peptide fractions was subsequently determined with UPLC and ESMS.  
2.1.1  Peptides of interest: Tyrocidines and analogues 
The antimicrobial peptides relevant to this study are selected tyrocidines and two of their 
analogues. These cyclic decapeptides are produced by Bacillus aneurinolyticus as part of a 
complex of peptides, namely tyrothricin which can be separated into two fractions. The one 
fraction contains neutral, linear pentapeptides, namely the gramicidins. The other fraction 
contains the tyrocidines which are basic cyclic decapeptides (8, 13). Tang et al. identified and 
determined the structures of 28 natural tyrocidines (8). The major tyrocidines, tyrocidine A1, A, 
B1, B, C1 and C, and the two analogues relevant to this study, phenycidine A (PhcA) and 
tryptocidine C (TpcC), are highly conserved in their amino acid sequence. With the basic 
sequence of cyclo[f1P2X3x4N5Q6Y7V8X9L10] the tyrocidines selected for this study only vary in 
the amino acid residue positions Trp3,4/Phe3,4, Lys9/Orn9 or Tyr7/Phe7/Trp7 (Table 2.1). The 
physicochemical properties of the tyrocidine peptides are therefore very similar and 
consequently the separation of these peptides can be a challenging task.  
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Table 2.1: Summary of the peptides selected for this study 
Identity Abbreviation Sequence
a
 
Theoretical 
Monoisotopic 
Mr
b
 
Major natural tyrocidines       
Tyrocidine C1 TrcC1 Cyclo-(VKLfPWwNQY) 1361.6921 
Tyrocidine C TrcC Cyclo-(VOLfPWwNQY) 1347.6764 
Tyrocidine B1 TrcB1 Cyclo-(VKLfPWfNQY) 1322.6812 
Tyrocidine B TrcB Cyclo-(VOLfPWfNQY) 1308.6655 
Tyrocidine A1 TrcA1 Cyclo-(VKLfPFfNQY) 1283.6703 
Tyrocidine A TrcA Cyclo-(VOLfPFfNQY) 1269.6546 
Natural tyrocidine analogues       
Tryptocidine C TpcC Cyclo-(VOLfPWwNQW) 1370.6924 
Phenycidine A PhcA Cyclo-(VOLfPFfNQF) 1253.6597 
Gramicidin S GS Cyclo-(VOLfPVOLfP) 1140.7059 
aConventional one-letter abbreviations are used for amino acid sequences [from Tang et al. (8)], except that O was 
used for Orn. Lower case one-letter abbreviations indicate D-amino acid residues. Identities were confirmed by our 
group (11, 12, 14).  
bThe theoretical monoisotopic Mr were calculated as the sum of the molecular weights of the constituent amino 
acids of the peptide.  
2.2 Materials 
Tyrothricin, gramicidin S (97.5 % purity according to manufacturers, 94% purity according to 
UPLC-MS, Table 2.5) the amino acids, Tyr, Phe and Trp, and trifluoroacetic acid (TFA, >98%) 
were supplied by Sigma (St Louis, USA). Brevibacillus parabrevis 8185 (referred to as Bacillus 
aneurinolyticus ATCC 8185 in this study) cultures were supplied by the American Type Culture 
Collection (Manassas, VA, USA). Lys was supplied by Merck (Darmstadt, Germany). The 
nutrient broth powder and tryptone were supplied by Oxoid (Basingstole, England) and the urea 
by ICN Biomedicals (Ohio, USA). For the TGYM medium Biolab (Wadeville, South Africa) 
supplied the peptone powder, agar powder and yeast extract. The glucose and skimmed milk 
powder were respectively supplied by Associated Chemical Enterprises (Glenvista, South 
Africa) and Clover (Roodepoort, South Africa). Merck Chemicals (Wadeville, South Africa) 
supplied the diethyl ether, acetone and sodium chloride. Acetonitrile (ACN) (HPLC-grade, far 
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UV cut-off) and methanol were obtained from Romil (Cambridge, England). The Nova-Pak® 
C18 (6 µm particle size, 60 Å pore size, 7.8mm × 300mm) semi-preparative and Nova-Pak® C18 
(5 µm particle size, 60 Å pore size, 150mm × 3.9mm) analytical HPLC columns were supplied 
by Millipore (Milford, USA). Biotage (Uppsala, Sweden) provided the Isolute-XL C8 column. 
Analytical grade water was prepared by filtering water from a reverse osmosis plant through a 
Millipore Milli-Q® water purification system (Milford, USA). 
2.3 Methods 
2.3.1 Purification of the tyrocidines from commercial tyrothricin 
The mixture of tyrocidine peptides were isolated from a commercial tyrothricin complex using 
an adapted organic extraction method (13). The dry tyrothricin powder (520 mg) was washed 
three times with ether:acetone (1:1, v/v). The pellet, which was collected via centrifugation (5 
minutes at 1.3 g) and dried under vacuum, contained a mixture of tyrocidines and their 
analogues (referred to as Trc mixture). In order to determine the purity of the Trc mixture – in 
terms of its tyrocidine content – the sample was analysed using semi-preparative RP-HPLC and 
UPLC linked to ESMS.  With the aim of separating the individual tyrocidines from each other, 
the crude Trc mixture was dissolved in methanol:water (1:1, v/v) (10 mg/mL) and separated by 
semi-preparative RP-HPLC, using a Nova-Pak® C18 (6 µm particle size, 60 Å pore size, 7.8 mm 
× 300 mm) semi-preparative HPLC column. Two Waters 510 pumps, controlled by MAXIMA 
software, comprised the chromatographic system and the injections were controlled manually. 
Results were monitored with a Waters 440 detector at 254 nm. An eluant A (0.1% TFA in water, 
v/v) and eluant B (10% A in 90% acetonitrile, v/v) were used to create a gradient of decreasing 
polarity at 35˚C (Table 2.2) (12, 15). For the semi-preparative RP-HPLC the flow rate was 3 
mL/min and the injection volume was 100 µL of 10 mg/mL crude tyrocidine mixture in 
methanol:water (1:1, v/v). Certain fractions required further purification on a reverse-phase 
analytical C18 Nova-Pak
® column (5 µm particle size, 60 Å pore size, 150 mm × 3.9 mm). The 
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chromatographic system comprised of two Waters 510 pumps, a Waters 717 Plus Autosampler 
and a Waters 440 detector (set at 254 nm). The whole system was controlled by Millennium32 
software. Although the same solvent gradient (Table 2.2) and temperature was applied, the flow 
rate had to be decreased to 1 mL/min. The sample volume and concentration per run was also 
decreased to respectively 50 µL and 1 mg/mL in methanol:water (1:1, v/v). 
Table 2.2: HPLC gradient program used for peptide purification and analysis 
 
Time (min) % Eluant Aa % Eluant Bb Curve type 
0.0 50 50 
 
0.5/1.0c 50 50 6 (linear) 
23.0 20 80 5 (curve) 
24.0 0 100 6 (linear) 
26.0 0 100 6 (linear) 
28.0 – – – 
30.0 50 50 6 (linear) 
35.0 50 50 6 (linear) 
aEluant A was 0.1% TFA in water  
bEluant B was 10% A in acetonitrile  
c0.5 min for semi-preparative RP-HPLC, 1.0 min for analytical RP-HPLC 
 
2.3.2 Production of peptides through Brevibacillus aneurinolyticus 8185 
For the production and isolation of tyrocidines and their analogues from B. aneurinolyticus 8185 
culture medium, B. aneurinolyticus 8185 was pre-cultured from lyophylised stocks in TGYM 
(0.5% tryptone, 0.1% glucose, 0.3% yeast extract, 0.05% methionine, pH 7.0), shaking at 220 
rpm at 37˚C. After 24 hours this pre-culture medium was added to nutrient broth (NB, 0.1% meat 
extract, 0.2% yeast extract, 0.5% peptone, 0.8% sodium chloride) supplemented with urea and 
the relevant amino acids (Table 2.3) (10). Subsequent to a second incubation step of 36 hours 
shaking at a slant (220 RPM) at 37˚C, the medium was acidified to a pH of 4.7 and left for 24 
hours at 37˚C. In order to isolate the tyrocidines, the media was centrifuged (2200g at 4˚C), the 
precipitate washed three times with methanol and lastly dried with nitrogen gas. The crude 
samples were dissolved in 50% ACN to a concentration of 5 mg/mL and then eluted on an 
Isolute-XL C8 column (500mg/10mL) (Biotage, Sweden) equilibrated in 50% ACN. After 
sample addition, the C8 column was washed two times with 50% ACN to remove contaminants. 
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Thereafter eluant B (Table 2.2) was used to elute the peptides from the column. The peptides 
were then purified following the same protocol as for the commercial tyrocidines. Semi-
preparative RP-HPLC on a Nova-Pak® C18 (6µm particle size, 60 Å pore size, 7.8 mm × 300 
mm) semi-preparative HPLC column was performed with an identical solvent gradient program 
(Table 2.2). The injection volume and concentration of 100 µL of a 10 mg/mL solution 
(methanol:water, 1:1,v/v) also remained constant. 
Table 2.3: Urea and amino acid supplementation of growth medium 
Peptide of 
interest 
 Supplement 
 
% Urea 
 
% Lys 
 
% Phe 
 
% Tyr 
 
% Trp 
TrcA+PhcA  0.1  0.5  0.5     
  0.1    0.5     
TrcA  0.1  
 
 0.5  0.5  
 TpcC  0.1  
 
 
 
 
 
 0.3 
The nutrient broth for Brevibacillus aneurinolyticus 8185 was supplemented with urea and different amino acids so 
as to obtain the peptides of interest (10). 
2.3.3 Analysis of the purified tyrocidines 
With the purpose of confirming the identity and determining the purity of the peptide fractions, 
each fraction was analysed using UPLC and TOF-ESMS. Direct injection TOF-ESMS analyses 
were performed on a Waters Q-TOF Ultima mass spectrometer fitted with an electrospray 
ionisation source. The peptide samples (3 µL of 200 µg/mL in acetonitrile/water, 1:1, v/v) were 
injected into the ESMS and subjected to a capillary voltage of 3.0 kV. The source voltage was 15 
V and the temperature 120˚C. Data was collected in the positive mode by scanning over an m/z 
range of 300-2000. For UPLC 3 µL peptide sample in water was chromatographed on an 
Acquity UPLC® BEH C18 column at a flow rate of 0.450 mL/min, using a 0.5 %
1 formic acid (A) 
to acetonitrile (B) gradient (100% A from 0 to 0.5 minutes, 0 to 58% B from 0.5 to 12 minutes 
and then 58 to 90% B from 12 to 13 minutes). In-line ESMS analysis of the analytes separated 
via UPLC was done with same settings as for the direct injection of peptide samples. 
                                                          
1
 1.0% Formic acid for UPLC of TrcB1 sample. 
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2.4 Results and Discussion 
2.4.1  Tyrocidines purified from commercial tyrothricin 
Tyrocidines C1, C, B1, B and A1 were purified from the commercial tyrothricin complex. A yield 
of 67.3% (350 mg) was obtained for the crude mixture of tyrocidine peptides through organic 
extraction from the tyrothricin complex. This is consistent with the 40:60 ratio of gramicidin to 
tyrocidine found in literature for the tyrothricin complex (13). ESMS-linked UPLC analysis of 
the organically extracted Trc mixture indicated the presence of the six major tyrocidines and 
their tryptocidine analogues (Figures 2.1 and 2.2).  
From Figure 2.2 A it is evident that the tyrocidines tend to oligomerise. The monomers, dimers, 
trimers and tetramers of the tyrocidines and their tryptocidine analogues can be observed. In the 
transformed mass spectrum of the monomeric peptides in the Trc mixture (Figure 2.2 B) the six 
major tyrocidines, TrcA (1269.6334), TrcA1 (1283.6462), TrcB (1308.6412), TrcB1 (1322.6578), 
TrcC (1347.6520) and TrcC1 (1361.6631), as well as their tryptocidine analogues, TpcB 
(1331.6530), TpcC (1370.6663) and TpcC1 (1384.6754), can be observed. 
The purity of the Trc mixture, in terms of its tyrocidine content in mass, was analysed with semi-
preparative RP-HPLC (Figure 2.3). The tyrocidine containing fraction (fraction B) and the 
fractions eluting before and after the tyrocidines (respectively fraction A and C) were collected 
and weighed analytically. Fraction B, the tyrocidine containing fraction, weighed 2.38 mg of the 
total 2.5 mg injected (Figure 2.3). Therefore the Trc mixture obtained through organic extraction 
from the commercial tyrothricin complex has a purity >95 %. Refer to table 2.4 for a summary of 
the composition and abundance of each peptide in the Trc mixture. 
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Figure 2.1:  A: ESMS linked UPLC analysis of the Trc mixture organically extracted from 
the comercial tyrothricin complex. 
B: Enlargement of the chromatogram to show the different peaks from the 
tyrocidines and analogues.  
A C18 RP-HPLC semi-preparative column was used for the first round of peptide purification 
from the Trc mixture organically extracted from tyrothricin. Six fractions (denoted I-VI) were 
initially collected via semi-preparative RP-HPLC (Figure 2.4).  
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Figure 2.2: TOF-ESMS spectra of the Trc mixture extracted from tyrothricin.  
A: The ESMS spectrum from m/z 300-2000 show the singly ([M+H]+) and 
doubly ([M+2H]2+) charged molecular species of the major tyrocidines for 
which monomers, dimers, trimers and tetramers were observed. 
B: The transformed mass spectrum of the monomeric tyrocidines in the mixture. 
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Figure 2.3:  The Trc mixture, obtained through organic extraction from the tyrothricin 
complex, was subjected to preparative C18 HPLC. Fraction A, B and C were 
collected separately and weighed analytically. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4:  Semi-preparative RP-HPLC chromatogram of the tyrocidine mixture. The 
indicated six fractions (fractions I to VI) were isolated during the first round of 
semi-preparative RP-HPLC purification. 
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Table 2.4: Summary of analysis of Trc mixture extracted from commercial tyrothricin 
Peptide Abbr Sequence
a
 
Detected 
monoisotopic 
Mr 
(theoretical 
Mr)
b
 
% 
Abundance 
in Trc 
mixture
c
 
Rt 
(min)
d
 
 
 
Fraction 
(Fig 2.4) 
Tyrocidine C1 TrcC1 
Cyclo-
(VKLfPWwNQY) 
1361.6781 
(1361.6921) 
10.3 8.02 I 
Tyrocidine C TrcC 
Cyclo-
(VOLfPWwNQY) 
1347.6626 
(1347.6764) 
14.3 8.08 II 
Tryptocidine C TpcC 
Cyclo-
(VOLfPWwNQW) 
1370.6792 
(1370.6924) 
3.5 8.38 - 
Tyrocidine B1 TrcB1 
Cyclo-
(VKLfPWfNQY) 
1322.6597 
(13226812) 
15.7 8.61e III 
Tyrocidine B TrcB 
Cyclo-
(VOLfPWfNQY) 
1308.6510 
(1308.6655) 
21.3 8.71 IV 
Tryptocidine B TpcB 
Cyclo-
(VOLfPWfNQW) 
1331.6632 
(1331.6815) 
3.1 9.04 - 
Tyrocidine A1 TrcA1 
Cyclo- 
(VKLfPFfNQY) 
1283.6500 
(1283.6703) 
13.2 9.47 V 
Tyrocidine A TrcA 
Cyclo- 
(VOLfPFfNQY) 
1269.6347 
(1269.6538) 
17.6 9.57 VI 
Tryptocidine A TpcA Cyclo-(VOLfPFfNQW) 
1292.6479 
(1292.6706) 
<1 9.90 - 
aConventional one-letter abbreviations are used for amino acid sequences [from Tang et al. (8)], except 
that O was used for Orn. Lower case one-letter abbreviations indicate D-amino acid residues.  
bThe theoretical monoisotopic Mr were calculated as the sum of the molecular weights of the constituent 
amino acids of the peptide; and the detected monoisotopic Mr determined from UPLC-MS.  
cAbundances were calculated from the peak areas determined with ESMS-linked UPLC of the Trc 
mixture.  
dThe UPLC chromatogram of the Trc mixture supplied the retention times. 
eWhile 0.5% Formic acid was used for the UPLC of the tyrocidines and analogues, 1.0 % Formic acid 
was used for TrcB1, explaining the delayed retention of TrcB1. 
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The first fraction (I) was analysed with UPLC and TOF-ESMS. The UPLC results showed that 
fraction I contained purified TrcC1 (>90%), with a retention time (Rt) of 7.93 minutes (Figure 2.5 
A). Direct TOF-ESMS analysis again revealed the tendency of the purified tyrocidines to 
oligomerise (aggregate) into dimers and trimers that are stable under ESMS conditions, as well 
as form adducts with cations such as sodium and hydrogen. In the TOF-ESMS spectra of Figure 
2.5 BI, the TrcC1 monomer and its dimers and trimers can be observed. In Figure 2.5 BII TrcC1 
(1361.6868) and its sodium adduct (1383.6722) can be observed. The minor impurities in the 
TrcC1 sample were also revealed to be TrcC (1347.6727) and TpcC (1393.6807). 
 
 
Figure 2.5: UPLC and TOF-ESMS analysis of purified TrcC1 
A: UPLC chromatogram of purified TrcC1 (200 µg/mL, 3 µL injection volume) 
providing peptide identity and retention time (in minutes). 
B: TOF-ESMS spectrum from m/z 300-2000 of purified TrcC1 indicating the 
TrcC1 monomers, dimers and trimers (I) and (II) the enlarged spectrum of the 
monomeric molecules present in the TrcC1 sample. Details on peptide purity 
are given in Table 2.5. 
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Fraction II contained purified TrcC (>90%), with a UPLC Rt of 8.07 minutes (Figure 2.6 A). 
Similar to that of TrcC1, TrcC also tended to oligomerise, as can be seen from the TOF-ESMS 
spectra in Figure 2.6 BI. Figure 6 BII shows the TrcC (1347.6713) and its sodium adduct 
(1369.6488). 
 
 
Figure 2.6: UPLC and TOF-ESMS analysis of purified TrcC 
A: UPLC chromatogram of purified TrcC (200 µg/mL, 3 µL injection volume) 
providing peptide identity and retention time (in minutes). 
B: TOF-ESMS spectrum from m/z 300-2000 of purified TrcC indicating the 
TrcC monomers, dimers, trimers and tetramers (I) and (II) the enlarged 
spectrum of the monomeric molecules present in the TrcC sample. Details on 
peptide purity are given in Table 2.5.  
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Analysis of fraction III indicated that it is a mixture of TrcB1 and TrcB. A sample that went 
through multiple semi-preparative C18 RP-HPLC purifications showed that TrcB1 was purified 
(>90%) with a Rt of 8.74 minutes (Figure 2.7 A). The TOF-ESMS indicates that TrcB1 formed 
monomers, dimers, trimers and tetramers (Figure 2.7 BI) and the TrcB1 monomer (1322.6730) 
with minor contamination from TrcB (1308.6589) (Figure 2.7 BII).  
 
 
Figure 2.7: UPLC and TOF-ESMS analysis of purified TrcB1 
A: UPLC chromatogram of purified TrcB1 (200 µg/mL, 3 µL injection volume) 
providing peptide identity and retention time (in minutes). 
B: TOF-ESMS spectrum from m/z 300-2000 of purified TrcB1 indicating the 
TrcB1 monomers, dimers, trimers and tetramers (I) and (II) the enlarged 
spectrum of the monomeric molecules present in the TrcB1 sample. Details on 
peptide purity are given in Table 2.5. 
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Fraction IV contained purified (>90%) TrcB with Rt of 8.41 minutes (Figure 2.8 A). As with the 
other tyrocidines and analogues, oligomers of TrcB were also detected. A minor impurity is due 
to the presence of TrcB1 (1322.6772) in the sample (Figure 2.8 BI and BII).  
 
 
Figure 2.8: UPLC and TOF-ESMS analysis of purified TrcB 
A: UPLC chromatogram of purified TrcB (200 µg/mL, 3 µL injection volume) 
providing peptide identity and retention time (in minutes). 
B: TOF-ESMS spectrum from m/z 300-2000 of purified TrcB indicating the 
TrcB monomers, dimers and trimers (I) and (II) the enlarged spectrum of the 
monomeric molecules present in the TrcB sample. Details on peptide purity are 
given in Table 2.5.  
  
 
0 2 4 6 8 10 12
0
2500
5000
7500
10000
12500 8.41
Retention time (min)
E
S
M
S
 s
ig
n
a
l
mass
2000 4000 6000
%
0
100
1308.6610
2617.3440
2631.3521
3926.0164
mass
500 1000 1500
%
0
100
1308.6610
1322.6772
1384.7028
A B I
B II [TrcB]
TrcB
monomers
TrcB
dimers
TrcB
trimers
Stellenbosch University http://scholar.sun.ac.za
2-17 
 
Fraction V was found to contain both TrcA1 and TrcA. Semi-preparative C18 RP-HPLC was not 
adequate for the separation of TrcA1 and TrcA. Therefore an analytical C18 RP-HPLC method 
(12, 15) was used to successfully purify TrcA1 to purity >95% from fraction V (Rt of 9.21 
minutes) (Figure 2.9 A). TrcA1 monomers (1283.6694) and dimers (2567.3562) can be observed 
in the TOF-ESMS spectra (Figure 2.9 BI). Its monomer, potassium and sodium adducts and 
minor contamination by TrcA can be seen in Figure 2.9 BII.  
 
 
Figure 2.9: UPLC and TOF-ESMS analysis of purified TrcA1 
A: UPLC chromatogram of purified TrcA1 (200 µg/mL, 3 µL injection volume) 
providing peptide identity and retention time (in minutes). 
B: TOF-ESMS spectrum from m/z 300-2000 of purified TrcA1 indicating the 
TrcA1 monomers and dimers (I) and (II) the enlarged spectrum of the 
monomeric molecules present in the TrcA1 sample. Details on peptide purity 
are given in Table 2.5.  
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The purification of TrcA to >90% purity from the Trc mixture, organically extracted from the 
commercial tyrothricin, proved to be quite difficult from fraction V and VI. Exhaustive 
analytical RP-HPLC of the isolated factions was not efficient for the purification of TrcA. 
Therefore the focus of obtaining pure peptides switched to the isolation of peptides from the 
cultures of the tyrothricin producer B. aneurinolyticus 8185. 
2.4.2 Tyrocidines purified from the culture broth of B. aneurinolyticus  
The culture medium of B. aneurinolyticus 8185 was supplemented with specific amino acids, in 
addition to urea, to obtain specific tyrocidine peptides/analogues (Table 2.3) (10). Initial 
analytical RP-HPLC analysis of the crude peptide extractions from culture medium indicated a 
large early eluting fraction containing a yellow pigment contaminating all of the tyrocidine 
extracts (Figure 2.10 A). In the process of refining the purification procedure, a C8 matrix wash 
step was used to remove the contaminating pigment prior to further purification via preparative 
C18 RP-HPLC (Figure 2.10 B).  
Supplementing the growth medium of B. aneurinolyticus 8185 with 0.5% Lys and 0.5% Phe 
produced peptide fractions that indicated two peaks with analytical C18 RP-HPLC analysis 
(Figure 2.11 A). TOF-ESMS analysis indicated that the larger peak (I) consisted of TrcA and the 
smaller peak (II) of PhcA.  
Supplementation with 0.5% Phe again resulted in a peptide fraction with two peaks as indicated 
with analytical HPLC (Figure 2.11 B). However this time the majority of peptide produced was 
PhcA (IV) and TrcA (III) was present in smaller amounts. Only TrcA was produced when the 
medium was supplemented with 0.5% Phe and 0.5% Tyr (Figure 2.11 C). TpcC was almost 
exclusively produced in large amounts when the culture medium was supplemented with 0.3% 
Trp (Figure 2.10 B).  
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Figure 2.10: Analytical RP-HPLC analysis of B. aneurinolyticus 8185 culture extract 
supplemented with 0.1 % urea and 0.3 % Trp. 
A: Analytical RP-HPLC chromatogram of methanol extracted sample from B. 
aneurinolyticus 8185 culture medium. 
B: Analytical RP-HPLC chromatogram of methanol extracted sample purified 
on an Isolute-XL C8 column. 
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Figure 2.11: A: Analytical RP-HPLC analysis of B. aneurinolyticus 8185 culture extract 
supplemented with 0.1 % urea, 0.5 % Lys and 0.5% Phe. 
B: Analytical RP-HPLC analysis of B. aneurinolyticus 8185 culture extract 
supplemented with 0.1 % urea and 0.5 % Phe. 
C: Analytical RP-HPLC analysis of B. aneurinolyticus 8185 culture extract 
supplemented with 0.1 % urea, 0.5 % Phe and 0.5% Tyr. 
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Peak fractions I to V - as depicted in Figure 2.11 - were further purified using semi-preparative 
C18 RP-HPLC. Fractions I, III and V yielded TrcA of >95% purity as indicated by UPLC-MS. 
TOF-ESMS spectra indicated the TrcA oligomers (Figure 2.12 BI) and monomeric TrcA 
(1269.6615) and its sodium adduct (1291.6343) (Figure 2.12 BII).  
 
 
Figure 2.12: UPLC and TOF-ESMS analysis of purified TrcA 
A: UPLC chromatogram of purified TrcA (200 µg/mL, 3 µL injection volume) 
providing peptide identity and retention time (in minutes). 
B: TOF-ESMS spectrum from m/z 300-2000 of purified TrcA indicating the 
TrcA monomers, dimers and trimers (I) and (II) the enlarged spectrum of the 
monomeric molecules present in the TrcA sample. Details on peptide purity are 
given in Table 2.5.  
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PhcA, with high purity of >95%, was purified from fractions II and IV using semi-preparative 
C18 RP-HPLC (Figure 2.13 A). Again the tendency of the tyrocidines to oligomerise can be 
observed in the TOF-ESMS spectra of PhcA (Figure 2.13 BI). In Figure 2.13 BII the PhcA 
monomer (1254.6625) and its sodium adducts can be observed. Minor “contamination” from 
TpcA is also evident. 
 
 
Figure 2.13: UPLC and TOF-ESMS analysis of purified PhcA 
A: UPLC chromatogram of purified PhcA (200 µg/mL, 3 µL injection volume) 
providing peptide identity and retention time (in minutes). 
B: TOF-ESMS spectrum from m/z 300-2000 of purified PhcA indicating the 
PhcA monomers and dimers (I) and (II) the enlarged spectrum of the 
monomeric molecules present in the PhcA sample. Details on peptide purity 
are given in Table 2.5.   
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After a preparative C18 RP-HPLC step of the crude TpcC sample (refer to Figure 2.10 B), UPLC 
analysis revealed a peptide fraction with two peak fractions (Figure 2.14 A). However, ESMS 
analysis of each peak revealed that they both consist of TpcC. The formation of the two peaks 
can be ascribed to peptide oligomerisation and protonation. A TpcC fraction of >95% purity was 
therefore obtained. This was confirmed by TOF-ESMS spectra of TpcC which indicated TpcC 
oligomers (Figure 2.14 BI), with the TpcC monomer (1370.6866) and its sodium adducts 
indicated in Figure 2.14 BII. 
 
 
 
Figure 2.14: UPLC and TOF-ESMS analysis of purified TpcC 
A: UPLC chromatogram of purified TpcC (200 µg/mL, 3 µL injection volume) 
providing peptide identity and retention time (in minutes). 
B: TOF-ESMS spectrum from m/z 300-2000 of purified TpcC indicating the 
TpcC monomers, dimers and trimers (I) and (II) the enlarged spectrum of the 
monomeric molecules present in the TpcC sample. Details on peptide purity 
are given in Table 2.5.   
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The commercial GS was also analysed using UPLC and TOF-ESMS. UPLC analysis revealed 
that the purity of the GS sample is 94% (Figure 2.15 A). In contrast to the tyrocidines, TOF-
ESMS spectra of GS did not reveal any tendencies of GS to oligomerise. In Figure 2.15 BI and 
BII the GS monomer (1140.7067) and its sodium and hydrogen adducts can be observed. 
Impurities can be ascribed to other gramicidin species. 
 
 
 
Figure 2.15: UPLC and TOF-ESMS analysis of GS 
A: UPLC chromatogram of purified GS (200µg/mL, 3 µL injection volume) 
providing peptide identity and retention time (in minutes). 
B: TOF-ESMS spectrum from m/z 300-2000 of purified GS indicating the GS 
monomer (I) and (II) the enlarged spectrum of the monomeric molecules 
present in the GS sample. Details on peptide purity are given in Table 2.5. 
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Table 2.5: Summary of the purification data 
Peptide 
Crude 
extract 
(mg) 
% Yield 
(Yield, 
mg) 
Theoretical 
Mr 
TOF-
ESMS Mr 
of ion 
signals 
Peak identity 
UPLC 
Rt 
% 
Purity 
Peptides purified from commercial tyrothricin complex 
Tyrocidine C1 350 7.1 (24.8) 1361.6921 
1347.6727 TrcC 
7.93 93 
1361.6868 TrcC1 
1383.6722 TrcC1 + 2Na
+ 
1393.6807 
TpcC + H+ + 
2Na+ 
Tyrocidine C 350 
10.1 
(35.3) 
1347.6764 
1347.6713 TrcC 
8.07 91 
1369.6488 TrcC + 2Na+ 
Tyrocidine B1 350 2.1 (7.3) 1322.6812 
1194.5812 unknown 
8.74 93 
1308.6589 TrcB 
1322.6730 TrcB1 
1360.6169 TrcB1 + K
+ 
Tyrocidine B 350 
13.0 
(45.4) 
1308.6655 
1308.6610 TrcB 
8.41 90 1322.6772 TrcB1 
1384.7028 TpcC1 
Tyrocidine A1 350 1.2 (4.3) 1283.6703 
1269.6521 TrcA 
9.21 94 
1283.6694 TrcA1 
1305.6488 TrcA1 + 2Na
+ 
1321.6135 TrcA1 + K
+ 
Peptides purified from B. parabrevis 8185 culture extract 
Tyrocidine A 
300 2.9 (8.7) 1269.6546 
1269.6515 TrcA 
9.29 98 
  1291.6343 TrcA + 2Na+ 
Phenycidine A 300 0.3 (0.8) 1253.6597 
1253.6625 PhcA 
9.61 98 
1267.6758 PhcA1 
1275.6411 PhcA + 2Na+ 
1297.6293 PhcA + 4Na+ 
Tryptocidine C 200 1.1 (2.1) 1370.6924 
1370.6866 TpcC 
8.18 95 1371.6887 TpcC + H
+ 
1392.6675 TpcC + 2Na+ 
Commercial peptide 
Gramicidin S - - 1140.7059 
570.3521 [GS]2+ 
8.40 93 
1126.7009 unknown 
1140.7067 GS 
1141.7164 GS + H+ 
1154.7256 GS + 2H+ + Na+ 
The UPLC chromatograms of the purified peptides supplied the UPLC retention times (in minutes) and were used to 
calculate their purity. The observed monoisotopic Mr were obtained from the TOF-ESMS spectra. The expected 
monoisotopic Mr were calculated as the sum of the molecular weights of the constituent amino acids. The 
percentage yield was calculated as the percentage of the mass of the crude commercial tyrocidine complex, or as the 
percentage of the mass of the crude extract from B. parabrevis 8185 culture medium. 
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2.5 Conclusions 
A mixture of tyrocidine peptides (Trc mixture), of >95 % purity in terms of tyrocidine peptide 
content, was successfully extracted from the commercial tyrothricin. Using preparative and 
analytical RP-HPLC, TrcA1, B1, B, C1 and C with purities >90%, were effectively purified from 
the Trc mixture. Supplementation of the culture broth of B. aneurinolyticus 8185 with specific 
amino acids eased the process of peptide purification and made it possible to acquire sufficient 
amounts of pure rare peptides in order to perform studies on their bioactivity and 
physicochemical properties. It was especially a breakthrough in the case of PhcA and TpcC since 
the purification of these peptides in large amounts have not previously been possible from the 
commercial tyrothricin mixture. The optimised RP-HPLC purification methodology enabled the 
purification of the produced peptides, as well as tyrocidines from commercial tyrothricin, to 
>90% purity (Table 2.5). Any minor contamination was as a result of the presence of other 
tyrocidines or analogues. The identity, purity and chemical integrity of each fraction were 
confirmed with UPLC and TOF-ESMS analysis. The major tyrocidines (TrcC1, C, B1, B, A1 and 
A) and two of their analogues, PhcA and TpcC, were successfully purified (Table 2.5) for the 
bioactivity and physicochemical studies reported in Chapters 3-6. 
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Chapter 3 
Development and optimisation of antifungal assays to determine 
tyrocidine activity 
3.1 Introduction 
In preparation for our research described in Chapters 4 and 5 and our article (Addendum Chapter 
3, (1)) published on the gel-based antifungal assay in which the influence of culture conditions 
on antimicrobial peptide (AMP) activity and fungal growth were highlighted, antifungal assays 
were optimised in terms of two representative fungal pathogens, Fusarium solani and Botrytis 
cinerea, as well as for tyrocidine antifungal activity. The microtiter plate treatment and growth 
medium, as well as the percentage ethanol in the peptide solvent, were chosen for optimal fungal 
growth and maximum tyrocidine activity.  
Tyrocidines, similar to the majority of AMPs, are very sensitive to their environment. Their 
environment influences the degree of tyrocidine aggregation and consequently their activity (2). 
The amphipathic tyrocidines have a tendency to aggregate in aqueous environments, forming 
complex structures (2-5). Ethanol in water dilution is used to solubilise the tyrocidines in order 
to perform dilution assays. The extent of their aggregation is influenced by initial concentration 
of the tyrocidine stock solution in addition to the percentage ethanol used to get the peptides into 
solution. However, Dantigny et al. (6) illustrated that, at a concentration range of 3% to 5%, 
ethanol kills various fungi species and reduces their growth rate at lower concentrations (6). As 
one of our aims is to determine the degree of antifungal activity of tyrocidines and their mode of 
action, any inhibitory effect observed must not be attributed solely to ethanol. In the course of 
assay development different concentrations of ethanol were assessed for their influence on 
fungal growth and peptide activity. Gramicidin S (GS), an analogue of the tyrocidines with 50% 
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sequence identity, was used as control peptide. It is soluble in water and does not tend to 
aggregate. GS was previously shown to have antifungal activity in both broth and agar media (7) 
and is known to be highly lytic to eukaryotic cells (8). 
Since fungal species survive in various environments on earth (9), it follows that different 
species will prosper to varying degrees in different mediums. Therefore the growth of F. solani 
and B. cinerea was determined in different broth mediums as wel as on different agar mediums. 
During the course of assay development and optimisation, the influence of different mediums on 
the activity of the tyrocidine mixture was also assessed.   
3.2 Materials 
The fungal strains Fusarium solani STEU 6188 and Botrytis cinerea CKJ1731 were provided by 
the Department of Plant Pathology, University of Stellenbosch. The potato dextrose broth (PDB), 
potato dextrose agarose (PDA) and Tween 20® were obtained from Fluka (St. Louis, USA). 
Biolab (Wadeville, Gauteng) provided the tryptone soy broth (TSB), yeast extract and lysogeny 
broth (LB). Ethanol (99.9%) was obtained from Merck Chemicals (Pty) (Wadeville, Gauteng). 
The sterile polypropylene plates were provided by Nunc (Roskilde, Denmark), while Corning 
(Corning, USA) provided the sterile microtiter plates. Bovine milk casein was supplied by Fluka 
Chemicals (Buchs, Switzerland). The Na2HPO4 and KH2PO4 were supplied by Merck 
(Darmstadt, Germany). Capital Enterprises (Hillcrest, South Africa) supplied the KCl. Analytical 
quality water was prepared by passing water from a reverse osmoses plant through a Millipore 
(Milford, USA) Milli Q® water purification system. 
The peptides, the mixture of tyrocidine peptides (Trc mixture), tyrocidine C (TrcC) and 
gramicidin S (GS), were purified and analysed as described in Chapter 2. 
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3.3 Methods 
3.3.1 Growth and harvesting of fungi 
F. solani was grown at 25 ˚C on PDA until sporulation (± 2 weeks). Spores were harvested with 
3 mL 0.1 % Tween-analytical water. B. cinerea was grown in culture plates on sterile strawberry 
halves at 23-25 ˚C until sporulation (± 3 weeks). B. cinerea spores were harvested dry using 
vacuum. Subsequent to harvesting, spores were counted using a counting chamber. Standard 
practices to ensure sterility were followed. 
3.3.2 Treatment of microtiter plates 
Broth microdilution assays were performed in unblocked and casein blocked plates. Casein 
blocked plates were prepared using sterile 0.5% casein in Dulbecco’s phosphate buffered saline 
(PBS) (10, 11). Spores of either B. cinerea or F. solani were suspended in half strength PDB to a 
concentration of 2.5 × 104 spores/mL (12). Of the broth-spore suspension 90 µL were added to 
the wells of either sterile unblocked 96-well microtiter plates or casein blocked microtiter plates. 
The Trc mixture was dissolved in ethanol (15 %) to a concentration of 1.00 mg/mL. Doubling 
dilution series were performed in polypropylene microtiter plates using ethanol (15 %). 
Thereafter 10 µL peptide was added to the broth-spore suspensions in the microtiter plates. 
Microtiter plates were incubated at 25 ˚C for 48 hours. Light dispersion of each well was 
spectrophotometrically determined at 595 nm using a BioRad microtiter plate reader. 
3.3.3 Determining growth of fungi in different mediums 
Growth of F. solani and B. cinerea in PDB, yeast supplemented TSB (YTSB, TSB containing 
20% m/v yeast extract), LB, PDA and YTSA was determined using 96-well microtiter plates. 
The agar plates were prepared by pipetting 70 µL PDA/YTSA (65°C) into sterile microtiter 
plates using the reverse pipetting method (13) and letting it cool before the addition of spore-
containing broth suspensions. Broth suspensions consisted of half strength PDB, YTSB or LB 
and either F. solani or B. cinerea spores at a concentration of 2.5 × 104 spores/mL (broth media) 
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or 1.0 × 105 spores/mL (agar media) of which 100 µL was added to microtiter plates for growth 
determination in the broth media and 30 µL was added onto prepared PDA/YTSA plates for 
growth determination on agar media. Plates were incubated at 23-25 ˚C and growth measured 
every 24 hours for 96 hours. Light dispersion of each well was spectrophotometrically 
determined at 595 nm using a BioRad microtiter plate reader. 
3.3.4 Determining growth of fungi in different concentrations of ethanol 
The influence of respectively 1.0%, 1.5% and 2.0% ethanol on the growth of F. solani and B. 
cinerea was determined using broth assays in 96-well microtiter plates. Of the broth suspensions, 
which consisted of half strength PDB, YTSB or LB and spores at a concentration of 2 × 104/mL 
(12) and final ethanol concentrations of 0%, 1.0%, 1.5% or 2.0%, 100 µL was added to each 
well. Plates were incubated at 25 ˚C and growth measured every 24 hours for 96 hours (B. 
cinerea) or 72 hours (F. solani). Light dispersion of each well was spectrophotometrically 
determined at 595 nm using a BioRad microtiter plate reader. 
3.3.5 Different ethanol concentrations for peptide preparation 
Broth microdilution assays with B. cinerea were used to assess different ethanol concentrations 
for peptide preparation. B. cinerea spores were suspended in half strength PDB to a 
concentration of 2.5 × 104 spores/mL (12). The peptides were dissolved in an ethanol:water 
solution of either 10% or 15% to a concentration of 1.00 mg/mL. Doubling dilution series were 
made in polypropylene microtiter plates using ethanol:water solutions of respectively 10% and 
15%. Into each well 90 µL of the broth suspension was added followed by 10 µL peptide. 
Peptide treated and growth controls had a final ethanol concentration of either 1.0% or 1.5%. 
3.3.6 Determining tyrocidine activity in PDB, YTSB, PDA and YTSA 
The activities of the Trc mixture and GS in PDB, YTSB, PDA and YTSA were compared using 
broth and agar microdilution assays (1, 12, 13). The agar plates were prepared by pipetting 70 
µL PDA/YTSA (65°C) into sterile microtiter plates using the reverse pipetting method (13) and 
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letting it cool before the addition of spore-containing broth suspensions. Broth suspensions 
consisted of half strength PDB or YTSB and either F. solani or B. cinerea spores at a 
concentration of 2.5 × 104 spores/mL (broth assays) or 1.0 × 105 spores/mL (agar assays) (12). 
The Trc mixture was dissolved in ethanol (15 %) to a concentration of 1.00 mg/mL. Doubling 
dilution series were made in polypropylene microtiter plates using ethanol (15 %). Into each well 
90 µL (broth assays) or 20 µL (agar assays) of the broth suspension was added followed by 10 
µL peptide. Growth control received 10 µL of 15 % ethanol in water solution instead of peptide. 
Sterility control was a combination of PDB or YTSB analytical water and 1.5 % ethanol. All 
wells had a final volume of 100 µL. Subsequent to peptide addition the microtiter plates were 
incubated at 23-25 ˚C for 48 hours. Light dispersion of each well was spectrophotometrically 
determined at 595 nm using a BioRad microtiter plate reader. 
3.3.7 Data and Statistical analysis 
In order to calculate the percentage growth inhibition the light dispersion at each concentration 
was used as described by Rautenbach et al. (14). GraphPad Prism® 4.03 (GraphPad Software, 
San Diego, USA) was used to plot the dose response curves. Non-linear regression and 
sigmoidal curves (with a slope default setting at <7) were fitted for dose response analysis (14). 
The point halfway between top and bottom (IC50) represents the concentration necessary to cause 
50% growth inhibition. The minimum inhibition concentration (MIC), calculated as the x-value 
at the intercept between the slope and the top plateau of a full dose-response curve, was denoted 
as ICmax (14) to make the distinction with MIC values obtained from visual inspection of a dose-
response result. 
GraphPad Prism® was also used for the statistical analysis of data. Analysis included 95% 
confidence levels, absolute sum of squares, standard error of the mean, Bonferroni’s post test and 
Newman-Keuls multiple comparison test. 
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3.4 Results and Discussion 
3.4.1 Influence of treatment of microtiter plates on peptide activity 
During previous studies the 96-well microtiter plates for broth assays were blocked with casein 
in PBS to decrease non-specific binding and consequently increase peptide activity (10, 11). 
However, when we compared the activities of the tyrocidines between blocked and unblocked 
plates, we found that the tyrocidines exhibited higher activity in the unblocked low protein 
binding plates (Figure 3.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Treatment of microtiter plates with casein. The activity of the Trc mixture is 
compared, in terms of its IC50 values for B. cinerea and F. solani, when using 
casein blocked microtiter plates or unblocked microtiter plates. Each activity 
determination is the mean of at least three biological repeats (three technical repeats 
per assay) ± standard error of the mean (SEM). 
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Casein has been shown to bind Ca2+ (15) and the tyrocidines to form complexes with Ca2+ 
whereupon they either change in their degree of activity or type of activity (2). Therefore the 
decrease in activity in the blocked plates can be the result of the tyrocidines associating with 
Ca2+ which on its turn binds to casein and resultantly there is a decrease in available active 
peptides. At high tyrocidine concentrations peptide aggregation was also a probable cause of 
activity loss in the casein-blocked microtiter plates. In the reported studies we used unblocked 
low protein binding 96-well plates. 
3.4.2 Growth of B. cinerea and F. solani in different mediums 
Different species of fungi can be found in different niches on earth. Fusarium species, for 
instance, survives from arctic regions through to tropical regions (9). It follows therefore that 
various fungal species will prosper in varying degrees in different mediums (Table 3.1). Our 
results confirmed this premise. F. solani prospered in YTSB and LB and its growth was much 
faster in these two mediums than in PDB (Figure 3.2 A). B. cinerea, on the other hand, exhibited 
faster growth in PDB than in YTSB and LB (Figure 3.2 B). Both B. cinerea and F. solani grew 
faster on the gelatinous YTSA and PDA than in the YTSB, PDB and LB broths (Figure 3.3). 
Nevertheless, the growth of F. solani was faster on YTSA than on PDA (Figure 3.3 A) and the 
growth of B. cinerea faster on PDA than YTSA (Figure 3.3 B). Statistical analysis confirmed 
that these differences are significant. The growth of F. solani in PDB was significantly 
(P<0.001) lower than its growth in YTSB, LB, PDA and YTSA (Figure 3.4). Even though there 
was no significant difference in F. solani growth between YTSB and LB, the growth in these 
two mediums was significantly (P<0.001) lower than on the two agar mediums PDA and YTSA. 
Furthermore, the growth of F. solani on YTSA was significantly higher than on PDA. 
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Table 3.1: Summary of characteristics of different mediums 
Medium Abbreviation 
Common 
use 
% 
Nitrogen 
% 
Fermentable 
sugars 
Vitamins Salt Composition 
Potato 
dextrose 
broth 
PDB 
Primarily 
for fungal 
growth 
** *** ** ** 
83% glucose, 17% 
potato extract, 9.5-
10.5% N, <20% NaCl 
Tryptone 
soy broth 
TSB 
Versatile 
medium 
**** ** *** *** 
50% tryptone, 16.7% 
soy-peptone, 16.7% 
NaCl, 8.3% P2HPO4, 
8.3% dextrose 
Yeast 
extract 
tryptone 
soy broth 
YTSB 
Novel 
medium 
**** ** **** **** 
20% tryptone, 6.7% 
soy-peptone, 46.7% 
NaCl, 3.3 % P2HPO4, 
3.3% dextrose, 20% 
yeast extract 
Lysogeny 
broth 
LB 
Primarily 
for bacterial 
growth 
*** * 
***  
(Vit B) 
**** 
40% tryptone, 20% 
yeast extract, 40% 
NaCl 
* = low, ** = medium, *** = high, **** = very high 
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Figure 3.2:  Growth of F. solani (A) and B. cinerea (B) in PDB, YTSB and LB media over a 
period of 96 hours. Each data point is the mean of at least 8 repeats with SEM. 
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Figure 3.3:  Growth of F. solani (A) and B. cinerea (B) on PDA and YTSA media over a 
period of 96 hours. Each data point is the mean of at least 8 repeats ± SEM. 
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mediums. Furthermore, in contrast to F. solani, the growth of B. cinerea was significantly higher 
on PDA than on YTSA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Comparison of growth of F. solani in PDB, YTSB, LB, PDA and YTSA over a 
period of 96 hours. According to the Newman-Keuls multiple comparison test F. 
solani growth in PDB is significantly lower than growth in YTSB, LB, PDA and 
YTSA (**P<0.01, ***P<0.001); growth in LB and YTSB are significantly lower 
than on PDA and YTSA (###P<0.001) and the growth on PDA significantly lower 
than the growth on YTSA ($$$P<0.001). Each growth measurement is the mean of 
at least 8 repeats ± SEM. 
In terms of nutrient composition F. solani prospered in the nitrogen and salt rich YTSB and 
YTSA mediums while B. cinerea preferred the less complex PDB and PDA mediums (Table 
3.1). To accurately determine growth inhibition the optical density (OD595) reading must at least 
have a value between 0.2-0.3 and B. cinerea only reached that growth density after 96 hours in 
YTSB (Figure 3.3 B and 3.5). Consequently broth assays performed in YTSB with B. cinerea 
were evaluated after a period of 96 hours. The variance in the growth of fungi from liquid broths 
to solid agar mediums may have an influence on peptide activity. Therefore one can only get a 
comprehensive view of peptide activity if their activity is evaluated in/on both liquid broth and 
solid agar mediums. 
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Figure 3.5: Comparison of growth of B. cinerea in PDB, YTSB, LB, PDA and YTSA over a 
period of 96 hours. According to the Newman-Keuls multiple comparison test B. 
cinerea growth in LB and YTSB are significantly lower than growth in PDB, 
PDA and YTSA (**P<0.01, ***P<0.001); growth in PDB are significantly lower 
than on PDA and YTSA (#P<0.05, ###P<0.001) and the growth on YTSA 
significantly lower than the growth on PDA ($$P<0.01, $$$P<0.001). Each growth 
measurement is the mean of at least 8 repeats ± SEM. 
 
3.4.3 Growth of fungi in different concentrations of ethanol 
As previously stated the tyrocidines tend to aggregate in aqueous environments forming complex 
structures which may influence their activity (3, 16). Since it is difficult to recover peptides from 
solvents such as dimethyl sulfoxide (DMSO), an ethanol/water mixture was generally used to 
solubilise the tyrocidines, but ethanol is a universal sterilising agent. It was therefore important 
to determine that the inhibitory effect observed is as a result of the tyrocidine action and not due 
to ethanol. The same percentage ethanol was therefore used throughout, from the initial peptide 
preparation through to the dilution series and in the growth control. Tyrocidines are soluble at 
about 1-2 mg/mL in ethanol concentrations of 10-20% (v/v).  For dose-response assays we 
generally dilute the peptides 10 times on the assay medium which yields a final ethanol 
concentration of 1-2%. In order to assess the influence of the residual ethanol on fungal growth, 
F. solani and B. cinerea were cultured in YTSB, PDB and LB at final ethanol concentrations of 
1.0%, 1.5% and 2.0%.  
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In Figure 3.6 the growth of F. solani and B. cinerea is illustrated in the different media at the 
various ethanol concentrations.  Since we previously established that B. cinerea only reaches an 
adequate OD in YTSB subsequent to 96 hours of incubation (Figure 3.2 B and 3.5), B. cinerea’s 
growth at different ethanol concentrations in YTSB was measured up to 96 hours. As expected 
the growth of both fungal species were affected by increasing concentrations of ethanol (Figure 
3.6). The effect was more pronounced in YTSB (Figure 3.6 AI and BI) and LB (Figure 3.6 AIII 
and BIII) than in PDB (Figure 3.6 AII and BII). Furthermore, F. solani (Figure 3.6 A) growth 
was more stable in the various ethanol concentrations than that of B. cinerea (Figure 3.6 B). 
In Figure 3.7 the growth of F. solani at the various ethanol concentrations and in the different 
mediums is statistically compared. According to the Newman-Keuls multiple comparison test F. 
solani growth in YTSB medium is significantly (P<0.001) lower at ethanol concentrations of 
1.5% and 2.0% compared to growth at 1.0% ethanol; and the growth in LB and PDB 
significantly (P<0.001) lower at 2.0% ethanol compared to the growth in 1.0% and 1.5% ethanol. 
When the growth in the three different mediums at a specific ethanol concentration is compared, 
the percentage growth in YTSB at 1.5% ethanol is significantly (P<0.001) lower than the growth 
in PDB and LB; and at 2.0% ethanol the growth in YTSB and LB is significantly lower than the 
growth in PDB (P<0.001). B. cinerea growth at the various ethanol concentrations in YTSB, 
PDB and LB is statistically compared in Figure 3.8. Since the growth of B. cinerea in YTSB and 
LB is relatively slow compared to PDB, growth after 48 and 96 hours is compared. Except for B. 
cinerea growth at 2.0% ethanol in LB, there is no significant difference in the growth of B. 
cinerea after 48 hours in each medium at the different ethanol concentrations. After 96 hours the 
growth in both LB and YTSB at 2.0% ethanol is significantly lower than the growth at 1.0% and 
1.5% ethanol. Similar to F. solani, the growth of B. cinerea was also more stable in PDB.  After 
48 hours (Figure 3.8 A), at a concentration of 1.0% ethanol, the growth in YTSB (P<0.01) and 
LB (P<0.001) is significantly lower than in PDB. This variance in growth increases with 
increasing ethanol concentrations. 
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Figure 3.6: Growth of F. solani (A) and B. cinerea (B) in YTSB (I), PDB (II) and LB (III) at 
ethanol concentrations of 1.0%, 1.5% and 2.0%. Each data point represents the 
mean of at least 8 repeats ± SEM. 
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Figure 3.7: Percentage growth of F. solani after 48 hours in YTSB, PDB and LB media at 
ethanol concentration of 1.0%, 1.5% and 2.0%. According to the Newman-Keuls 
multiple comparison test there is significant difference between the growth of F. 
solani in the different ethanol concentrations in each medium (###P<0.001). The 
growth in YTSB and LB is also significantly lower than the growth in PDB 
(***P<0.001); and the growth in YTSB lower than the growth in LB ($$P<0.01, 
$$$P<0.001) at the various ethanol concentrations. Each data point represents the 
mean of 12 repeats ± SEM.  
After 96 hours (Figure 3.8 B), as was expected, there is less variance between the different 
mediums. However, at an ethanol concentration of 2.0% the growth in YTSB and LB is 
significantly (P<0.001) lower than at concentrations of 1.0% and 1.5% and the growth in PDB is 
still significantly (P<0.001) higher than the growth in YTSB and LB. From these results it is 
evident that increasing concentrations of ethanol effects the growth of both F. solani and B. 
cinerea, especially at an ethanol concentration of 2.0%. Therefore a final ethanol concentration 
of 2.0% would not be advisable for peptide activity determination. 
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Figure 3.8: Percentage growth of B. cinerea after 48 hours (A) and 96 hours (B) in YTSB, PDB 
and LB media at ethanol concentration of 1.0%, 1.5% and 2.0%. According to the 
Newman-Keuls multiple comparison test there is significant difference between the 
growth of B. cinerea in 1.0 - 1.5% and 2.0% ethanol concentrations in each medium 
(###P<0.001). The growth in YTSB and LB is also significantly lower than the 
growth in PDB (**P<0.01, ***P<0.001); and the growth in LB lower than the 
growth in YTSB ($P<0.05, $$P<0.01) at the various ethanol concentrations. Each 
data point represent the mean of 12 repeats ± SEM. 
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Furthermore, the growth of both the fungal species was relatively unaffected in PDB medium 
and there was no significant difference for both F. solani and B. cinerea between 1.0% and 1.5% 
ethanol. This is interesting since F. solani growth was much faster in YTSB and LB than in PDB 
(Figure 3.2 A and 3.4), but more affected by ethanol. Therefore the activity of the tyrocidines 
diluted in 10% and 15% ethanol (final concentrations of 1.0% and 1.5%) was compared in PDB. 
3.4.4 Different ethanol concentrations for peptide preparation 
Tyrocidines are amphipathic (17) cyclic decapeptides (18) with a β-sheet conformation that have 
a tendency to aggregate in aqueous environments, forming complex structures (3-5, 19). Their 
activity may be dependant on, or may vary in efficacy, depending on the degree of their 
aggregation. An ethanol in water solution is used to get the tyrocidines into solution in order to 
perform dilution assays. The extent of peptide aggregation, and therefore activity, will be 
determined by the percentage ethanol used. The higher the percentage ethanol, the lower the 
predilection to aggregate will be, but also the lower the fungal growth (as illustrated in section 
3.4.3). Tyrocidines are soluble in ethanol concentrations of 10-20% (v/v) which in an assay 
environment gives final concentrations of 1-2% ethanol. We determined in section 3.4.3 that 
ethanol concentrations of 2.0% significantly decreases the growth of B. cinerea and F. solani. 
Such high ethanol concentrations may mask or synergise with peptide activity. Furthermore, B. 
cinerea and F. solani were more susceptible to increases in ethanol concentrations in YTSB and 
LB media. Consequently the activities of the Trc mixture, TrcC and GS were compared when 
prepared in either a 10% or 15% ethanol concentration (final concentrations of 1.0% and 1.5% 
ethanol) in PDB (Figure 3.9).  
According to the Newman-Keuls multiple comparison test the activities of the Trc mixture, TrcC 
and GS were significantly higher when prepared in a 15% ethanol solution than a 10% ethanol 
solution. Therefore in order to obtain maximum peptide activity, without simultaneously causing 
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a significant inhibitory effect from ethanol, an ethanol concentration of 15% (to give a final 
concentration of 1.5%) were chosen as standard to dissolve and dilute peptides. 
 
Figure 3.9: Comparison between the activity of the Trc mixture, TrcC and GS prepared either 
in 10% or 15% ethanol (EtOH) against B. cinerea grown in PDB. Antifungal 
activities of the Trc mixture, TrcC and GS were determined at 2.5 µg/mL prepared 
in either 10% or 15% ethanol, final ethanol concentrations in assay culture 1.0 % 
and 1.5%. According to the Newman-Keuls multiple comparison test the activity of 
the Trc mixture, TrcC and GS prepared in 15% ethanol is higher than that of 
peptides prepared in 10% ethanol (* P <0.05, ** P <0.01, *** P <0.001). The 
average of 18 repeats ± SEM is shown. 
3.4.5 Antifungal activity of tyrocidines and gramicidin S in PDB, PDA, YTSB, and YTSA. 
Various investigators in our group found that the tyrocidines’ activities against a variety of target 
cells is influenced by their environment. If the peptides are in an aqueous or organic 
environment, or if monovalent and divalent ions are present, their conformation and degree of 
self-assembly could be influenced (2). Different conformations and levels of self-assembly affect 
the type and/or degree of peptide activity (20, 21). Mediums with various compositions will 
therefore influence tyrocidine activity in varying degrees.  
Since F. solani exhibited the most rapid growth in YTSB (Figure 3.2 A) and B. cinerea in PDB 
(Figure 3.2 B), microdilution assays were used to compare the activities of the Trc mixture and 
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GS in PDB and YTSB liquid media; and on PDA and YTSA agar medium against F. solani and 
B. cinerea (Figure 3.10). In terms of the inhibition of F. solani the Trc mixture’s antifungal 
activity was higher in YTSB than in PDB (Figure 3.10 A). The tyrocidines’ activity decreased 
significantly on the agar mediums, especially PDA. For both PDA and YTSA 100 % inhibition 
of F. solani could not be reached at a concentration of 100 µg/mL. The activity of GS was more 
consistent in the various mediums. There was a slight decrease of activity on the agar medium, 
but not as significant as that for the Trc mixture. The variance in activity may either be ascribed 
to different growth forms of F. solani in the various mediums, differences in peptide 
conformation that may influence their activity or the shielding/masking of the peptide target in 
one or more of the mediums. 
The influence of medium composition on the activity of the Trc mixture and GS against B. 
cinerea was also determined (Figure 3.10 B). Inhibition of B. cinerea in PDB could be 
determined after 48 hours. However, as was illustrated in section 3.4.2, growth of B. cinerea is 
slow in YTSB and therefore inhibition determinations could only be performed after a period of 
96 hours. The activity of the Trc mixture was much more consistent against B. cinerea in the 
different mediums. A decrease in activity was again observed on the agar mediums, but was not 
as noteworthy. B. cinerea growth could still be inhibited at concentrations below 16 µg/mL. 
GS’s activity was again relatively consistent in/on all four mediums with slightly lower activity 
on the YTSA medium. 
The Trc mixture’s, and to a lesser extent GS’s, activities are influenced by the activity test 
environment. The degree whereby their activities differed was also affected by the target 
organism. The activity against B. cinerea in the different mediums does not seem to fluctuate as 
significantly as the activity against F. solani. Evidently the composition of the environment does 
not only have an influence on the growth of fungi, but also on the activity of the tyrocidines and 
GS. 
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Figure 3.10: Activity parameters for the Trc mixture and GS for inhibition of F. solani (A) and 
B. cinerea (B) in YTSA, YTSB, PDA and PDB. Activity determinations were 
performed in triplicate with triplicate technical repeats per assay ± SEM.
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3.5 Conclusion 
The tyrocidines were found to exhibit an increase in activity when higher percentages ethanol 
was used for the dissolving and dilution of peptides. However, at higher concentrations ethanol, 
fungal growth was inhibited. The growth of both F. solani and B. cinerea was unaffected at 
concentrations 1.5% ethanol and therefore 15% ethanol in peptide solvent must preferably be 
used to avoid any inhibitory effect as a result of ethanol, but to still retain tyrocidine activity. A 
concentration of 15 % ethanol was chosen as standard for peptide solvent and PDB was chosen 
as standard assay medium, especially for mode of action studies (Chapters 4-6). Furthermore, a 
final ethanol concentration of 1.5% was included in growth controls to normalise any influence 
ethanol may have on the results. All assays reported in Chapters 4-5 were performed in 
unblocked low protein binding microtiter plates. Since the growth of fungi, in this case F. solani 
and B. cinerea were clearly influenced by their environment, as well as the activities of the 
tyrocidine mixture and to a lesser extent GS, activity tests on PDA and in YTSB medium were 
also included in Chapters 4-5 to obtain a more accurate understanding of the tyrocidines 
antifungal action. 
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Addendum (Chapter 3) 
A novel 96-well gel-based assay for determining antifungal activity 
against filamentous fungi 
In the course of the development and optimisation of the antifungal assays, the significant effect 
of the assay environment on activity test results was observed. Furthermore, it was noticed that 
the morphogenic effect of the peptides (i.e. hyperbranching) influenced the accuracy of the assay 
results. Consequently an activity test was developed which will allow activity determination on 
an alternative medium to that of broth; and which will also minimise the inaccuracy experienced 
with assay tests that rely on spectrophotometric analysis of results. 
The Addendum to Chapter 3 has been published in Journal of Microbiological Methods, Volume 
91, September 2012, pages 551-558; first author A. M. Troskie (all experimental work, data 
analysis, writing of article, co-authors N. M. Vlok (initial experimental work) and M. 
Rautenbach (co-writer and editing, critical evaluation of study and data). This article, as 
published, is included as Addendum Chapter 3 of this thesis. 
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Abstract 
In recent years the global rise in antibiotic resistance and environmental consciousness lead 
to a renewed fervour to find and develop novel antibiotics, including antifungals. However, 
the influence of the environment on antifungal activity is often disregarded and many in vitro 
assays may cause the activity of certain antifungals to be overestimated or underestimated. 
The general antifungal test assays that are economically accessible to the majority of 
scientists primarily rely on visual examination or on spectrophotometric analysis. The effect 
of certain morphogenic antifungals, which may lead to hyperbranching of filamentous fungi, 
unfortunately renders these methods unreliable. To minimise the difficulties experienced as a 
result of hyperbranching, we developed a straightforward, economical 96-well gel-based 
method, independent of spectrophotometric analysis, for highly repeatable determination of 
antifungal activity. For the calculation of inhibition parameters, this method relies on the 
visualisation of assay results by digitisation. The antifungal activity results from our novel 
micro-gel dilution assay are comparable to that of the micro-broth dilution assay used as 
standard reference test of The Clinical and Laboratory Standard Institute. Furthermore, our 
economical assay is multifunctional as it permits microscopic analysis of the preserved assay 
results, as well as retendering highly reliable data. 
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1. Introduction 
The upsurge in antimicrobial resistance in recent years, together with the detrimental impact 
of conventional antibiotics on the environment, necessitates the search for novel 
antimicrobials (Hancock, 2001; Hancock, 1997; Steinstraesser et al., 2009). However, to 
assess the activity of potential antifungals, a standardised accurate quantitative test is vital. 
Various antifungal growth assays have been developed, each with their own advantages and 
disadvantages (Broekaert et al., 1990). The disc-plate diffusion assay, where substance 
saturated paper discs are placed on the top/at the edge of an emerging fungal lawn (Franrich 
et al.; 1983, Mauch et al. 1988, Roberts and Selitrennikoff, 1986), is a commonly utilised 
method (Broekaert et al., 1990). However, since the extent of fungal growth inhibition can 
merely be evaluated on arbitrary scores and the in situ concentrations cannot be accurately 
determined, the disc plate diffusion assay and analogous spot and radial assays are only semi-
quantitative tests (Broekaert et al., 1990). Furthermore, diffusion tests require an appreciable 
amount of the test substance and are not readily adapted for high throughput analyses. 
Methods that permit more accurate quantification of inhibition are procedures where the 
length of the fungal hyphae is measured (Broekaert et al., 1988) or were the dry mycelia 
weight is measured (Odebode et al., 2006). These methods are still not ideal as they are 
arduous and hyphi measurement can only be applied to young fungal germlings (Broekaert et 
al., 1990). Methods that are not based on light absorption distinguish between live and dead 
cells by either metabolic measurement (Broekaert et al., 1990) or flow cytometry (Green et 
al., 1994). However, the fungal development stage in one culture and thus metabolism is 
unfortunately not always uniform (Damir, 2006; Rautio et al., 2006) and it has also been 
observed that some organisms increase their metabolic rate when experiencing stress (Fehri et 
al., 2005; Hilpert et al., 2010; Tzeng et al., 2005). Consequently tests based on the 
measurement of metabolic components are not recommended for the evaluation of fungal 
Stellenbosch University http://scholar.sun.ac.za
4 
 
growth inhibition (Broekaert et al., 1990). With the purpose of eliminating the complications 
in fungal growth inhibition tests, Broekaert et al. (1990) developed a quantitative broth 
dilution assay based on the absorbance at 595 nm that was set as the standard reference test 
(M38-A2) for antifungal activity by The Clinical and Laboratory Standard Institute (CLSI) 
(previously known as The National Committee for Clinical Laboratory Standards, United 
States of America) (CLSI, 2008).  
As the broth assays could be adapted to be done in 96-well microplates, this assay could be 
used for high through put analyses. However the broth assay is highly dependent on 
spectrophotometric analysis. Moreover, fungi can be found in diverse niches on earth and do 
not always grow well in liquid environments. They can be surface pathogens on for instance 
grapes (Cotoras and Silva, 2005) and potatoes (El-Banna et al., 1984), or they can develop in 
the soil (Vakalounakis and Chalkias, 2004) or the xylem (Alaniz et al., 2007) of plants. 
Different fungi will therefore thrive in varying extents in various environments and 
consequently also in different experimental mediums and/or settings. Also fungi have 
different growth stages that generally differ in sensitivity to fungicides. It is therefore 
advisable that substances evaluated for its ability to inhibit fungal growth be tested in or on 
more than one growth medium and growth stage. Broth dilution assay only assess antibiotics 
on their ability to inhibit the fungi in a liquid environment.  
The broth dilution inhibition test assays, based on spectrophotometric measurements, are 
better suited to the more homogenous bacterial growth in suspension than heterogeneous 
fungal growth. The growth of bacteria increases the optical density of the medium uniformly 
giving a generally consistent increase in spectrophotometric measurements. However, 
antibiotics inhibiting fungal growth could have morphogenic and non-morphogenic activity 
on fungal growth of filamentous fungi. Morphogenic antifungals will alter the morphology of 
fungi while non-morphogenic antifungals, although inhibiting fungal growth, won’t lead to 
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any alterations in morphology. One of the effects of morphogenic antifungals is 
hyperbranching of filamentous fungi: natural hyphal elongation is inhibited and multiple 
germination tubes and hyphi form, leading to high density growth in one small area. The 
variable influence on fungal growth will therefore influence the detected changes in optical 
density; therefore assays based on spectrophotometric measurements could lead to variance 
in determination of inhibition parameters of filamentous fungi. 
Du Toit and Rautenbach (2000) developed a quantitative micro-gel well diffusion assay 
which adapted the traditional radial diffusion test for bacteria so that it can be performed in 
microtiter plates. This test has the advantage that a larger scale experiment can be executed 
with a smaller amount of test substance than is used for the conventional radial diffusion 
assays (du Toit and Rautenbach, 2000). The dose response results could also be enhanced 
using Coomassie blue staining and preserved using formaldehyde for future analyses. It has 
been suggested that gel-based methods are better able to assist in exposing antimicrobial 
resistance (Pfaller et al., 2001). Using this gel-based assay as basis, our aim was to develop 
an economical, practical gel-based antifungal assay, comparable to broth-based assays that 
will eliminate the complications experienced using conventional methods for determining 
filamentous fungal inhibition. We modified the method of Du Toit and Rautenbach (2000) for 
determination of fungal growth inhibition on solid environments. To limit or eliminate the 
variance of visual and spectrophotometric measurements as a result of hyperbranching, we 
utilised Coomassie blue to enhance the visualisation of fungal growth/inhibition, which was 
determined by simple digitisation of the dose-response result.  
2. Materials 
The fungal strains Fusarium solani and Botrytis cinerea was provided by the Department of 
Plant Pathology, University of Stellenbosch. The potato dextrose broth (PDB), potato 
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dextrose agarose (PDA) and Tween 20® were obtained from Fluka (St. Louis, USA). Ethanol 
(99.9%) and sodium chloride were obtained from Merck Chemicals (Pty) (Wadeville, 
Gauteng). The yeast extract powder, tryptone soy broth and agar agar powder for the yeast 
extract tryptone soy broth (YTSB) and yeast extract tryptone agarose were from Biolab 
Merck (Wadeville, Gauteng). Strawberry halves were used for B. cinerea growth. The sterile 
polypropylene plates were provided by Nunc (Denmark). Sterile culture dishes and microtiter 
plates where obtained from Corning Incorporated (USA) and sterile petri dishes from Lasec 
(Cape Town, South Africa). Analytical quality water was prepared by passing water from a 
reverse osmoses plant through a Millipore (Milford, USA) Milli Q® water purification 
system. 
3. Methods 
3.1 Growth and harvesting of fungi 
Fusarium solani were grown at 23-25 ˚C on PDA until sporulation (± 2 weeks). Spores were 
harvested with 3 mL of 0.1 % Tween-analytical water. Botrytis cinerea were grown on 
sterilised strawberry halves in culture dishes at 23-25 ˚C until sporulation (± 3 weeks). Spores 
were harvested dry, using vacuum. Spores were then counted using a counting chamber. 
Standard practices to ensure sterility were followed throughout these procedures. 
3.2 Determining growth in different mediums 
Growth of F. solani and B. cinerea in PDB and YTSB was determined using 96-well 
microtiter plates (Refer to Table 1 for media compositions). The suspensions for the broths 
consisted of half strength PDB or YTSB, together with fungal spores so that in the end, each 
well had a total of 2000 spores (Broekaert et al., 1990) and a volume of 100 µL. Plates were 
incubated at 23-25 ˚C and growth measured every 24 hours for 96 hours. Light dispersion of 
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each well was spectrophotometrically determined at 595 nm using a Biorad microtiter plate 
reader. 
3.3 Micro-broth dilution antifungal assay 
The activities of gramicidin S and bifonazole were determined against F. solani and B. 
cinerea using micro-broth dilution assays (Broekaert et al., 1990; du Toit and Rautenbach, 
2000). All procedures were performed so as to ensure sterility. The broth dilution assays were 
performed in sterile 96-well microtiter plates. The broth suspension consisted of fungal 
spores suspended in half strength PDB whereof 90 µL were added to the wells so that each 
well had a total of 2000 spores (Broekaert et al., 1990). Gramicidin S was dissolved in 15 % 
ethanol to a concentration of 1.00 mg/mL. Doubling dilution series were made in 
polypropylene microtiter plates using 15% ethanol. Bifonazole was diluted in 20% ethanol to 
a concentration of 1.00 mg/mL and doubling dilution series were made with half strength 
PDB. Antibiotic (10 µL) were then added to the wells containing broth suspension. Growth 
control received 10 µL of 15% ethanol instead of antibiotic. Sterility control was a 
combination of half strength PDB and a final ethanol concentration of 1.5%. All wells had a 
final volume of 100 µL. Subsequent to antibiotic addition the microtiter plates were covered 
tightly with tinfoil, sealed with parafilm and incubated at 23-25 ˚C for 48 hours. Light 
dispersion of each well was spectrophotometrically determined at 595 nm using a Biorad 
microtiter plate reader. 
3.4 Micro-gel antifungal assay 
The PDA (65 ˚C) was pipetted into sterile microtiter plates using the reverse pipetting method 
(du Toit and Rautenbach, 2000) so that each well contained 70 µL. On the cooled/set plates 
20 µL of spore-half strength PDB solution was added so that each well had 2000 spores. 
Gramicidin S and bifonazole were respectively dissolved in 15% and 20% ethanol to a 
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concentration of 1.00 mg/mL. Doubling dilution series were made in polypropylene 
microtiter plates using either 15% ethanol (gramicidin S) or half strength PDB (bifonazole). 
After the spores had time to settle on the PDA, a 10 µL of fungicide dilution was added. 
Growth control received 10 µL of 15% ethanol in water solution. Sterility control was a 
combination of 20 µL half strength PDB and 10 µL 15% ethanol. The microtiter plates were 
incubated at 23-25 ˚C for 48 hours. Light dispersion of each well was spectrophotometrically 
determined at 595 nm using a Biorad microtiter plate reader. 
Table 1 
Summary of characteristics of different mediums for fungal cultures 
Medium Abbr. 
Commo
n use 
Nitrogen 
Ferment-
able 
sugars 
Vita-
mins 
Salt Composition 
Potato 
dextrose 
broth/ 
agar 
PDB/ 
PDA* 
Primarily 
for 
fungal 
growth 
average high average average 
83% glucose, 17% potato 
extract, 9.5-10.5% N,  
<20% NaCl 
*includes 1% agar 
Yeast 
extract 
tryptone 
soy broth/ 
agar 
YTSB/
YTSA* 
Novel 
medium 
Very  
high 
average 
Very 
high 
Very 
high 
20% tryptone, 6.7% soy-
peptone, 46.7% NaCl, 3.3 
% hydrogen phosphate, 
3.3% dextrose, 20% yeast 
extract 
*includes 1% agar 
 
3.5 Staining and destaining 
The PDA plates were stained with Coomassie blue stain (0.063% Coomassie blue R-250, 
50% methanol, 10% acetic acid) for one hour. Subsequent to gently shaking out the stain, the 
plates were destained (12.5% isopropanol, 10% acetic acid) for 72 hours, changing the 
destain three times. The results were captured with a Canon 600D camera. 
3.6 Digitisation of results 
For the digitisation of the results from the stained PDA plates, high resolution (18 mega 
pixels) photographs of the plates were analysed as gels, converted to grey scale, in UN-
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SCAN-IT gelTM, version 6.1 from Silk Scientific Corporation. The average pixel count for 
each well was used to calculate the growth or growth inhibition of B. cinerea and F. solani by 
gramicidin S and bifonazole. 
3.7 Data processing 
In order to calculate the percentage growth inhibition the light dispersion or average pixel 
count at each concentration was used (Eq. 3.7.1) (Rautenbach et al., 2005).  
% growth inhibition      
    ( A595 of well - Average A595 of background)
Average A595 of growth wells - Average A595 of background
   3.7.1 
GraphPad Prism® 4.00 (GraphPad Software, San Diego, USA) were used to plot the growth 
and dose response curves. Non-linear regression and sigmoidal curves (with a slope <7) were 
fitted (Eq. 3.7.2) (Rautenbach et al., 2005) for dose response analysis.  
slopeActivityIC
bottomtopbottom
Y



50log101
)(
 
 
Top represents growth at high fungicide concentration and bottom growth in the absence of 
fungicide. The point halfway between top and bottom (IC50) represents the concentration 
necessary to cause 50% growth inhibition. The activity slope, related to the Hill slope, 
defines the slope of the curve. The ICmax represents the x-value at the intercept between the 
slope and the top plateau. The ICmax is therefore the calculated concentration of minimum 
inhibition (MIC) (Rautenbach et al., 2005). For determining the lethal concentration (LC) 
values we used the first fungicide concentration where no growth is both visually and 
microscopically observable in a well. 
GraphPad Prism® was also used for the statistical analysis of data. Analysis included 95% 
confidence levels, absolute sum of squares, standard error of the mean and Newman-Keuls 
multiple comparison test. 
3.7.2 
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4. Results and Discussion 
4.1 Growth of fungi in different environments 
Different species of fungi can be found in different niches on earth. It follows therefore that 
various fungal species will prosper in varying degrees in different mediums. We tested this 
hypothesis by monitoring the growth of F. solani and B. cinerea in/on different mediums 
(Refer to Table 1 for composition of media). 
Both B. cinerea and F. solani grew faster on the gelatinous YTSA and PDA than in the 
aqueous YTSB and PDB (Figure 1). In terms of nutrient composition F. solani prospered in 
the nitrogen and salt rich YTSB and YTSA mediums, while B. cinerea preferred the less 
complex PDB and PDA mediums (Figure 1). However, to more reliably determine growth 
inhibition the OD595 measurement must at least have a value >0.10 (OD reading reliable at 
two significant digits). B. cinerea only reached such growth density after 96 hours in 
YTSB/YTSA and consequently any broth assays performed in YTSA/YTSA with B. cinerea 
can only be evaluated after a period of 96 hours. Hence it was decided that micro-broth 
dilution assays, as well as a novel micro-gel assay using PDB and PDA respectively as 
growth media, will be utilised for development of our micro-gel assay and comparison of the 
antifungal activity of the commercial fungicide, bifonazole, and the broad spectrum 
antimicrobial and lytic peptide, gramicidin S. 
4.2 Antifungal assays 
Broth dilution assays will support fungal growth form and/or species that prosper in 
environments with high water and low oxygen levels. The variation in fungal growth on the 
different mediums suggest that the fungi will be more susceptible to fungicidal action in 
certain mediums than in other and thus the growth medium could have an influence on the 
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activity of the antifungal compounds tested. The use of only broth dilution assays is 
consequently not adequate in determining the scope of antifungal activity of a substance. 
Therefore, to better assess the activity of a potential fungicide, it is necessary to evaluate their 
activity both in liquid broth and on solid/gel media.  
We confirmed the antifungal activity of a known fungicide, bifonazole and a broad spectrum 
antimicrobial peptide, gramicidin S using a standard the micro-broth dilution antifungal assay 
accepted by the CLSI (CLSI, 2008), The two antifungal compounds exhibited micromolar 
liquid phase activity towards both B. cinerea and F. solani, the two selected filamentous 
fungal species (Table 2).  
 
 
 
 
 
 
 
 
 
 
Fig. 1. Growth of F. solani and B. cinerea in PDB and YTSB (A) on PDA and YTSA (B). 
The growth progression of the fungi in/on the various media was evaluated over a period of 
96 hours. Each growth measurement is the mean of at least 8 repeats ± SEM. Growth was 
determined spectrophotometrically. 
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Table 2  
Summary of the activity parameters obtained for bifonazole and gramicidin S against B. 
cinerea and F. solani.  
Growth 
Medium 
Fungal 
target 
Bifonazole Gramicidin S 
IC50±SEM (n) ICmax±SEM (n) IC50±SEM (n) ICmax±SEM (n) 
PDB 
B. cinerea 7.7 ± 1.6 (5) 16 ± 2.3 (5) 1.8 ± 0.3 (4) 2.7 ± 0.7 (4) 
F. solani 14 ± 1.7 (5) 53 ± 9.0 (5) 2.6 ± 0.2 (4) 5.3 ± 1.8 (4) 
PDA 
B. cinerea 9.6 ± 0.5 (4) 20 ± 0.3 (4) 2.2 ± 0.2 (4) 4.1 ± 0.2 (4) 
F. solani 25 ± 2.4 (5) 71 ± 8.7 (5) 6.1 ± 0.1 (7) 8.3 ± 0.3 (7) 
The inhibition parameter values of gramicidin S and bifonazole are given in µM. Each value represents the 
mean of n biological repeats, with 4 technical repeats per assay ± SEM. 
 
 
4.3 Development of a 96-well gel-based antifungal assay 
We adapted the micro-gel diffusion assay described by du Toit and Rautenbach (2000) to be 
suitable for antifungal activity determination. For example, PDA was used as solid growth 
medium, fungal spores were place on top of the gel and we introduced a novel data 
visualisation method using digitisation.  
Spectrophotometer light absorption readings of the micro-gel dilution assays were initially 
used to assess the activity of gramicidin S and bifonazole. Hyperbranching can influence 
results to over- or underestimate antifungal activity. Due to the hyperbranching and uneven 
growth, the readings were comparable, but slightly more error prone to that of the micro-
broth antifungal assay (results not shown). Optimisation of the data visualisation was 
therefore very important. Although most of the problems associated with the determination of 
antifungal activity in different environments are addressed by doing both the broth and 
micro-gel dilution assays, one problem still remains: hyperbranching of filamentous fungi 
induced by morphogenic antifungals. Hyperbranching leads to very dense growth of fungi on 
one spot and there is no hyphal elongation. Therefore the fungal growth is not uniform in a 
well and will lead to false readings, as most microtiter plate readers only determine the light 
absorption or dispersion through the middle of the plate’s well. A method where the growth 
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of the entire well can be determined will therefore be ideal, as well as having the option to 
determine mode of action and survival microscopically in the same assay.  
In our novel micro-gel assays, performed on PDA, the fungi in each well were stained with 
Coomassie blue (so as to be able to distinguish more accurately between areas of no growth 
and growth), photographed or scanned and analysed by digitisation software (UN-SCAN-IT 
gel
TM, version 6.1). The PDA plates stained satisfactorily and clear visual distinction could be 
made between growth and well with medium or no growth (Figure 2). Because the fungi were 
fixed and stained the result is preserved for further analysis, such as microscopy. In Figure 3, 
microscopy photographs of the fungal growth in some of the wells are shown and it is clear 
that the observed F. solani growth was due to hyperbranching in the presence of the 
antifungal compound. Furthermore, the staining process accentuates the morphology of the 
fungi which allows for enhanced microscopic photography (Figure 3). The ability to discern 
fungal morphology and colonies is enhanced. Therefore one is better able to detect any 
alterations induced by antibiotic action and, if the initial spore concentration is known, the 
inhibition of fungal germination/growth at a certain concentration of antibiotic can be 
determined through colony counting.  
Staining the PDA plates not only assisted in improving the microscopic visualisation, 
including hyperbranching, but also facilitated the preservation of the PDA plates (Figure 2). 
By digitally capturing the enhanced assay results and digitising it (specifically measuring the 
pixel intensity in each well) the well in its entirety is taken into account and a small patch of 
growth won’t be missed, or alternatively, seen as high/dense growth. The digitized data 
showed that our assays were highly repeatable with the standard error of the mean (SEM) for 
percentage inhibition at each concentration at less than 2%. 
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Fig. 2. A representative 96-well PDA plate with Coomassie blue stained F. solani. The dose 
response of bifonazole (columns 3-6) and gramicidin S (columns 8-11) towards F. solani are 
visualised by die blue stained fungi. The growth controls (Gr) are shown in column 2 and 
blank/sterility (Bl) controls in column 1. LC values are indicated with the dotted line. 
 
Fig. 3. Microscopic visualisation of the activity of gramicidin S and bifonazole against B. 
cinerea and F. solani cultured on PDA after Coomassie blue staining. Bifonazole (A2 80µM; 
A3 40µM; A4 20µM) and gramicidin S (B2 22µM; B3 11µM; B4 2.7µM) treated B. cinerea 
spores are compared to growth control (B1) and sterility control (A1). F. solani growth 
control (D1, C1 is sterility control) is compared to F. solani treated with bifonazole (C2 
322µM; C3 161µM; C4 40µM) and gramicidin S (D2 22µM; D3 11µM; D4 5.5µM). Images 
were captured using a Leica light microscope coupled to a DCM 510 digital camera. 
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4.4 Comparison of inhibition parameters determined on agar gel and in broth media 
Comparing the dose response curves obtained from the broth assay with digitised assay 
results for the two fungicides towards F. solani and B. cinerea, a marked increase in 
repeatability and prediction accuracy is visible (Figure 4). In terms of the repeatability for the 
individual antibiotic concentrations, the error (95% confidence interval) is less for the 
digitised gel-based assay results than for the broth assay results. Evaluating the dose response 
as a whole, the 95% prediction interval for the sigmoidal fits for the digitised gel-based assay 
results are narrower/closer to the fitted sigmoidal line, than for the broth dilutions assays. In 
our hands we found more consistent repeats for the individual fungicide concentrations and a 
better sigmoidal fit to the data points obtained for the digitised gel-based assay results than 
for the broth dilution assays. Especially for B. cinerea, a culture that exhibits significant 
hyperbranching and resultantly gave more variation between experimental repeats using 
spectrophotometric measurements, a more reliable sigmoidal fit could be obtained for the 
experimental repeats for the digitised gel-based assay than for the broth-based assay repeats. 
In terms of the repeatability for the determination of activity parameter against the two 
filamentous fungi, the 96-well gel-based assay consistently delivered more accurate 
parameter results with regard to standard error of the mean (Table 2, Figures 5 and 6). 
Gramicidin S and, to a lesser extent, bifonazole inhibited the growth of both B. cinerea and F. 
solani during PDB assays and PDA assays (Table 2). However, some variance in the activity 
parameters obtained for gramicidin S and bifonazole could be observed between the results 
from the PDB assays and the digitised PDA assays. A small, but non-significant increase was 
observed in the activity parameters for bifonazole against B. cinerea with the IC50 value 
increasing from 7.7 µM in PDB assay to 9.6 µM for the digitised assay (Figure 6). The ICmax 
value increased from 16 µM to 20 µM, with some hyperbranching visible at 20 mM. (Table 
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2). The same LC for bifonazole was found in both types of assays (indicated with arrow in 
Figure 5). The activity parameters for gramicidin S against B. cinerea also remained 
relatively constant, only increasing slightly from 1.8 µM to 2.2 µM for the IC50 value, 2.7 µM 
to 4.1 µM for the ICmax value, but giving the same LC in both assays (indicated with arrow in 
Figure 5). Extensive hyperbranching was visible at 2.7 mM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Representative dose response curves of bifonazole against F. solani (top two graphs) 
and B. cinerea (bottom two graphs) in PDB (left hand graphs) and PDA (right hand graphs). 
The solid line in each graph represents the sigmoidal fit to the data points. The dotted lines 
represent the 95% prediction interval for the sigmoidal line fit to the data. Each data point is 
the mean of at least 16 determinations and the error bar represents the 95% confidence 
interval of the data point. 
A significant change was observed in the activity parameters for both bifonazole and 
gramicidin S against F. solani from the PDB assay results to the digitised PDA assay results 
(Figures 5 and 6). An increase in the IC50 value of bifonazole of almost two fold (14 µM to 
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25 µM) was observed and the ICmax value increased from 53 µM to 71 µM, by a factor of 1.3. 
We also observed that the bifonazole LC value doubled (indicated with arrows in Figure 5), 
which may be an overestimation as extensive hyperbranching was detected at 40 mM (Figure 
3).  
 
 
 
 
 
 
 
 
 
 
Fig. 5. Representative dose response curves illustrating the activity of bifonazole against F. 
solani (A) and B. cinerea (C), and gramicidin S against F. solani (B) and B. cinerea (D) in 
PDB and on PDA. The arrows indicate the lethal concentrations where no growth was 
observed. Each data point represents the mean of at least quadruplicate biological repeats ± 
SEM, with quadruplicate technical repeats per assay. R2>0.997 was found for the sigmoidal 
fit of all the curves to the means of the data points. 
Similarly a significant increase in the IC50 value (2.6 µM to 6.1 µM) from PDB assay results 
to the digitised PDA assay results was also observed for gramicidin S (Figure 6). This 
correlated with the increased ICmax value from 5.3 µM to 8.3 µM (Table 2) and doubling of 
the LC value for gramicidin S (indicated with arrows on Figure 5), which may again be 
related to hyperbranching (Figure 3).  
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Fig. 6. Comparison of IC50 values obtained using results from PDB and digitised PDA assays. 
The average IC50 values ± SEM of gramicidin S (GS) against B. cinerea (Bc) and F. solani 
(Fs) and of bifonazole (Bf) against B. cinerea and F. solani are shown. One way ANOVA 
with Newman-Keuls multiple comparison test was used for the statistical analysis of at least 
quadruplicate biological repeats with quadruplicate technical repeats per assay.  
The observed decrease in activity of bifonazole and gramicidin S from broth to agar gel 
medium could be the result of an overestimation of the activity of bifonazole and gramicidin 
S against F. solani in the micro-broth assays. However, the decrease in activity may also be 
the result of variances in growth of fungal species in different environments, and a resultant 
increase in their ability to resist fungicide action in certain environments. The observed 
variance in activity may also be explained by differences in the mode of action employed by 
the antibiotics in/on different environments and that the specific mechanism of action of the 
antibiotics permits for better activity in a liquid environment. A liquid environment may also 
allow for better/uniform distribution of the antibiotic and resultantly higher antifungal 
activity is observed. However, the fact that both the activities of gramicidin S and bifonazole 
decreased significantly against only F. solani supports the idea that it is the growth of F. 
solani that is altered from the aqueous PDB environment to the gelatinous PDA environment, 
rendering F. solani less susceptible to fungicide action. This argument is supported by the 
Bf vs Fs GS vs Fs Bf vs Bc GS vs Bc
0
5
10
15
20
25
30
PDB
PDA
P<0.001
P<0.001
Compound and fungal target
A
c
ti
v
it
y
 (
IC
5
0
 i
n
m
M
)
Stellenbosch University http://scholar.sun.ac.za
19 
 
results depicted in Figure 1 that illustrates the enhanced growth of F. solani on PDA 
compared to that in PDB.  
Our results are comparable with that of Llop et al. (Llop et al., 1999) and Fernandez-Torres et 
al. (2003) who found that fungicide activity is dependent on the chosen medium. Evidently 
the “environmental factors” of the chosen activity test must be taken into account when 
assessing a novel anti-fungal and that more than one environmental condition must be 
included in the evaluations.  
5. Conclusions 
The digitised micro-gel assay method developed through this research decreases the 
difficulties experienced as a result of hyperbranching. Digitisation of results allows 
measuring of growth in the entire well in contrast to spectrophotometric results which usually 
only give a representation of the middle of the well. Therefore, the growth inhibition results 
obtained from the digitised micro-gel assays give a more realistic portrayal of growth/no 
growth in the entire well with a smaller error margin and higher repeatability (Figure 4). Our 
novel gel-based activity assay also provides additional benefits for the user. The staining 
process not only allows for the digitisation of results, but also improves the microscopic 
visualization of fungal morphology. This opens up doors for additional analysis of fungal 
inhibition that includes the study of the retardation/prevention of germination and any 
alterations in fungal morphology induced by the antifungal action (Figure 3). Furthermore, 
the staining process also allows for the preservation of the results. The minor downside of the 
gel-based method is that it is slightly more time consuming than the broth-based method. 
However, the multi-functionality and reliability of our novel 96-well gel-based antifungal 
assay renders it a straightforward useful method for determining antifungal activity against 
filamentous fungi.  
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Chapter 4 
Inhibition of agronomically relevant fungal  
phytopathogens by the tyrocidines 
4.1 Introduction 
With approximately one billion undernourished individuals on earth and a global population of 
seven billion people that is still growing, global food security is under threat. Microbial 
pathogens, including fungi, augment this predicament by causing a loss of up to 16 % (1) in the 
annual global food production. Furthermore, some fungal species secrete mycotoxins which can 
be toxic, as well as mutagenic with long term exposure, when ingested by humans and animals 
(2, 3). 
Conventional chemical fungicides are used to control fungal pathogens (4-7). However, there is 
increasing evidence of their detrimental effect on the environment and human health (8, 9). In 
addition, a number of fungal strains have developed resistance against conventional fungicides 
(7, 10). Therefore alternative, eco-friendly fungicides with a low risk for inducing resistance 
need to be developed (6, 9). 
Antimicrobial peptides (AMPs), with their broad range of activity and rapid antimicrobial action 
(11, 12), can be considered as potential alternatives to fungicides (5, 13-16). Furthermore, cyclic 
AMPs are more resistant to degradation by proteases (17), an advantageous property for 
agricultural application. Unfortunately the antimicrobial activity of AMPs has been shown to be 
negatively influenced by the presence of cations such as Ca2+, Mg2+, K+ and Na+ (14, 18) that are 
prevalent in the biosphere, agricultural and food products. Consequently, to be considered useful 
for agricultural application, an AMP must be active in the presence of these cations at 
biologically relevant concentrations. 
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The bacterium, Bacillus aneurinolyticus, produces a group of analogous peptides, namely the 
tyrocidines, as part of their secondary metabolite complex tyrothricin (19, 20),  The tyrocidines 
are part of a cyclic decapeptide family with conserved sequences forming β-sheets (21-23), only 
varying in one to three amino acid residues (refer to Tang et al. (20) and Chapter 1 for the 
primary structures of 28 natural tyrocidines). Following their discovery, it was illustrated that 
tyrocidines have significant antibacterial (24, 25) and anti-malarial (26) activity. However, to 
date only one study has been conducted on the antifungal activity of tyrothricin (the tyrocidine-
gramicidin metabolite complex of B. aneurinolyticus) against Candida albicans (27) and one 
report on the activity of tyrocidines against Neurospora crassa (28). The potential of tyrocidines 
to inhibit fungal phytopathogens and subsequently to act as a potential bio-fungicide, thus 
remains unexplored. The significant activity illustrated by the tyrocidines against bacteria (19, 
24, 25) and Plasmodium falciparum (26) prompted the investigation into the tyrocidines 
antifungal activity. The activity of the mixture of tyrocidines (Trc mixture) and eight tyrocidines 
and analogues (purification described in Chapter 2) were determined against selected 
agronomically important phytopathogens namely Fusarium solani, F. oxysporum, F. 
verticillioides, Cylindrocarpon liriodendri, Botrytis cinerea and Penicillium digitatum, P. 
glabrum, P. expansum, Talaromyces mineoluteus, T. ramulosus, Asperigellus fumigatis and 
Trichoderma atroviride isolates. The tyrocidines’ effect on fungal membrane integrity and the 
influence of the cations Ca2+, Mg2+, Na+ and K+ on their antifungal activity were also 
investigated.  
4.2 Materials 
Tyrothricin, bifonazole, trifluoroacetic acid (TFA, >98%), propidium iodide, Coomassie Blue R-
250 and gramicidin S (GS) were supplied by Sigma (St Louis, USA). The tyrocidine mixture and 
purified peptides were prepared as described in Chapter 2. Merck Chemicals (Wadeville, South 
Africa) supplied the sodium chloride, calcium chloride, magnesium chloride and ethanol 
(99.9%). Methanol and acetonitrile (HPLC-grade, far UV cut-off) were supplied by Romil Ltd. 
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(Cambridge, UK). Zymo Research (California, USA) supplied the ZR Fungal/Bacterial DNA Kit 
while Kapa Biosystems (Woburn, USA) supplied the Kapa Readymix. The Big Dye terminator 
cycle sequencing premix kit was obtained from Applied Biosystems (California, USA). The 
Tween 20®, potato dextrose broth (PDB) and potato dextrose agarose (PDA) were obtained from 
Fluka (St. Louis, USA). Biolab (Wadeville, South Africa) supplied the tryptone soy broth (TSB) 
powder, yeast extract and agar powder. Potassium chloride was provided by BDH Laboratory 
Supplies (Poole, England). Nunc (Roskilde, Denmark) supplied the polypropylene plates while 
Corning Incorporated (Corning, USA) supplied the sterile microtiter plates and culture dishes. 
The SYTOX green was obtained from Lonza (Walkersville, USA). Analytical quality water was 
prepared by passing water from a reverse osmoses plant through a Millipore (Milford, USA) 
Milli Q® water purification system.  
Asperigellus fumigatis ATCC 204305 and Fusarium oxysporum ATCC 10913 were from the 
American Type Culture Collection (ATCC) (Manassas, VA, USA). Fusarium solani STEU 
6188, Fusarium verticilliodes CKJ1730, Botrytis cinerea CKJ1731, Cylindrocarpon liriodendri 
STEU 6170 were provided by the Department Plant Pathology, University of Stellenbosch. 
Penicillium expansum CKJ1733 and Penicillium digitatum CKJ1734 were isolated from infected 
tangerines (July 2012, Stellenbosch, South Africa); Talaromyces mineoluteus CKJ1736 and 
Talaromyces ramulosus CKJ1735 were isolated from infected nectarines (March 2012, 
Stellenbosch, South Africa); Penicillium glabrum CKJ1732 and Trichoderma atroviride 
CKJ1729 were isolated from wood pallets used in the grape industry (February 2012, 
Wellington, South Africa). The isolated fungal species and strains were subsequently identified 
by us and placed in the CJK culture collection at department of Microbiology, University of 
Stellenbosch. 
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4.3 Methods 
4.3.1 Growth and harvesting of fungi 
F. solani, F. oxysporum, F. verticilliodes, C. liriodendri, P. digitatum, P. glabrum, P. expansum, 
T. mineoluteus, T. ramulosus, A. fumigatis and Tr. atroviride were grown at 25 ˚C on PDA until 
sporulation (± 2 weeks). Spores were harvested with 3 mL 0.1 % Tween-analytical water. B. 
cinerea was grown in culture plates on sterile strawberry halves at 23-25 ˚C until sporulation (± 
3 weeks). B. cinerea spores were harvested dry using vacuum. Subsequent to harvesting, spores 
were counted using a counting chamber. Standard practices to ensure sterility were followed.  
4.3.2 Identification of isolated fungi 
Fungal strains were identified by growing the strains on malt extract agar and Czapek yeast agar 
for seven days.  Based on conidiophore morphology, strains were placed into genera.  For 
species identification, DNA was extracted from strains after growing on PDA for seven days, 
using the ZR Fungal/Bacterial DNA Kit.  The ITS1–5.8S–ITS2 rDNA and -tubulin gene region 
was amplified using polymerase chain reaction (PCR).  Reaction mixtures (25 L) consisted of 5 
L Kapa Readymix and 0.250 M of primers ITS1 and ITS4 (29) for the internal transcribed 
spacer (ITS) region and primers Bt2a and Bt2b (30) for the -tubulin gene.  PCR products were 
sequenced using a Big Dye terminator cycle sequencing premix and sequenced with an ABI 
PRISM 310 automatic sequencer.  Sequence contigs were aligned in ClustalX (31) and manually 
adjusted in Se-Al (32) using a dataset of Visagie & Jacobs (33). The Trichoderma strain was 
identified using the Trichoderma database (nt.ars-grin.gov/taxadescriptions/ 
keys/TrichodermaIndex.cfm), as well as the online key to species of Trichoderma (TrichoKey) 
(34). 
4.3.3 Broth microdilution assays in broth media 
The activity of the Trc mixture against F. solani, F. oxysporum, F. verticillioides, C. liriodendri, 
B. cinerea, P. digitatum, P. glabrum, P. expansum, T. mineoluteus, T. ramulosus, A. fumigatis 
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and Tr. atroviride, as well as the activity of the eight purified tyrocidines and analogues, against 
B. cinerea and F. solani, were determined using broth microdilution assays (25, 35). Standard 
practices to ensure sterility were followed. The broth microdilution assays were performed in 
sterile 96-well microtiter plates. Of a 2.5 × 104 spores/mL broth suspension (PDB/water, 1:1, v/v) 
90 µL was added to each well (35). Alternatively, PDB was replaced by yeast supplemented 
tryptone soy broth (YTSB, TSB containing 20% m/v yeast extract). The Trc mixture was 
dissolved in 15 % ethanol to a concentration of 1.00 mg/mL. Doubling dilution series were made 
in polypropylene microtiter plates using 15% ethanol. Peptide (10 µL) was then added to the 
wells containing broth suspension. Growth control received 10 µL of 15% ethanol instead of 
peptide. Sterility control was a combination of half strength PDB (or YTSB) and 10 µL of 15% 
ethanol. All wells had a final volume of 100 µL and final ethanol concentration of 1.5%. As 
control the activity of bifonazole was determined against F. solani and B. cinerea. Bifonazole 
was dissolved in 20% ethanol to a concentration of 1.00 mg/mL and doubling dilution series 
were made using half strength PDB. Subsequent to peptide/fungicide addition, the microtiter 
plates were incubated at 23-25 ˚C for 48 hours. Light dispersion of each well was determined 
spectrophotometrically at 595 nm using a BioRad microtiter plate reader. 
4.3.4 Micro-gel dilution assays on potato dextrose agarose   
Micro-gel dilution assays were used to determine the activity of the Trc mixture on agar medium 
against F. solani and B. cinerea. The method as described by Troskie et al. (36) was followed. In 
brief, 96-well microtiter plates containing 70 µl PDA per well were prepared using the reverse 
pipetting method (36). Of a 1 × 105/mL spore-half strength PDB (PDB/water, 1:1, v/v) solution, 
20 µL were added to each well. The Trc mixture was prepared as described for the broth assays. 
Following peptide addition, the microtiter plates were incubated at 23-25 ˚C for 48 hours. The 
plates were subsequently stained with Coomassie Blue (0.063 % Coomassie Blue R-250, 50 % 
methanol, 10 % acetic acid) for one hour and afterwards destained (12.5 % isopropanol, 10 % 
acetic acid) for 72 hours. Results were captured with a Canon 600D camera. Image results were 
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analysed as gels in UN-SCAN-IT gel™ (version 6.1 from Silk Scientific Corporation) and the 
average pixel count for each well used to calculate growth inhibition (36). 
4.3.5 Light microscopy of peptide challenged spores and hyphae 
For the fungal hyphae studies, half strength PDB suspension containing spores of either B. 
cinerea or F. solani were distributed into the wells of sterile 96-well microtiter plates so that 
each well held a volume of 90 µL and 2000 spores. The plates were incubated for 16 hours at 23-
25˚C. The tyrocidines were dissolved and diluted in 15% ethanol using polypropylene plates. 
The final Trc mixture concentrations were 9 µg/mL (for F. solani) and 6 µg/mL (for B. cinerea). 
TrcA and TrcB were respectively added to F. solani and B. cinerea spores at concentrations of 6 
µM and 4.5 µM. Controls received 10 µL of a 15% ethanol solution (final concentration of 
1.5%). Each well had an end volume of 100 µL. The microscope studies with B. cinerea and F. 
solani spores were performed using the procedures described for the hyphae, leaving out the 16 
hour incubation step. Subsequent to the addition of the Trc mixture; events were monitored using 
a Leica light microscope coupled to a DCM510 digital camera 2 hours, 12 hours and 24 hours 
after peptide addition. 
4.3.6 Fluorescence microscopy 
Half strength PDB containing B. cinerea spores (2.5 × 104 spores/mL) were added to sterile 
microtiter plates in order for each well to have a volume of 90 µL. The Trc mixture (10 µL), 
dissolved in 25% ethanol and diluted in analytical grade water, was subsequently added so that 
the final peptide concentration was 3 µg/mL (± 2.3 µM) and the final ethanol concentration was 
less than 0.3%. The growth control had a final ethanol concentration of 0.3%. After incubation at  
25 ˚C for 2 hours for spores and 24 hour for hyphae, the cultures were incubated with 0.1 µg/mL 
propidium iodide for 15 minutes prior to image acquisition. Images were captured with a Nikon 
Eclipse E600 fluorescence microscope, using ultraviolet filters, fitted with a 100× Apochromat 
objective and a Media Cybernetics CoolSNAP-Pro monochrome cooled CCD camera. 
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F. solani hyphae were grown in half strength PDB from a starting concentration of 2.0 × 104 
spores/mL for 16 hours at 25˚C. Hyphae were incubated at 25 °C for 1 hour with 25 µM TrcA, 
TrcB, TrcC, GS and 25 µg/mL Trc mixture. Subsequent to the 1 hour incubation step, the hyphae 
were incubated for 10 minutes with 0.5 µM SYTOX green (37). SYTOX green uptake was 
captured with a Carl Zeiss confocal LSM 780 Elyra S1. The laser was set at 488 nm and the filter 
at 500-676 nm. The collected data was processed using ZEN 2011 software. 
4.3.7 Pre-incubation of peptides with chloride salts 
Procedures were followed as described for the broth microdilution assays with a few 
adjustments. Briefly, the Trc mixture, TrcA, TrcB and TrcC were pre-incubated for 60 minutes 
in NaCl, KCl, CaCl2 or MgCl2 at concentrations ranging from 2.0-100 mM. Each well received 
90 µL of the spore-broth suspension followed by the addition of 10 µL tyrocidine-cation 
suspension so that the wells had a final concentration of 6 µg/mL (Trc mixture) or 5 µM (TrcA, 
B and C) for B. cinerea and 18 µg/mL (Trc mixture) or 12 µM (TrcA, B and C)  for F. solani.  
The growth control received 10 µL of 15% ethanol pre-incubated in chloride salts. The activity 
control received Trc mixture or pure peptides without the chloride salts. Sterility control 
consisted of half strength PDB and final ethanol and chloride concentration of respectively 1.5% 
and 10 mM. After the addition of tyrocidine-salt mixture, the microtiter plates were incubated at 
25 ˚C for 48 hours. Light dispersion of each well was determined using a BioRad microtiter plate 
reader set at 595 nm. 
4.3.8 Data analysis 
In order to calculate the percentage growth inhibition the light dispersion at each concentration 
(average pixel count for PDA plates) was used as described by Rautenbach et al (38). GraphPad 
Prism® 4.03 (GraphPad Software, San Diego, USA) were used to plot the dose response curves. 
Non-linear regression and sigmoidal curves (with a slope default setting at <7 ) were fitted for 
dose response analysis (38). The point halfway between top and bottom (IC50) represents the 
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concentration necessary to cause 50% growth inhibition. The minimum inhibition concentration 
(MIC), calculated as the x-value at the intercept between the slope and the top plateau of a full 
dose-response curve, was denoted as ICmax (38) to make the distinction with MIC values 
obtained from visual inspection of a dose-response result. 
GraphPad Prism® 4.03 was also used for the statistical analysis of data. Analysis included 95% 
confidence levels, absolute sum of squares, standard error of the mean (SEM), ANOVA 
analyses, Bonferoni’s test and unpaired Student t-test. 
4.4 Results and discussion 
4.4.1 Antifungal activity of the tyrocidines  
The activity of antifungals has been shown to be influenced by the activity test’s environment 
(Chapter 3 and (36)). Agar-based methods have also been proposed to aid in the exposure of 
resistant microorganisms (39). Therefore both a broth-based assay (25, 35) and a gel-based assay 
described by Troskie et al. (36) was used to evaluate the Trc mixture’s activity against F. solani 
and B. cinerea on a gelatinous environment (Figure 4.1).  
 
 
 
 
 
 
Figure 4.1: Comparison of Trc mixture activity using broth (PDB) and gel-based microdilution 
assays (PDA) against F. solani (A) and B. cinerea (B). Each data point represents 
the mean ± SEM of duplicate biological repeats  with 3-4 technical repeats per 
biological repeat.  
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The Trc mixture showed potent activity in the broth media against both target cells and retained 
its activity on gel media against B. cinerea with a slight ICmax increase from 4.8 to 7.6 µg/mL. 
However, the tyrocidine’s activity was significantly reduced against F. solani on PDA medium 
relative to the PDB medium (Figure 4.1). The ICmax obtained against F. solani in PDB was 7.1 
µg/mL, while on the PDA, even at a concentration of 100 µg/mL, 100 % inhibition could not be 
reached. From these results it was, however, evident that the tyrocidines do have potent 
antifungal activity, particularly in broth media, therefore all the subsequent assays were 
performed in broth media. 
In order to put the Trc mixture’s antifungal activity into perspective, its ability to inhibit F. 
solani and B. cinerea was compared to that of bifonazole, a known antifungal, and to the purified 
tyrocidines and analogues (Figure 4.2, also refer to Table 4.1 and Figure 4.3).  
 
 
 
 
 
 
 
 
Figure 4.2: Comparison of the antifungal activity of Trc mixture, purified tyrocidines and 
bifonazole against B. cinerea and F. solani. The average of at least 5 biological 
repeats (each with 3-4 technical repeats) with standard error of the mean (SEM) is 
shown. Significant differences in activity between bifonazole and all the tyrocidines 
against F. solani (***P<0.001) and B. cinerea (**P<0.01) were found with One-
way ANOVA using Bonferoni’s test. The tyrocidines/analogues all had similar 
activity (P>0.05).  
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Both the activities of the Trc mixture and purified tyrocidines were significantly higher than that 
of bifonazole. The Trc mixture’s and the purified tyrocidines activities were statistically similar 
(P>0.05), which substantiates the theorem that the individual tyrocidines contribute similarly to 
the antifungal activity in the Trc mixture (Figure 4.3). Due to the conserved nature of the 
tyrocidine structure it is highly probable that they share a similar major mode of action and 
target. Only the activity of the tryptocidine, TpcC, was significantly lower than that of the other 
tyrocidines, PhcA as well as that of GS against B. cinerea and F. solani, in PDB media (which 
can be considered a low salt media) (Figure 4.3A). Since the environment/culture conditions of 
fungi may influence their target cell properties, as well as growth and the peptide environment 
may influence peptide activity, selectivity and peptide mechanism of antimicrobial action (13, 
40-42), the activity determinations were also performed in YTSB (considered as a high salt 
media). When the activities of the individual tyrocidines were determined in YTSB (Figure 
4.3B) the phenycidine, PhcA, stood out as the peptide with significantly lower activity compared 
to the other tyrocidines.  
Sequence wise these two analogues differ from some of the tyrocidines in only one residue, 
namely a Trp7 or Phe7 instead of the Tyr7 of the major tyrocidines. The side chain of Trp 
contains a bicyclic indole group which makes it structurally larger than Tyr. Tyr only differs 
from Phe in an additional OH-group. However, this minor difference makes tyrosine 
amphipathic, dipolar and ionisable (pKa = 10.07). Phe and Trp are also more hydrophobic than 
Tyr (Tyr>Trp>>>Phe) (44). The three aromatic amino acids also differ in their hydropathies (Phe 
= 2.8, Trp = -0.9, Tyr = -1.3) (43). It could be that the Tyr residue has the optimal chemical 
properties for target interaction and activity in both the low salt (PDB) and high salt (YTSB) 
media. 
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Table 4.1: Antifungal activities of the tyrocidine mixture, the eight purified tyrocidines and gramicidin S against B. cinerea and F. solani  
 
Peptide 
B. cinerea PDB B. cinerea YTSB F. solani PDB F. solani YTSB 
ICmax ± SEM (n) IC50 ± SEM (n) ICmax ± SEM (n) IC50 ± SEM (n) ICmax ± SEM (n) IC50 ± SEM(n) 
ICmax ± SEM 
(n) 
IC50 ± SEM (n) 
Trc mix 4.8±0.7 (6) 3.0 ± 0.2 (6) 3.7 ± 0.9 (3) 2.6±0.5 (3) 9.3±1.2 (3) 3.8± 0.4 (3) 5.2  0.4 (3) 3.4±0.1 (3) 
TpcC 8.9±1.5 (3) 4.8±0.1 (3) 5.0±0.4 (3) 3.4±0.3 (3) 32±2.8 (3) 18±4.5 (3) 18±5.8 (3) 7.9±1.8 (3) 
TrcC1 3.5±0.2 (6) 2.4±0.2 (6) 4.9±0.3 (3) 3.4±0.3 (3) 4.3±0.4 (3) 3.2±0.2 (3) 7.8±1.9 (3) 4.9±0.7 (3) 
TrcC 3.6±0.1 (6) 2.3±0.2 (6) 4.5±0.4 (3) 3.0±0.1 (3) 5.9±0.6 (3) 3.5±0.2 (3) 6.7±0.6 (3) 3.7±0.1 (3) 
TrcB1 5.1±1.0 (6) 3.3±0.4 (6) 6.3±1.7 (3) 4.1±0.6 (3) 11±4.0 (3) 7.7±2.6 (3) 8.3±1.4 (3) 5.5±1.0 (3) 
TrcB 4.1±0.7 (6) 2.6±0.2 (6) 4.4±0.4 (4) 2.5±0.2 (4) 7.9±0.7 (3) 5.7±0.4 (3) 9.1±2.1 (3) 4.6±0.8 (3) 
TrcA1 5.2±0.6 (6) 3.5±0.4 (6) 4.7±0.2 (4) 3.3±0.1 (4) 4.0±0.4 (3) 2.9±0.3 (3) 7.5±1.5 (3) 5.5±1.0 (3) 
TrcA 3.6±0.2 (6) 2.6±0.1 (6) 3.3±0.3 (3) 2.0±0.1 (3) 4.6±0.9 (3) 3.2±0.4 (3) 5.4±0.5 (3) 3.3±0.2 (3) 
PhcA 6.9±1.4 (5) 4.7±1.1 (5) 15±2.4 (3) 10±1.7 (3) 7.2±1.0 (3) 5.2±0.8 (3) 34±7.8 (3) 18 ±1.2 (3) 
GS 1.8±0.3 (7) 1.3±0.2 (7) 2.5±0.0 (4) 1.8±0.1 (4) 2.2±0.1 (3) 1.6±0.1 (3) 8.4±1.2 (3) 4.8±0.9 (3) 
The values of the tyrocidine mixture are given in µg/mL and those of the purified peptides and gramicidin S in µM. Each value represents the mean of n biological repeats, with 
3-5 technical repeats per assay±SEM. 
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Figure 4.3: The activities of the tyrocidines in PDB (A) and YTSB (B) are compared in terms 
of their activity parameters (ICmax) against both F. solani and B. cinerea. Activity 
determinations were performed at least in triplicate. According to the Newman-
Keuls multiple comparison test the ICmax of TpcC for F. solani in PDB was 
significantly higher (***P<0.001) than all the other peptides and for B. cinerea 
significantly higher than TrcA, TrcB, TrcC1 (***P<0.001), TrcA1, TrcB1, TrcC 
and PhcA ($$P<0.01). In YTSB PhcA’s ICmax against B. cinerea was significantly 
higher than that of TrcA1, TrcB1, TrcC1, TpcC (**P<0.01), TrcA, TrcB and TrcC 
($P<0.05). For F. solani PhcA’s ICmax was also significantly higher than that of 
the major tyrocidines (***P<0.001) and that of TpcC (##P<0.01). 
Surprisingly no activity-structure relationships regarding the tyrocidines’ other 
structural/chemical parameters could be established. Neither the size of the tyrocidines, their 
surface area, side chain surface area nor lipophilicity seemed to play a role in the degree of 
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antifungal activity exhibited by the tyrocidines (results not shown). Minor differences in activity 
are most probably due to minor differences in peptide aggregation (21, 23), such as different 
tendencies to form dimers and higher order structures (44) which can potentially influence the 
initial binding to the fungal target. Furthermore, small differences in amino acid structure can 
influence the tightness of binding to the targets.  For example, tightness of binding of the 
tyrocidines to membranes could be modulated by the cationic residue (Lys or Orn) and the 
aromatic amino acid residues (26).  
However, it must also be kept in mind that the structure-activity relationships of individual 
tyrocidines may not give an adequate representation of the true activity events. A hypothesis has 
also been proposed suggesting that the tyrocidines form higher-order structures for biological 
activity (44, 45). In this scenario the structural and chemical characteristics of this higher-order 
structure has to be taken into account and not necessarily that of the individual tyrocidines when 
comparing activities. The higher antifungal activity observed for the major tyrocidines may 
imply that the presence of a Tyr7 may favour the formation of a higher-order structure with high 
antifungal activity and/or stability in various environments. 
With the purpose of determining the spectrum of antifungal activity of the tyrocidines, the 
growth inhibition by the Trc mixture was assessed using microbroth dilution assays with F. 
solani, F. oxysporum, F. verticillioides, C. liriodendri, B. cinerea, P. digitatum, P. glabrum, P. 
expansum, T. mineoluteus, T. ramulosus Tr. atroviride and A. fumigatis as target organisms. 
With IC50 values between 2.0 and 8.9 µg/mL, the Trc mixture exhibited significant inhibitory 
activity against all of the fungal pathogens relevant to this study. Refer to Table 4.2 for a 
summary of inhibitory values in µg/mL and the corresponding values in µM.  
In our comparative assays over 48 hours the tyrocidines were found to be 2-4 fold more active 
towards C. liriodendri, B. cinerea, T. mineoluteus, T. ramulosus P. digitatum and P. expansum, 
than toward A. fumigates, Tr. atroviride P. glabrum, F. solani, F. oxysporum and F. 
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verticillioides. This variance in activity can point to the possibility that the nature of the target 
cell influences/determines the tyrocidines’ activity. The different fungal strains may present the 
same tyrocidine target, such as the fungal cell membrane, but differ in their sensitivity due to 
target concentration. The difference could also be ascribed to the difference in the growth rate of 
various fungi species (46), i.e. the growth characteristics of the various fungi species may differ 
over the test period of 48 hours rendering the fungi less or more susceptible to tyrocidine 
activity. However, for the case of F. solani and B. cinerea the differences in activity are probably 
related to differences in the initial cell wall interaction. 
 
Table 4.2:  Summary of activity parameters obtained for the Trc mixture against selected fungal 
pathogens 
 
a The Trc mixture consists of a group of tyrocidines with relative molar mass (Mr) ranging from 1200-
1400. An average Mr of 1303.7 was calculated from the tyrocidine abundances and used to calculate the 
approximate inhibition parameters in µM. Each value represents the mean of at least three biological 
repeats with 3-4 technical repeats per assay ± SEM. 
Fungal pathogens 
IC50 ± SEM µg/mL 
(µM)a 
ICmax ± SEM 
µg/mL (µM)a 
Asperigellus fumigatis ATCC 204305 4.8±0.49 (3.7) 8.6±0.69 (6.6) 
Fusarium solani STEU 6188 4.7 ± 0.4 (3.6) 9.3 ± 1.2 (7.1) 
Fusarium oxysporum ATCC 10913 6.2 ± 0.5 (4.8) 10 ± 1.1 (7.7) 
Fusarium verticilliodes CKJ1730 8.2 ± 1.9 (6.3) 12 ± 2.9 (9.2) 
Botrytis cinerea CKJ1731 3.0 ± 0.2 (2.3) 4.8 ± 0.7 (3.7) 
Cylindrocarpon liriodendri STEU 6170 2.0 ± 0.1 (1.5) 2.9 ± 0.1 (2.2) 
Trichoderma atroviride CKJ1729 7.5 ± 0.0 (5.8) 9.8 ± 0.2 (7.5) 
Penicillium glabrum CKJ1732 8.9 ± 0.2 (6.8) 11 ± 0.4 (8.4) 
Talaromyces ramulosus CKJ1735 2.7 ± 0.3 (2.1) 3.7 ± 0.4 (2.8) 
Talaromyces mineoluteus CKJ1736 2.5 ± 0.1 (1.9) 3.3 ± 0.2 (2.5) 
Penicillium expansum CKJ1733 3.8 ± 0.3 (2.9) 5.2 ± 0.3 (4.0) 
Penicillium digitatum CKJ1734 2.3 ± 0.1 (1.8) 3.7 ± 0.2 (2.8) 
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4.4.2 Salt tolerance/sensitivity of the tyrocidine’s antifungal activity 
It has been observed that peptide activity and selectivity are influenced by their environment (13, 
41, 42). Cations, for example Na+, K+, Mg2+ and Ca2+, have been illustrated to decrease the 
activity of the majority of antimicrobial peptides (47-51). The antibacterial activities of the 
tyrocidines have been shown to be variably affected by the presence of metal cations (12, 45).  
Since the incentive of this research is to explore the potential of an antifungal agent, and the 
agricultural and food processing environments are exposed to salts, the tyrocidines were tested 
for the ability to retain activity against fungi in the presence of chloride salts containing 
biological relevant metal cations. Accordingly their activity against B. cinerea and F. solani was 
determined in the presence of 0.2 to 10 mM Ca2+, Mg2+, Na+ and K+. The Trc mixture and 
selected purified tyrocidines proved to be salt tolerant, except in the presence of Ca2+  which lead 
to a significant loss (P<0.001) of >70% activity against F. solani (Figure 4.4 A). The tyrocidines 
were slightly more salt tolerant against B. cinerea with regards to 5 mM Ca2+, but TrcB showed 
the highest loss in activity (Figure 4.4 B). This is probably due to the solubility and aggregation 
differences (44, 45) of the three selected peptides in 5 mM CaCl2.  
The loss in activity in the presence of increasing concentrations of CaCl2 was compared for B. 
cinerea and F. solani. A significant (P<0.01) decrease (±30%) in activity against B. cinerea 
could be observed at a concentration as low as 0.3 mM Ca2+ (Figure 4.5 A). From a 
concentration of 1.3 mM Ca2+ and higher, the decrease in activity is more severe (P<0.001) and 
the Trc mixtures’ ability to inhibit B. cinerea decreased by 50%. However, at 5 mM CaCl2, 
±40% activity of the Trc mixture against B. cinerea was still retained, while the activity against 
F. solani continued to decrease with increasing CaCl2 concentrations (Figure 4.5 A). 
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Figure 4.4: Antifungal activity of tyrocidines pre-incubated in chloride salts. The Trc mixture 
and purified tyrocidines were incubated for 60 minutes in 5 mM CaCl2, MgCl2, 
NaCl and KCl before F. solani (A) and B. cinerea (B) were exposed to the 
peptide-salt mixtures. According to the unpaired t-test the Trc mixtures, TrcA, B 
and C’s activities in the presence of 5 mM CaCl2 were significantly less 
(***P<0.001) than in the control and in the presence of the other salts for both 
target fungi.  
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The activity of TrcA was much more stable in the presence of Ca2+, especially against B. cinerea 
(Figure 4.5 B). Even at a concentration of 10 mM Ca2+ TrcA only lost ±30% of its activity 
compared to the almost 90% loss in activity of TrcB (Figure 4.5 C) and ±50% loss of TrcC 
(Figure 4.5 D). This may again be the result of solubility and aggregation differences of the 
peptides (44, 45). 
The Trc mixtures’ activity against F. solani only started to decrease at a concentration of 1.3 mM 
Ca2+ (P<0.05) but at a concentration of 2.5 mM Ca2+ 50% activity against F. solani was lost 
(P<0.001) (Figure 4.5A). Similar results for F. solani as target was found for the purified TrcA, 
B and C (Figure 4.5 B-D).  At Ca2+ concentrations higher than 5 mM all the tyrocidines lost most 
of their activity against F. solani. 
From these results it is clear that the sensitivity of tyrocidines to Ca2+ is target cell and fungal 
target dependent. There are two likely reasons for a decrease in activity against fungal target 
cells in the presence of cations. First, the presence of cations can promote peptide aggregation 
leading to a lowering in the number of available and “active” peptide molecules (50). Second, 
the decrease in activity can also be the result of interference with a specific peptide target that is 
dependant on ionic interactions or ion fluctuations in membranes (52). The tyrocidines’ activity 
was only influenced by the presence of Ca2+. If the decrease in tyrocidine activity was as a result 
of interference by divalent cations in the interaction with the negative phospholipids, one would 
expect the same decrease in activity for Mg2+. The absence of an effect on activity by the 
divalent Mg2+ indicates that the tyrocidines’ target interaction or mode of action is specifically 
inhibited by Ca2+. This could alternatively imply that the target is protected by exogenous Ca2+ 
or that the tyrocidine complexes with Ca2+ is less active, specifically against fungi such as F. 
solani. 
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Figure 4.5: The influence of [CaCl2] on the activity of (A) 12.5 g/mL Trc mixture, 12 µM (B) 
TrcA, (C) TrcB and (D) TrcC against F. solani and B. cinerea. The average of a 
minimal of six repeats with SEM is shown in all graphs. 
4.4.3 Influence of tyrocidines on fungal morphology 
As indicated by the growth inhibition assay results, the tyrocidines exhibit significant antifungal 
activity. Light microscopy was used to analyse the morphological effect of tyrocidines on the 
spores and hyphae of fungi. Alterations in fungal morphology as a result of antifungal peptide 
activity are used to classify the peptides either as morphogenic, peptides that lead to alterations 
in fungal morphology, or non-morphogenic, although the peptides inhibit fungal growth there are 
no visible morphological changes. Morphogenic antifungal peptide activity can for instance 
result in hyperbranching of fungi (53).  
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The Trc mixture, at 9 µg/mL (double the IC50 concentration), was added to 16 hour old F. solani 
cultures. The Trc mixture had a considerable effect on the hyphae of F. solani (Figure 4.6). After 
12 hours the difference between the control (Figure 4.6 A2) and tyrocidine treated hyphae 
(Figure 4.6 B2) is significant. There is, in comparison to the control, minimal progress in growth 
and atypical branching can be observed. The hyphal cells treated with the Trc mixture also 
appear thicker/swollen compared to the control. The hyperbranching of the tyrocidine treated 
hyphae is more pronounced after 24 hours (Figure 4.6 B3). In contrast dense, matt-like growth is 
visible in the control (Figure 4.6 A3).  
Similar results were obtained for the Trc mixture on B. cinerea hyphae (results not shown). From 
the microscopy studies it is evident that the tyrocidines do not only inhibit fungal hyphae growth, 
but also alters the morphology of the hyphae by inducing hyperbranching. The effect of the Trc 
mixture on B. cinerea spores was visualised 2, 12 and 24 hours after peptide addition. Two hours 
after the addition of 6 µg/mL Trc mixture, there was no visible difference between the control 
(Figure 4.6 C1) and the tyrocidine treated spores (Figure 4.6 D1). After 12 hours of incubation, 
germination of the B. cinerea spores, with long healthy germination tubes, can be observed in the 
control (Figure 4.6 C2).  
Germination is evidently retarded in the tyrocidine treated spores (Figure 4.6 D2). Germination 
of individual spores is visible, however, the germination tubes are short compared to that of the 
control and they appear swollen. After 24 hours of incubation the tyrocidine treated spores 
appear swollen and multiple germination tubes are visible. On some of the germination tubes 
dichotomous branching can be seen (Figure 4.6 D3). The Trc mixture had similar effects on the 
spores of F. solani. In Figure 6E the extensive hyperbranching of F. solani 5 days post treatment 
with 3.2 µg/mL Trc mixture can be seen. As expected the purified tyrocidines had a similar 
effect on fungal morphology. Extensive hyperbranching was observed for B. cinerea spores 
treated with 4.5 µM TrcB (Figure 4.6 F) and retarded germination and multiple germination 
tubes for F. solani spores treated with 3.0 µM TrcA (Figure 4.6 G).  
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Figure 4.6: F. solani hyphae and B. cinerea spores treated with tyrocidines. Spores were 
incubated in half strength PDB and either directly treated or cultured for 16 hours to 
yield hyphae prior to peptide addition. Trc mixture was added to a final 
concentration of 9 µg/mL for F. solani hyphae (B) and 6 µg/mL for B. cinerea spores 
(D). F. solani hyphae control (A) and B. cinerea spore control (C) had a final ethanol 
concentration of 1.5%. Events were captured (40x magnification) at 2 hours (A1-
D1), 12 hours (A2-D2) and 24 hours (A3-D3) after peptide treatment. Overt 
morphology changes in F. solani spores are shown 5 days post treatment (E). 
Retarded germination and hyperbranching was observed for B. cinerea spores treated 
with 4.5 µM TrcB (F) and F. solani spores treated with 3 µM TrcA (G). 
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The morphology of fungal hyphae and spores are clearly influenced by the tyrocidines and it is 
evident that these peptides induce hyperbranching. This hyperbranching can possibly be the 
result of channel-blocking activity (54), interference with the cell cycle (55, 56) or peptide 
induced septin mislocalization (57, 58).  Morphological abnormalities as a result of peptide 
action are commonly observed (51) and have been ascribed to the interference with Ca2+ 
signalling (54). It is hypothesised that one aspect of hyphal elongation takes place through a Ca2+ 
regulated process (59) and interference of this process by AMPs may for instance induce 
hyperbranching (54). The observed hyperbranching as a result of tyrocidine action may, 
therefore, be due to the tyrocidines targeting Ca2+ gradients necessary for hyphal elongation and 
remains to be elucidated in future studies. Rautenbach et al. (26) illustrated that the tyrocidines 
hamper the life-cycle and development of Plasmodium falciparum. The tyrocidines may possibly 
have a similar effect on the spores of certain fungal species, interfering with the cell cycle and 
inducing retarded germination and hyperbranching.  
Further investigation into the changes in fungal spores and hyphae, show that the mode of action 
of the tyrocidines is related to cell permeabilisation. Fluorescence imaging with the membrane 
impermeable dye propridium iodide (PI) showed that after 2 hours 3 µg/mL Trc mixture leads to 
overt permeabilisation of B. cinerea spores and PI uptake (Figure 4.7 A).  
Similarly we found pronounced PI uptake in B. cinerea hyphae after 24 treatment with the 
tyrocidines (Figure 4.7 B). The permeabilisation of fungal hyphae was confirmed by SYTOX 
green uptake after 1 hour treatment of F. solani with the Trc mixture and selected purified major 
tyrocidines. With the tyrocidine concentration at 25 M, ±100% release of the dye was obtained 
for F. solani hyphae, similar to Triton X-100 and GS. The SYTOX green results for Trc mixture 
and TrcC are shown in Figure 4.7 C-E. TrcA and B treatment of F. solani lead to similar dye 
uptake (results not shown). 
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Figure 4.7: Fluorescence microscopy of tyrocidine treated spores and hyphea. B. cinerea spores 
(panel A) and hyphae (panel B) incubated with 3 g/mL Trc mixture and propidium 
iodide mixture at 4x magnification. Panel C-E shows F. solani hyphae incubated 
with SYTOX green alone (C), 25 g/mL Trc mixture (D) and 25M TrcC. The top 
panels are fluorescence images while the bottom panels are phase-contrast images, 
with propidium iodide or SYTOX green. 
4.5 Conclusion 
Evidently the tyrocidines exhibit significant low micromolar antifungal activity against a range 
of phytopathogens and their activity remains relatively stable in the presence of biological salts. 
The absence of overt structural-activity relationships implies that the conserved sequence of 
tyrocidines - NQYVOLfP - may be important for activity, with the aromatic dipeptide unit - Ff, 
Wf or Ww - determining the hydrophobicity and putative active dimer formation (Chapter 2, (44, 
45)). The tyrocidines’ major mode of action involves the disruption of fungal membrane 
integrity, but they also have morphogenic activity, indicating a non-membrane target or targets. 
Because of the tyrocidines’ broad spectrum and potent antifungal activity, general salt tolerance 
and possible multiple targets reducing the risk of overt resistance, they are promising candidates 
that warrant further investigation as potential bio-fungicides.  
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Chapter 5 
Investigation into tyrocidine antifungal mode of action 
5.1 Introduction 
Antimicrobial peptides (AMPs) are the primary defence system of nearly all organisms on earth 
(1-3). AMPs show significant activity against various pathogens that include bacteria (4, 5), 
parasites (6, 7), fungi and even viruses (3, 8). In recent years there has been growing interest in 
AMPs as novel/alternative antibiotics, mainly as a result of the resistance developing against 
conventional chemical antibiotics (9, 10). Despite the recent increase in AMP interest and 
research, there is still a relatively large gap in our understanding of their mode(s) of 
antimicrobial action. Previously AMP activity was hypothesised to be predominantly as a result 
of membrane/lytic activity (11). However, there is increasing evidence of alternative/additional 
modes AMP antimicrobial action (12), including interference with the cell cycle (13),  
interference with cell wall synthesis (14) and induction of apoptosis (15). Furthermore, it has 
also been proposed that AMPs may utilise more than one mode of action (MOA) (16).  
As is the case with the majority of AMPs, the tyrocidines’ MOA has not yet been elucidated. 
Only lytic activity has been observed for the tyrocidines against Gram-positive bacteria (17), 
however,  a non-lytic mode of action was observed against Plasmodium falciparum and it has 
been proposed that the tyrocidines interfere with cellular development of P. falciparum via an 
unknown mechanism (6). 
In Chapter 4 we illustrated that the tyrocidine mixture (Trc mixture), the six major tyrocidines 
and two tyrocidine analogues, PhcA and TpcC, have significant antifungal activity and that 
except for the tyrosine (Tyr) residue in position seven, there are no overt structure-activity 
relationships. Studies with membrane impermeable dyes pointed to the likelihood that tyrocidine 
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activity leads to disturbances in fungal membrane integrity. Building on the knowledge that the 
tyrocidines exhibit significant antifungal activities and that they most probably have a membrane 
related target, a more in depth study was conducted on their potential mode(s) of antifungal 
action focussing on the fungal membrane as potential target in relation to their antifungal 
activities (from Chapter 4). 
5.2 Materials 
The Trc mixture, tyrocidines and gramicidin S (GS) were purified and analysed for purity as 
described previously in Chapter 2. Merck Chemicals (Wadeville, South Africa) supplied the 
diethyl ether, acetone, sodium phosphate tris(hydroxymethyl)aminomethane  (Tris), sulphuric 
acid and ethanol (99.9%). Fusarium solani STEU 6188 and Botrytis cinerea CKJ1731 were 
provided by the Department Plant Pathology, University of Stellenbosch. The Tween 20® and 
potato dextrose broth (PDB) were obtained from Fluka (St. Louis, USA). Nunc (Roskilde, 
Denmark) supplied the polypropylene plates while Corning Incorporated (Corning, USA) 
supplied the sterile microtiter plates and culture dishes. Sterile petri dishes were obtained from 
Lasec (Cape Town, South Africa). The SYTOX Green was obtained from Lonza (Walkersville, 
USA). Analytical quality water was prepared by passing water from a reverse osmoses plant 
through a Millipore (Milford, USA) Milli Q® water purification system. The lipids 1-palmitoyl-
2-oleoylphosphatidylcholine (POPC), 1-palmitoyl-2-stearyl(5-doxyl)-sn-glycero-3-
phosphatidylcholine (5-DOX), 1-palmitoyl-2-stearyl(12-doxyl)-sn-glycero-3-
phosphatidylcholine (12-DOX), and 1,2-dioleoyl-sn-glycero-3-phosphotempocholine (TEMPO), 
as well as glycosylceramide (GlcCer) were purchased from Avanti Polar Lipids (Alabaster, 
USA). Tyrothricin, trifluoroacetic acid (TFA, >98%), ergosterol, EDTA (≥ 99.8%), β-glucanase 
(from Aspergillus niger, Lot# 1407360V, 1.42 U/mg), proteinase K (from Engyodontium album) 
and chloroform were purchased from Sigma (St. Louis, USA). Fluka Chemie (Munich, 
Germany) provided the calcein and molybdate while tris(hydroxymethyl)aminomethane  (Tris), 
sulphuric acid, sodium phosphate and Triton X-100 was provided by Merck (Darmstadt, 
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Germany). Sephadex G50 was obtained from Pharmacia Fine Chemicals and the sodium chloride 
and calcium chloride from J-T. Baker (Deventer, The Netherlands). The 100 nM polycarbonate 
membranes and extruder were from Averstin. Roth (Karlsruhe, Germany) provided the ascorbic 
acid. The 5 mL filters were from Roland Vetter Laborbedarf (Ammerbuch, Germany).  
5.3 Methods 
5.3.1 Culturing of fungi and harvesting of spores 
The fungi were cultured and spores harvested as described in Chapters 3 and 4. 
5.3.2 Beta-glucanase and proteinase K treatment 
The methods described by van der Weerden et al. (18) were followed. In brief, B. cinerea and F. 
solani hyphae were grown for 16 hours in half strength PDB in sterile microtiter plates from a 
starting concentration of 2000 spores/well. Hyphae were then treated with 2 mg/mL β-glucanase 
for 1 hour  at 37˚C or 1 mg/mL proteinase K for 40 minutes at 25˚C (18). After washing the 
fungal hyphae three times with PDB, 90 µL PDB was added to each well followed by the 
addition of 10 µL peptide to give a final concentration of 6.5 µg/mL Trc mixture, 2.5 µM TrcA 
and GS, 5.0  µM TrcB and TrcC. After a further incubation step of 36 hours at 23-25˚C, light 
dispersion at 595 nm was determined using a BioRad microtiter plate reader. 
5.3.3 Fluorescence microscopy 
F. solani hyphae were grown in half strength PDB from a starting concentration of 2.0 × 104 
spores/mL for 16 hours at 25˚C. Hyphae were incubated at 25 ˚C for 1 hour with 3 µM, 6 µM, 12 
µM or 25 µM of TrcA, TrcB, TrcC, PhcA, TpcC, and GS. 1% Triton-X 100 served as lytic 
control. Subsequent to the 1 hour peptide addition step, the hyphae were incubated for 10 
minutes with 0.5 µM SYTOX green (19). SYTOX green uptake was quantified with a Carl Zeiss 
confocal LSM 780 Elyra S1. The laser was set at 488nm and the filter at 500-676nm. The 
collected data were analysed using ZEN 2011 software. 
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5.3.4 SYTOX green uptake assays 
B. cinerea hyphae were grown in half strength PDB (PDB/water, 1:1, v/v) in sterile microtiter 
plates for 24 hours at 23-25˚C from a starting concentration of 2000 spores per well. The hyphae 
were incubated for 10 minutes with 1.0 µM SYTOX green prior to peptide addition. The Trc 
mixture, TrcA, TrcB, TrcC and GS were dissolved in 25% ethanol, diluted in analytical grade 
water and added to the hyphae at 12 µg/mL (Trc mixture), 12 µM (TrcA, TrcB and TrcC) and 8 
µM (GS). The final ethanol concentration was less than 0.3%. SYTOX green uptake 
measurement commenced immediately upon tyrocidine addition using a Varioskan fluorometer 
at wavelengths 488 nm (excitation) and 538 nm (emission) for 1 hour. 
5.3.5 Lipid vesicle preparation 
For large unilamellar vesicle (LUV) preparation procedures were followed as described by Dathe 
et al. (20). For preparation of the calcein containing LUVs, dried lipid was vortexed in 80 mM 
calcein buffer (10 mM Tris, 0.1 mM EDTA, pH 7.4) and extruded 35 times through two stacked 
100 nm polycarbonate membranes (85 times for glucosylceramide containing LUVs (21)). 
Untrapped calcein was removed with Sephadex G50 columns using a minicolumn centrifugation 
method (22). Subsequent to elution, salt buffer (10 mM Tris, 0.1 mM EDTA, 154 mM NaCl, pH 
7.4) were added to the LUVs at a 1:1 ratio. Phosphate analysis was used to determine the lipid 
concentration (23).  
5.3.6 Peptide-induced calcein release 
Calcein release from the LUVs as a result of peptide interaction was fluorometrically monitored 
on a Jasco FP-6500 spectrofluorometer (20). Different concentrations of peptide (ranging from 
0.3 µM to 100 µM) in buffer (10 mM Tris, 0.1 mM EDTA, 154 mM NaCl, pH 7.4) were 
prepared in a quartz cuvette containing a magnetic stirrer. Into these peptide preparations LUV 
suspension was injected to give a final volume of 2500 µL and LUV concentration of 25 µM. 
The decrease in self-quenching as a function of time was fluorometrically monitored (excitation 
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490 nm, emission 520 nm) at 25°C. Leakage of 100% was induced by the addition of 100 µL of 
a 10% (v/v) Triton X-100 solution. Percentage leakage, F(%), after one minute was calculated by 
the equation 100(%)(I – I0)/(I100% - I0), where I is the intensity observed in the peptide solution 
and I0 and I100% are the fluorescence intensities measured respectively in the absence of peptide 
and in the presence of Triton X-100 (20). Percentage dye release at each peptide concentration 
was used to fit dose-response curves from which the EC50 (the effective peptide concentration 
that induces 50% leakage) was determined. 
5.3.7 Quenching studies 
POPC vesicles with different concentrations of 12-DOX, 5-DOX and TEMPO were prepared by 
dissolving the lipids in chloroform and combining the appropriate volumes of POPC and labelled 
lipids followed by drying under nitrogen. TrcB and TrcC were dissolved in ethanol to give a 
final concentration of 120 µM. A volume of 20 µL peptide was added to each of the lipid-
containing tubes and vortexed to dissolve the lipid film. Subsequently 1180 µL buffer (10 mM 
Tris, 0.1 EDTA, pH 7.4) was added followed by vortexing. A constant end volume of 1200 µL 
was obtained with a final lipid concentration of 200 µM, peptide concentration of 2 µM and the 
content of labelled lipid ranged from 0 to 40 mol %. Baseline fluorescence of the labelled lipids 
was determined in the absence of peptides. Tryptophan fluorescence and quenching was 
measured with a Perkin Elmer LS 50B Luminescence Spectrometer at excitation of 280 nm, 
emission of 300 nm and scan range of 300-500 nm. Quenching is given by F/F0 =  exp(-
∏(c/70)(R0
2 – X2 – z2)), where F0 and F are the fluorescence intensities in respectively the 
absence and presence of the quencher, R0 is the critical quenching distance of the W-doxyl pair 
(12 Å), X is the minimum allowed lateral distance between the fluorophore and quencher, z is the 
difference in the depth between the quencher and fluorophore, c is the mole fraction of the 
quencher molecule, and c/70 gives the number of quencher molecules per square angstrom 
assuming that the cross-sectional area of a lipid is 70 Å2. The distance of tryptophan from the 
bilayer centre, zcf, was calculated using the parallax equation zcf = Lcl + (-70/∏c(ln(F1/F2) – 
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L21
2))/2L21), with Lcl being the distance of the shallow quencher from the bilayer centre, F1 and 
F2 are respectively the fluorescence intensities in the presence of the shallow and deeper 
quenchers and L21 the difference in depth between the shallow and deeper quenchers. The 
distances of the applied quenching groups from the bilayer centre have been reported to be 19.5, 
12.2 and 5.85 Å for respectively TEMPO, 5-DOX and 12-DOX (22). 
5.3.8 Data and statistical analysis  
In order to calculate the percentage growth inhibition the light dispersion at each concentration 
was used as described by Rautenbach et al. (24). GraphPad Prism® 4.03 (GraphPad Software, 
San Diego, USA) were used to plot the dose response curves. Non-linear regression and 
sigmoidal curves (with a slope default setting at <7) were fitted for dose response analysis (24). 
The point halfway between top and bottom (IC50) represents the concentration necessary to cause 
50% growth inhibition. The minimum inhibition concentration (MIC), calculated as the x-value 
at the intercept between the slope and the top plateau of a full dose-response curve, was denoted 
as ICmax (24) to make the distinction with MIC values obtained from visual inspection of a dose-
response result. 
GraphPad Prism® was also used for the statistical analysis of data. Analysis included 95% 
confidence levels, absolute sum of squares, standard error of the mean, Newman-Keuls multiple 
comparison test, Student t-test and Bonferroni’s post test. 
5.4 Results and discussion 
The antifungal activities of the individual tyrocidines were previously determined and we found 
that the purified six tyrocidines, TrcA1, A, B1, B, C1 and C, as well as the two analogues, PhcA 
and TpcC were able to inhibit both F. solani and B. cinerea (refer to Chapter 4 and Table 5.1). 
The preliminary studies in Chapter 4 with membrane impermeable dyes also indicated that the 
fungal membrane may be a target for tyrocidine antifungal action. Therefore we explored the 
interaction of the tyrocidines with biological fungal membranes, model fungal membranes as 
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well as any correlation between their antifungal activity parameters (determined in Chapter 4) 
and their membrane interaction. Since the peptides have to initially traverse the cell wall to 
interact with the cell membrane, we investigated the effect of the absence of the cell wall on the 
antifungal activity of the tyrocidines. 
5.4.1 Cell wall as target 
The cell wall and components of it, for instance proteins, have been illustrated to influence/be 
targets for AMP antifungal activity (18). With the aim of ascertaining if the tyrocidines’ activity 
is related to a protein target, proteinase K was used to remove proteins from the surface of B. 
cinerea and F. solani cell walls prior to the addition of peptide as described by van der Weerden 
et al. (18). Comparison of untreated and β-glucanase treated growth controls did not yield any 
optical density differences between the growth of treated and untreated B. cinerea and F. solani 
cultures (results not shown). The tyrocidines maintained their activity against both B. cinerea 
and F. solani after proteinase K treatment (results not shown). A slight increase in activity was 
observed against F. solani. These results indicate that the tyrocidines do not have a protein target 
sensitive to proteinase K in the cell walls of either F. solani or B. cinerea. The increase in 
activity can probably be ascribed to peptides gaining access through a more vulnerable cell wall 
and/or acting on a more vulnerable cell membrane. 
When these two fungi were treated with -glucanase, the activity of the tyrocidines towards B. 
cinerea remained unaffected by this treatment. However, there was a significant (P<0.001) 
activity loss of ±30% for 6.3 g/mL Trc mixture towards the -glucanase treated F. solani 
(Figure 5.1).  Similarly, the three purified tyrocidines, 2.5 µM TrcA, 5 µM TrcB and 5 µM TrcC, 
suffered significant (P<0.001) activity loss against -glucanase treated F. solani (Figure 5.1).  
The significant (P<0.001) activity loss of the Trc mixture, TrcA, TrcB and TrcC against the -
glucanase treated F. solani (Figure 5.1), indicates that tyrocidine activity, especially at lower 
concentration of peptide, could at least in part be determined by a cell wall related target in F. 
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solani. The activity of GS, on the other hand, is not significantly influenced by the 
presence/absence of F. solani’s cell wall. However, the possibility that pre-treatment with -
glucanase could trigger fungal defence and consequently affect tyrocidine activity must also be 
considered. 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Activity of tyrocidines against β-glucanase treated F. solani. The Trc mixture’s 
and purified tyrocidines’ activities were significantly influenced by the β-
glucanase treatment of F. solani cell wall (***P<0.001) as determined with the 
Student t-test (One-tailed). The average of at least 3-8 determinations with 
standard error of the mean (SEM)  is shown. 
5.4.2 Cell membrane as target 
In terms of their antibacterial activity the tyrocidines are regarded as membrane active lytic 
peptides (17). Therefore, with regards to their antifungal activity, the fungal membrane may also 
be a major target.  Consequently, the two dyes SYTOX green and propidium iodide - that can 
only reach the cell interior if the cell plasma membrane is structurally compromised or if 
membrane potential is dissipated - were used as indicators of cell membrane permeabilisation 
during initial studies in Chapter 4. The studies showed that the tyrocidine treatment induced dye 
uptake in both spores and hyphae. 
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TrcA, TrcB, TrcC, PhcA, TpcC and GS’s influence on F. solani membrane integrity was further 
investigated using the membrane impermeable dye SYTOX green (Figure 5.2 and 5.3). 
Subsequent to one hour incubation period with peptide, SYTOX green fluorescence was 
observed in the F. solani hyphae treated with 3, 6, 12 and 25 µM purified peptide. In Figure 5.2 
it can be observed that SYTOX green uptake is induced by all of the peptides at 6 µM compared 
to that of the control (Figure 5.2 H). Compared to the tyrocidines and analogues, 6 µM GS 
induced the highest uptake of SYTOX green (Figure 5.2 F) and is comparable to the SYTOX 
green uptake induced by 1 % TritonX-100 (Figure 5.2 G). In terms of the tyrocidines and their 
analogues, the activity of TrcA (Figure 5.2 A) and TrcC (Figure 5.2 C) appear to result in the 
highest SYTOX green uptake. It appears as if initial membrane permeabilisation takes place at 
the growth tips of hyphae and sites of hyphal branching. This is especially evident with TrcB 
(Figure 5.2 B), PhcA (Figure 5.2 D) and TpcC (Figure 5.2 E), the peptides which has not yet 
succeeded to induce overt membrane disruption at a concentration of 6 µM. This could possibly 
be an indication of the areas of a fungal cell/hyphae and/or fungal cellular processes that the 
tyrocidines target. 
Figure 5.3 depicts the percentage SYTOX green fluorescence induced by the individual peptides 
in relation to the SYTOX green fluorescence induced by 1% Triton X-100. All of the peptides 
tested, TrcA, TrcB, TrcC, PhcA, TpcC and the membrane active GS (6) led to a loss in the 
membrane integrity of F. solani (Figure 5.2 and 5.3). However, there was variation in the degree 
to which they could induce membrane disruption. Only the SYTOX green uptake induced by GS 
(P<0.001), TrcA (P<0.001), TrcB (P<0.01) and TrcC (P<0.01) was significantly higher than that 
of the untreated hyphae (Figure 5.3A). The SYTOX green uptake observed for PhcA and TpcC 
cultures did not differ significantly from the untreated cultures. At a higher concentration of 
peptide (25 µM) there is no significant difference in the SYTOX green uptake induced by the 
individual peptides (Figure 5.3B).  
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Figure 5.2: Peptide-induced SYTOX green fluorescence in F. solani hyphae. 24 hour old F. 
solani hyphae were treated for 1 hour with 6 µM  TrcA (A), TrcB (B), TrcC (C), 
PhcA (D), TpcC (E) and GS (F) prior to staining with 0.5 µM SYTOX green. 
Hyphae treated with 1% TritonX-100 (G) and untreated hyphae (H) served as 
controls. 
When the percentage peptide-induced SYTOX green uptake in F. solani, at a peptide 
concentration of 3 µM peptide, are compared to the ICmax values obtained for the individual 
peptides against F. solani (refer to Chapter 4), a relationship between high antifungal activity 
and high membrane activity can be observed (Figure 5.4). GS is clearly the outlier resulting in 
both the highest antifungal activity and SYTOX green uptake. The importance of the Tyr residue 
in position seven, highlighted in Chapter 4 as being important for tyrocidine antifungal activity, 
is again emphasised as being important for the disruption of membrane integrity. The two 
tyrocidine analogues with respectively a Trp7 and Phe7 are clearly grouped as the peptides with 
the lowest membrane activity (Figure 5.4). 
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Figure 5.3:  Membrane disruptive activities of TrcA, TrcB, TrcC and GS on 24 hour F. solani 
hyphae. Hyphae were incubated for 1 hour with 3 µM (A) or 25 µM (B) peptide 
prior to SYTOX green staining. 1% Triton X-100 served as control. Peptide 
concentration is compared to the percentage peptide-induced SYTOX green 
fluorescence with regards to the fluorescence induced by 1% TritonX-100. 
According to One way Anova using Newman-Keuls multiple comparison test the 
fluorescence induced by the major tyrocidines are significant compared to the 
untreated hyphae (***P<0.001, **P<0.01), but some of their activities were 
significantly lower than that of GS (###P<0.001, ##P<0.01). The average of at least 
three determinations with SEM is shown. 
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Figure 5.4: The percentage fluorescence induced in F. solani hyphae at a concentration of 3 
µM peptide are compared to the ICmax values obtained for F. solani in Chapter 4.  
5.4.3 Kinetics of fungal membrane permeabilisation 
To assess the kinetics of membrane permeabilisation, 24 hour B. cinerea cultures and fresh 
spores were incubated for 10 minutes with SYTOX green and subsequently treated with peptide 
(Figure 5.5).  
Very fast uptake of SYTOX green in the B. cinerea cultures was detected for the Trc mixture 
and purified tyrocidines, suggesting that tyrocidine activity lead to a loss in the barrier integrity 
of the fungal cell wall and membranes. This dye uptake was much faster than both Triton X-100 
treatment and treatment with 8 M of the lytic peptide GS. However, the membrane 
permeabilisation activity of the Trc mixture plateaus after approximately 20 minutes and after 60 
minutes does not induce SYTOX green uptake to the same extent as 1% Triton X-100 (Figure 
5.5). Similar results were found for the dye uptake in spores (results not shown). Therefore, at 
tyrocidine concentrations which results in complete fungicidal inhibition of B. cinerea growth, 
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tyrocidine-induced SYTOX green uptake is only half of that observed for 1% Triton X-100, but 
similar to that of the known membrane active analogous peptide GS.  
These results suggest that the tyrocidines do not induce the complete disintegration of fungal 
membranes at these fungicidal concentrations, as is the case with Triton X-100. Similar results 
were obtained with purified tyrocidines indicating a shared mode of membrane action for the 
tyrocidines (Figure 5.5). The tyrocidines could potentially both induce damage to the fungal cell 
wall and permeabilise membranes to gain entry to internal targets.  
 
 
 
 
 
 
 
 
 
Figure 5.5: SYTOX green uptake by B. cinerea hyphae treated with the tyrocidines. B. cinerea 
hyphae were incubated for 10 minutes with SYTOX green, followed by the 
addition of 12 µg/mL Trc mixture, 12 M TrcC, 12 M TrcA, 8 M GS or 1% 
Triton X-100. SYTOX green uptake was monitored for 1 hour. Data are the average 
of two repeats with 1% Triton X-100 serving as lysis control. 
When the membrane permeabilisation activities of the three major tyrocidines are compared a 
strong relationship is again observed between high antifungal activity and membrane activity. 
TrcA has relatively higher biological activity against F. solani and induces a higher percentage 
SYTOX green uptake in F. solani hyphae than TrcC (Figure 5.6). The opposite is true for B. 
cinerea. TrcC, with a lower IC50 than TrcA, induces a higher percentage of SYTOX green 
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fluorescence in B. cinerea hyphae after one hour. From Figure 5.6 it is also evident that at 12 µM 
the tyrocidines are much more lytic toward F. solani than B. cinerea. This difference is even 
more pronounced if the ICmax/IC50 values (Chapter 4) against the two species are taken into 
account, with the peptides being generally less active against F. solani. These results raise the 
question if the tyrocidines’ mode(s) of action against the two fungal species are similar. It would 
appear as if the action of the tyrocidines is more membrane targeted against F. solani than 
against B. cinerea. Previous investigations in our group have indicated that the tyrocidines have 
an additional mode of antibacterial action to that of membrane activity which is enhanced by the 
presence of Ca2+ (25, 26). In Chapter 4 it was illustrated that although the activity of the 
tyrocidines against B. cinerea were influenced by the presence of Ca2+, it was much less 
susceptible than their activity against F. solani. It could therefore be hypothesised that the 
membrane activity of the tyrocidines are negatively influenced by the presence of Ca2+, but that 
their additional mode(s) of action are less susceptible or even enhanced by the presence of Ca2+ 
and that these additional mode(s) of action are employed against  B. cinerea. An alternative 
explanation is that F. solani and B. cinerea have differences in their growth/rates in PDB 
medium (refer to Chapter 3) which may influence their membrane permeability and sensitivity 
towards the tyrocidines. 
Even though there are conserved sequence differences between the different tyrocidines, they all 
seem to be membrane active, albeit to different degrees at lower concentrations (Figure 5.3 and 
5.4). There is also a strong correlation between high antifungal activity and ability to 
permeabilise fungal membranes (Figure 5.4 and 5.6). However, it has been observed that if any 
AMP is present at an adequate concentration the permeability of the cytoplasmic membrane 
increases (12). The connection between high antifungal activity and membrane permeabilisation 
may not necessarily be lytic activity, but the ability of the peptides to transverse the membrane 
and interact with an internal target.  
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Figure 5.6: Comparison of TrcA, TrcB and TrcC’s ability to disturb the integrity of F. solani 
and B. cinerea membranes after an incubation period of one hour at a concentration 
of 12 µM. TrcA, TrcB and TrcC induced SYTOX green uptake was significantly 
lower in B. cinerea than in F. solani (**P<0.01, *P<0.05) as determined with the 
Student t-test (One-tailed). 
Therefore it still remains to be elucidated if the tyrocidines have additional or alternative 
mode(s) of action, especially at lower concentrations. This is of particular interest since we have 
illustrated in Chapter 4 that tyrocidine activity leads to retarded germination and hyperbranching. 
Hyperbranching/retarded germination activity can be the result of peptide interference with 
regulators of spore germination, hyphal elongation and lateral branching such as GTPases (27, 
28), cAMP signalling (29, 30), formins and septins (27, 29), the Spitzenkorper, the microtubule 
cytoskeleton (27, 31),  and actin polymerization. In some fungi it also seems as if the cell cycle a 
regulatory influence has on hyphal branching (27, 32). Therefore there is the possibility that the 
tyrocidines target any one or more of the above mentioned processes in addition to membrane 
disruption. 
5.4.4 Peptide induced calcein release 
In order to further study the tyrocidines’ membrane activity, peptide-induced calcein release 
from model membranes (LUVs), comprising of either POPC:Erg or POPC:GlcCer, was 
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investigated. Ergosterol (Erg) is the major sterol in filamentous fungal membranes (33) and 
glucosylceramides (GlcCer) the most common neutral glycosphingolipid found in fungi (21). 
TrcA, TrcB and TrcC, TpcC, PhcA and GS were investigated for their ability to disturb the 
integrity of fungal model LUVs composed either of POPC:Erg (70:30) or POPC:GlcCer (70:30). 
The individual tyrocidines and their analogues resulted in varying degrees of calcein release 
from the different LUVs (Figure 5.7). Dose-response curves of calcein release after one minute 
was used to calculate the EC50’s of the peptides (Table 5.1).  
The ability to induce calcein release varied both between peptide and LUV identity. With regard 
to the POPC:Erg LUVs, TrcC exhibited the highest dye release activity (EC50 of 0.38 µM). 
TpcC, PhcA and TrcB followed with comparable EC50’s of respectively 0.57, 0.59 and 0.64 µM. 
In terms of the other tyrocidines, TrcA had the lowest lytic activity with an EC50 of 0.75 µM. 
With an EC50 of 2.38 µM, GS exhibited the lowest calcein release and therefore lytic activity. A 
decrease in calcein release and larger diffrences between the activities of the individual peptides 
were observed for POPC:GlcCer LUVs. Although the membrane activity of TrcC decreased by a 
factor of two, TrcC still exhibited the highest activity. TrcB and PhcA exhibited the second 
highest activity, followed by TpcC. TrcA, with an EC50 of 3.07 µM, and GS, with an EC50 of 
7.83 µM, again exhibited the lowest calcein release activity.  
Comparing the peptide structures with their membrane activities it could be observed that TrcC, 
with two Trp residues, displayed the highest calcein release activity. This activity is followed by 
TrcB, a peptide with one Trp residue. The lowest dye release activity is exhibited by TrcA whose 
sequence does not contain any Trp residues. These results are consistent with results from 
Schmidtchen et al. (34) who found that end-tagging short AMPs with Trp increases their 
membrane activity and selectivity for ergosterol-containing model fungal membranes. 
Conversely, this observed trend for increased membrane activity and selectivity for Trp 
containing peptides are not applicable to the two tyrocidine analogues. TpcC, with three Trp 
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residues, exhibited lower dye release activity than PhcA, whose sequence does not have any Trp 
residues. TpcC also exhibited lower or similar lytic activity against the model membranes than 
that of TrcC and TrcB, respectively possessing only two and one Trp residue. These results could 
possibly imply that a Trp residue increases membrane activity and selectivity, but that other 
factors, such as the importance of the Tyr residue in the major tyrocidines, also plays a role in 
the membrane disruptive activity of the tyrocidines. 
 
Figure 5.7: Kinetics of large unilamillar vesicle (LUV) permeabilisation. Representative 
dequenching of calcein fluorescence (F) induced by TrcC from POPC:GlcCer 
(70:30) LUVs as a function of time. The lipid concentration was 25 µM and the 
concentration of TrcC ranged from 0.32 µM to 8 µM in buffer (10 mM Tris, 0.1 
mM EDTA, 154 mM NaCl, pH 7.4). After approximately 4 minutes, total 
dequencing was induced by the addition of Triton X-100. 
GS exhibited lower dye release activity than all of the tyrocidines and their analogues. The 
tyrocidines significant decrease (up to four fold) against membranes consisting of POPC:GlcCer 
indicate that these peptides are sensitive to the presence of glucosylceramides. These results 
could be noteworthy since the GlcCersoybean used in this study to prepare the POPC:GlcCer is 
structurally very similar to GlcCerF.solani, the main neutral glycolipid in F. solani (35). 
GlcCerF.solani differs from GlcCersoybean in only two positions. GlcCerF.solani has a methyl group on 
its ninth carbon and a double bond on its third carbon which is not present in GlcCersoybean (21). 
0 50 100 150 200 250 300
0
50
100
150
200
250
300
350
400
450
500
550
600
650
Triton X-100
TrcC (0.3-8.0 M)
Time (sec)
F
 (
%
)
Stellenbosch University http://scholar.sun.ac.za
5-18 
 
This could possibly explain the relatively lower activity of the tyrocidines against F. solani 
compared to B. cinerea.  
Table 5.1 Comparison of antifungal and LUV permeabilisation activity parameters for selected 
tyrocidines 
  B. cinerea F. solani   
POPC:Erg 
(70:30) 
  
POPC:GlcCer 
(70:30) 
 
IC50
1 
 
IC50
1 
 
EC50
2 
 
EC50
2 
Trc mix 2.72 ± 0.39 
 
3.88 ± 0.34 
 
- 
 
- 
TrcA1 2.73 ± 0.20  
2.92 ± 0.33 
 
- 
 
- 
TrcA 2.25 ± 0.40 
 
3.17 ± 0.39 
 
0.75 ± 0.60 
 
3.07 ± 0.29 
TrcB1 2.59 ± 0.20   
6.62 ± 1.76 
 
- 
 
- 
TrcB 2.11 ± 0.25 
 
5.68 ± 0.44 
 
0.64 ± 0.05 
 
1.23 ± 0.00 
TrcC1 2.34 ± 0.33  
3.21 ± 0.19 
 
- 
 
- 
TrcC 2.03 ± 0.29 
 
3.33 ± 0.22 
 
0.38 ± 0.02 
 
0.61 ± 0.06 
PhcA 3.20 ± 0.23 
 
5.19 ± 0.82 
 
0.59 ± 0.10 
 
1.26 ± 0.14 
TpcC 4.33 ± 0.63 
 
17.7 ± 4.49 
 
0.57 ± 0.15 
 
2.02 ± 0.12 
GS  1.06 ± 0.03   1.62 ± 0.05   2.38 ± 0.03   7.83 ± 0.30 
1The IC50 values determined in Chapter 4 are included for comparison. 
2 The LUV permeabilisation activity values represent the average of duplicate repeats ±SEM. 
Comparing the calcein release results with both biological activity and SYTOX green 
fluorescence results, a few inconsistencies in the activity order of the individual peptides can be 
observed. First inconsistency is the high antifungal but generally low lytic activity of GS. The 
antifungal activity of GS is potent against both F. solani and B. cinerea and is generally higher 
than that of the tyrocidines. Furthermore, in contrast to the calcein release activity, the SYTOX 
green uptake induced by GS was significant (Figure 5.2 and 5.3). However, in the model 
membranes GS’s calcein release activity is considerably lower than that of the tyrocidines. For 
the POPC:GlcCer LUVs, GS’s calcein release activity is almost 13-fold lower than that of TrcC 
and for the POPC:Erg LUVs 6-fold lower (Table 5.1). This may indicate that the 
permeabilisation of the fungal hyphae may depend on alternative factors, other than membrane 
permeabilisation, such as self-promoted uptake via lesions in the cell wall (36). The hypothesis 
that AMP interaction with other cellular structures (such as cell wall components) may 
enhance/influence AMP membrane disruptive activity, has also been offered (37). 
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TrcA exhibited antifungal activity (Chapter 4 and Table 5.1) and induction of SYTOX green 
fluorescence (Figure 5.3) equal to that of TrcC. However, the calcein release activity of TrcA 
was considerably lower than that of TrcC. TrcA’s calcein release activity is even lower than that 
of TpcC, the tyrocidine with the lowest antifungal activity (Table 5.1 and Chapter 4). TrcB, 
PhcA and TpcC were expected to exhibit lower calcein release activity than TrcC since they in 
general exhibited lower antifungal activity and SYTOX green uptake in F. solani. This 
discrepancy between model membrane results and that of the biological results could indicate 
that other factors in the cell membrane influence biological membrane activity and/or other 
cellular parameters/targets influence the antifungal activity of the tyrocidines, for instance the 
composition of the cell wall. In addition the differences between a biological system (i.e. 
growing fungal cells) and a model system (i.e. static liposomes) must be considered. While only 
the interaction of the peptides with the model membrane is measured in the liposome model, 
various factors contribute to the interaction of peptides with living cells. The growth rate, the cell 
metabolism, the cell cycle as well as defence mechanisms are just some of the factors which may 
influence the peptide activity in a biological system. 
 The lower lytic activity of the tyrocidines and analogues against the liposomes containing 
GlcCer and the loss of activity towards glucanase treated F. solani may indicate that the peptides 
interact with carbohydrate moieties that could either enhance or inhibit their antifungal activity. 
This is not the case for GS, which was only less lytic in the presence of GlcCer, indicating a 
difference in mode of action. These results could also support the theory that the tyrocidines 
have additional targets to that of the cell membrane, for instance depending on the composition 
of the cell wall, and that other cellular parameters and events may determine their antifungal 
activity, especially at lower tyrocidine concentrations.  
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5.4.5 Tryptophan quenching studies 
In order to further understand tyrocidine interaction with model membranes tryptophan 
fluorescence quenching experiments using n-doxyl phosphatidylcholines (TEMPO-, 5-DOX- and 
12-DOX) were used to determine if and how deep the tyrocidines insert into POPC:Erg and 
POPC:GlcCer model membranes (Figure 5.8). Two tryptophan containing peptides, TrcB and 
TrcC, were used as representative tyrocidines. According to results using the parallax method 
(22, 38) the distance of TrcB from the bilayer centre for POPC:Erg and POPC:GlcCer was 
respectively 10.9 Å and 11.3 Å. For both the POPC:Erg and POPC:GlcCer membranes TrcC’s 
distance from the bilayer centre was 11.9 Å (Table 5.2). 
The parallax analysis is most accurate when the Trp residue is close to the quencher (39). From 
Figure 5.8 it is evident that the POPC:GlcCer bound TrcC was the most affected by 5-DOX and 
12-DOX compared to TEMPO. The tryptophan fluorescence of TrcC and TrcB, bound to 
POPC:Erg and POPC:GlcCer was the most strongly quenched by 5-DOX and 12-DOX  (Table 
5.2). The calculated distances for Trp (zcf) from the bilayer centre show that TrcC and TrcB 
insert into the membrane bilayer and are positioned close to the phosphate head groups. 
Furthermore, the tryptophan’s of both peptides have relatively the same position in the bilayer 
and that their positions are not significantly influenced by the composition of the membrane. 
These results indicate that the tyrocidines interact with and insert into fungal model membranes.  
The depths of insertion for TrcB and TrcC are  comparable for both the POPC:Erg and 
POPC:GlcCer membranes,  contrary to what one would expect from the calcein release, SYTOX 
uptake and biological activity results. It would therefore seem as if it is not necessarily the depth 
of membrane insertion that determines the membrane permeabilisation and biological activity of 
the tyrocidines. The variance in biological/membrane activity observed for TrcB and TrcC can 
either be related to a non-membrane related target/mode of action or to other/additional 
parameters that determine the activities of the tyrocidines.  
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        A     B               C 
 
Figure 5.8:  Representative fluorescence spectra of TrcC bound to POPC:GlcCer vesicles 
containing (A) TEMPO, (B) 5-DOX and (C) 12-DOX-labelled lipids. The lipid 
concentration (cl) was 200 µM while the concentration of peptide (cp) was 2 µM. 
The fraction of the spin-labelled lipids was 10, 15, 20, 30 and 40 mol %. The dotted 
line represents vesicles without spin-labelled lipids. 
 
Table 5.2  Quenching of tryptophan fluorescence by nitroxide-labeled lipids and distances 
between tryptophan and bilayer centre 
    POPC:Erg (70:30 mol/mol)   POPC:GlcCer (70:30 mol/mol) 
 
 
TrcB 
 
TrcC 
 
TrcB 
 
TrcC 
    S zcf (Å)   S zcf (Å)   S zcf (Å)   S zcf (Å) 
Tempo 
 
-1.1503 11.4 
 
0.3004 9.2 
 
-0.0014 9.8 
 
0.0048 8.9 
5-DOX 
 
-4.0804 10.9 
 
-4.0842 11.9 
 
-3.9633 11.3 
 
-4.5665 11.9 
12-DOX   -3.0129 11.2   -0.0246 10.4   -2.6895 10.5   -2.9581 10.3 
S is the slope of the plot F/Fo vs the mole fraction of lipids carrying spin labels 19.5 Å (TEMPO) 12.2 Å (5-DOX) 
and 5.85 Å (12-DOX) (30) from the bilayer centre . F/Fo is the ratio of W fluorescence intensity in vesicles 
containing quencher to that of vesicles without. 
As we mentioned above, there is the suggestion that the tyrocidines may form higher-order 
structures necessary for activity, in particular dimers which displays an amphipathic structure 
(25, 40). The interaction of these higher-order structures with the target membrane bilayer of 
fungi may be different to the model membranes as these biological membranes have much more 
complex structures. 
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5.5 Conclusion 
Studies with the membrane impermeable dye SYTOX green and calcein release studies with 
model membranes indicate that the tyrocidines are active against fungal membranes. Although 
induction of high SYTOX green fluorescence could be related to high biological activity and the 
importance of the Tyr7 residue, high calcein release activity did not necessarily correlate to high 
biological membrane activity or high antifungal activity. Kinetics of fungal membrane 
permeabilisation indicated that although higher antifungal activity could be related to increased 
membrane activity, tyrocidine concentrations that led to 100 % fungal death did not result in 
complete disintegration of the fungal membrane. Furthermore, tryptophan quenching studies 
indicate that tyrocidines insert into fungal model membranes, but depth of insertion does not 
appear to determine either high calcein release or biological activity. These results suggest that 
other factor(s) in addition to membrane composition influences/determines the tyrocidines ability 
to permeabilise the fungal membrane; and/or the tyrocidines act on additional target(s) or lead to 
cellular events causing cell death that is not only due to membrane permeabilisation. The 
decrease in tyrocidine antifungal activity in the absence of the fungal cell wall supports the 
hypothesis that additional factors influence/determines tyrocidine antifungal activity. 
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Chapter 6 
Synergistic activity of the tyrocidines, antimicrobial 
cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin 
B and caspofungin against Candida albicans biofilms 
6.1 Introduction 
In recent years a rise in the frequency and variety of human fungal infections has been observed 
(1) with growing resistance against conventional antifungal drugs (1-4).  The widespread use of 
broad spectrum antibiotics together with the growth in immune compromised individuals (1-3), 
immune-suppression, chemotherapy and radiotherapy (1, 4) are just some of the factors that have 
led to this increase in the occurrence of resistant fungal pathogens. Candida species in particular 
lead to serious infections and are recognised as one of the major causative agents of nosocomial 
infections (5, 6). Candida albicans is the most commonly isolated species, which predominantly 
forms biofilms on biotic and abiotic surfaces. Biofilms are microbial communities embedded in a 
polymeric matrix (4-7). Biofilm formation on biological and/or inert surfaces is usually the 
culprit behind the instigation of candidiasis (5, 8, 9). Furthermore, C. albicans biofilms have 
been shown to be particularly resistant to antifungal agents commonly used to control fungal 
infections, including amphotericin B and fluconazole (5, 8, 10-12).  
Amphotericin B (AmB) and caspofungin (CAS) are currently two key drugs in the treatment of 
fungal infections (13, 14). AmB acts through the binding of its hydrophobic moiety to the fungal 
sterol ergosterol, resulting in the formation of transmembrane channels and cytoplasmic leakage 
(14-16). However, AmB’s severe nephro- and renal toxicity in some cases necessitates the 
premature termination of AmB treatment (14). Furthermore, there is a rise in isolates resistant to 
AmB treatment (17-19). CAS, a semi-synthetic lipopeptide from the echinocandin family, 
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inhibits the synthesis of the major structural component in fungal cell walls, 1,3-β-D-glucan (1, 
8, 20). Although CAS has a very good track record regarding side-effects with limited 
development of microbial resistance, resistance against CAS has been observed (1, 20). Strains 
of C. albicans with mutations in their (1,3)-D-glucan synthase show in vitro resistance against 
caspofungin (1). 
The rise in fungal pathogens resistant to conventional treatments (6, 21) has driven the search for 
novel antifungal compounds and treatments that simultaneously exhibit specificity toward fungal 
cells and low risk for inducing pathogen resistance. Combinatorial treatment is considered as a 
solution to the development of resistance against an individual compound. Combining 
compounds that act synergistically in general allows for lower drug dosage with concurrent 
decrease in toxicity (6). 
Antimicrobial peptides (AMPs) are the first line of defence in most organisms (22) and in recent 
years have been considered as potential alternatives/supplements to traditional antifungal 
compounds (6). The tyrothricin complex (the tyrocidine-gramicidin metabolite complex from 
Bacillus aneurinolyticus) was one of the first antibiotic preparations to be used as a topical 
antibiotic (23, 24) The tyrocidine component of the tyrothricin complex has been illustrated to 
have significant anti-bacterial (24, 25) and anti-malarial (26) activity. So far only tyrothricin (the 
tyrocidine-gramicidin complex) has been observed to have activity against C. albicans (27).  
To our knowledge this is the first investigation on the activity of the tyrocidines against 
planktonic and biofilm C. albicans cells. We report the antiyeast and antibiofilm activity of the 
three major tyrocidines (tyrocidine A, B and C) and two of their analogues (phenycidine A and 
tryptocidine C) against C. albicans. The membrane impermeable dye propidium iodide was used 
to investigate the tyrocidines effect on the integrity of biofilm cell membranes. With 
combinatorial treatment in mind the tyrocidines were also evaluated for potential enhancing 
effect on the in vitro biofilm eradication activity of AmB and CAS. A Caenorhabditis elegans 
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infection model was used to assess the in vivo efficacy and toxicity of tyrocidine A in 
combination with CAS. 
6.2 Materials  
6.2.1 Strain and media 
The Candida albicans SC5314 known to form biofilms was used in this study as target organism 
(28). Overnight cultures were grown in YPD (1% yeast extract, 2% peptone and 2% glucose) or 
on YPD agar (1% yeast extract, 2% peptone, 2% glucose and 1.5% agar). PBS (pH 7.4) was 
prepared with NaCl (8 g/L), KCl (0.2 g/L), Na2HPO4 (1.44 g/L) and KH2PO4 (0.24 g/L). C. 
albicans was grown in RPMI 1640 medium with L-glutamine and without bicarbonate (pH 7.0) 
purchased from Sigma (St. Louis, USA).  
6.2.2 Peptides 
The tyrocidines were purified and analysed for purity as described in Chapter 2. De novo 
sequencing using electrospray mass spectrometry by Vosloo et al. (29) and Spathelf (30) 
confirmed the identity of the tyrocidines and analogues. All the tyrocidines (TrcA, TrcB, TrcC, 
TpcC and PhcA) used in this study had purities >90% according to ultra-performance liquid 
chromatography linked to high resolution electrospray mass spectrometry (refer to Chapter 2). 
Gramicidin S (GS) (97.5 % purity according to manufacturers, 94% purity according to UPLC-
MS, Chapter 2) was supplied by Sigma (St Louis, USA). 
6.3 Methods 
6.3.1 Anti-planktonic yeast assays 
The anti-yeast activity of the Trc mixture (group of tyrocidines isolated from commercial 
tyrothricin (26)), selected tyrocidines, tyrocidine analogues and gramicidin S (GS) was 
determined using the standard NCLLS M27-A protocol (31).  
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6.3.2 Biofilm prevention activity assays 
The ability of the tyrocidines and analogous peptides to prevent the formation of C. albicans 
biofilms was determined using micro-dilution assays in 96-well tissue culture microtiter plates as 
optimised by the Plant-Fingus Interaction group (PFI) at the Centre of Microbial and Plant 
Genetics (CMPG) at the KU Leuven in Belgium (32). C. albicans cells in RPMI 1640 medium 
(1 × 10 cells/mL) were incubated with 0.78-100.0 µM tyrocidines (final ethanol concentration of 
1%) for 24 hours at 37°C. One percent ethanol in RPMI 1640 medium was the control treatment. 
The biofilms were washed with PBS and biofilm formation was determined using 
CellTiterBlue™ (Promega, Madison,WI) staining. After 1 hour incubation at 37°C, fluorescence 
was measured with a Multimode Microplate Reader, Synergy MX, BioTek, at wavelengths 535 
nm (excitation) and 617 nm (emission).  
6.3.3 In vitro biofilm eradication assay 
In vitro eradication activity was determined using 96-well microtiter as optimised by the PFI at 
the CMPG at the KU Leuven in Belgium (32). C. albicans biofilms were grown in 96-well 
microtiter plates in RPMI 1640 medium at 37°C. Subsequent to a PBS wash step, the biofilms 
were incubated with tyrocidine (concentration range 1.6-200.0 µM) in RPMI 1640 medium (final 
ethanol concentration of 1%) for 24 hours at 37°C. One percent ethanol in RPMI 1640 medium 
served as control treatment. The combined eradication activity of the tyrocidines and CAS/AmB 
was determined by incubating 24 hour old biofilms with 0.04-5.0 µM of either AmB (Sigma-
Aldrich, St Louis, USA) or CAS (Merck, United Kingdom), in the absence or presence of either 
1.8, 3.0 or 6.2 µM TrcA, TrcB or TrcC (final ethanol concentration of 0.05% and DMSO of 
0.05%), for 24 hours at 37°C. Biofilm survival was measured using CellTiterBlue™ assays and 
the BEC50 was defined as the concentration that resulted in 50% eradication of 24 hour old C. 
albicans biofilms. Combinatorial activity of AmB/CAS and the tyrocidines were assessed by 
statistically comparing the BEC50 values of AmB/CAS alone, and in combination with 
tyrocidines, using the Bonferroni’s multiple comparison test, as well as determining the 
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fractional inhibitory concentration index (FICI) (33). The FICI was calculated using the 
following equation: 
FICI = [CA+B/ CA] + [CB+A/CB] 
where CA and CB are the BEC50’s of the antifungal compounds alone and CA+B and CB+A are the 
BEC50’s of the antifungal compounds in combination. A FICI ≤0.5 was interpreted as 
synergistic, a FICI between 0.5-4.0 as indifferent and a FICI 4.0 as antagonistic (33). 
6.3.4 Membrane-permeability assay 
The membrane disruptive activity of the tyrocidines on 24 hour old C. albicans biofilms was 
determined using the membrane impermeable dye propidium iodide from Sigma-Aldrich (St. 
Louis, USA). Twenty-four hour old C. albicans biofilms were prepared as described for the 
biofilm eradication experiments. Subsequent to 24 hour treatment with tyrocidines (0.78-100.0 
µM) at 37°C, the biofilms were washed with PBS and incubated with 1.5% propidium iodide in 
the dark for a further 20 minutes. Propidium iodide fluorescence was measured as described by 
Bink et al. (33) and fluorescence values of samples were corrected with values obtained for 
untreated biofilms. Triton X-100 (1%) served as the lytic control. 
6.3.5 Assay for determination of endogenous reactive oxygen species 
The induction of endogenous reactive oxygen species (ROS) was determined using the 
fluorescent dye 2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA) (Molecular Probes
®, 
Eugene, USA). C. albicans biofilms were grown in 96-well microtiter plates in RPMI 1640 
medium for 24 hours and treated for 24 hours with 0.78-100.0 µM tyrocidines. Biofilms were 
washed with PBS and incubated for 1 hour with 10.0 µM H2DCFDA shaking at 37°C. 
Fluorescence was measured with a Multimode Microplate Reader, Synergy MX, BioTek, at 
excitation wavelength of 492 nm and emission of 525 nm (2). The relationship between 
endogenous ROS generation in C. albicans and tyrocidine antifungal activity was investigated 
using the antioxidant ascorbic acid. The influence of 10 mM ascorbic acid on the biofilm 
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eradication and ROS induction activity of 100 µM TrcA, TrcB and TrcC was determined (34, 
35). Citric acid served as the pH control. 
6.3.6 In vivo studies using Caenorhabditis elegans model system  
The toxicity of TrcA and its combined effect on the in vivo activity of CAS was evaluated using 
the C. elegans model system described by Breger et al. (36). The efficacy of CAS alone, or in 
combination with TrcA, to increase survival of C. albicans infected nematodes, was evaluated 
over a period of seven days. The temperature sensitive C. elegans Δglp-4Δsek-1 mutants were 
stored on Escherichia coli OP50 covered NGM (0.25% Bacto Peptone, 0.3% NaCl, 1.7% Agar) 
plates at 16°C. Prior to infection, the nematodes were collected and treated with bleach in order 
to collect the eggs which were then incubated at 25°C so that all the nematodes reached the same 
growth phase (L3-L4) four days later for C. albicans infection and treatment studies. Nematodes 
were infected for two hours with C. albicans and subsequent to transfer to pathogen-free media, 
treated with 0.095/0.19 µM CAS, 3.0 µM TrcA, 0.095/0.19 µM CAS in combination with 3.0 
µM TrcA or a combination of 0.5% ethanol and 0.5% DMSO as control. For the toxicity test the 
nematodes were treated with 3.0 and 6.0 µM TrcA and nematode survival was monitored for 
seven days. The control group received 0.5% ethanol. For both experiments survival was 
calculated relative to the survival on day 0. 
6.3.7 Data analysis  
Analyses of dose-response assay data were done with GraphPad Prism® 4.03 (GraphPad 
Software, San Diego, USA) using non-linear regression to generate sigmoidal curves and  the 
data normalisation function (range 0-100%) if required (37). The IC50, BEC50 and BIC50 
represent the concentration necessary to cause 50% growth inhibition, biofilm eradication and 
biofilm prevention, respectively. The inhibition/eradication/prevention concentration, calculated 
as the x-value at the intercept between the slope and the top plateau of a full dose-response 
curve, was denoted as ICmax (37), to make the distinction with minimal inhibition concentration 
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(MIC) values obtained from visual inspection of a dose-response result. The values calculated 
from the full dose-response curves were used for statistical analyses. MIC and minimum biofilm 
prevention concentration (BIC) was defined as the lowest concentration that induced ≥ 95% 
inhibition compared to the growth control. 
GraphPad Prism® 4.03 (GraphPad Software, San Diego, USA) was used for the statistical 
analysis of data. Analysis included 95% confidence levels, absolute sum of squares, standard 
error of the mean (SEM), Student t-tests and One-way ANOVA analyses using Bonferroni’s 
multiple comparison test. 
6.4 Results and discussion 
6.4.1 Antifungal activity against Candida albicans planktonic cells 
The Trc mixture, the three pure major tyrocidines (TrcA, TrcB and TrcC) and their analogues 
(PhcA and TpcC) showed noteworthy activity against planktonic C. albicans cells. Although 
their activity was not as high as that of AmB and CAS, the activities of the tyrocidines were still 
in the low micromolar range (Table 6.1). The Trc mixture exhibited high antifungal activity 
against C. albicans characterised by a MIC (minimal inhibitory concentration) of 6 µg/mL 
(Table 6.1). Purified tyrocidines and TpcC, as well as the analogous peptide gramicidin S (GS) 
were characterised by antifungal activity with MIC values of 6.25 µM (IC50s ranging from 3.1-
4.6 µM), whereas the phenycidine (PhcA) had a significantly higher MIC of 12.5 µM (IC50 of 
7.9 µM) (Table 6.1 and Figure 6.1).  
Tyrocidines have a highly conserved sequence, differing in some cases in only one amino acid 
residue. The major tyrocidines have the basic sequence of cyclo[f1P2X3x4N5Q6Y7V8X9L10] and 
the relevant tyrocidines only vary in one or two residue positions, Trp3,4 or Phe3,4 in the aromatic 
dipeptide unit. The two tyrocidine analogues in this study, PhcA (a phenycidine) and TpcC (a 
tryptocidines), respectively have a Phe7 and Trp7 instead of the Tyr7 that is found in the major 
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tyrocidines (refer to Chapter 2). Except for PhcA, the minor differences in their sequences did 
not appear to significantly influence their fungicidal activity. Since PhcA has the highest 
hydrophobicity, the lower activity observed for PhcA could possibly be ascribed to peptide 
aggregation or alternatively point to the role of a residue with hydrogen bonding character such 
as Tyr a or Trp in residue position 7. 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: The activity parameters (IC50 values in µM, expect Trc mixture in g/mL) of the 
individual peptides against planktonic C. albicans cells. Each data point represents 
the value of an individual biological activity determination (with three technical 
repeats per assay) with the line representing the mean of the individual data points. 
According to One-way ANOVA with Bonferroni’s multiple comparison test the 
IC50 values of PhcA are significantly (***P<0.001) higher than the values for the 
other tyrocidines, TpcC and GS. 
6.4.2 Activity against Candida albicans biofilm cells 
Apart from their activity against planktonic cells, the tyrocidines and analogues were also able to 
prevent the formation of C. albicans biofilms in vitro (Table 6.1). However, greater variation in 
the biofilm prevention activity of the individual peptides could be observed compared to their 
activity against planktonic cells. In terms of their BIC values TrcA, TrcB and GS exhibited equal 
biofilm prevention activity, all characterised by BIC values of 12.5 µM, whereas the BIC values 
of PhcA, TpcC and TrcC were two-fold higher (Table 6.1). Similar to their activities against the 
planktonic cells, the tyrocidines’ activities were again lower than that of AmB and CAS. 
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However, bearing in mind that the AmB and CAS formulations have both been optimised for 
pharmaceutical use, in comparison the tyrocidines show good potential for further optimisation 
for use against C. albicans infections. 
The tyrocidines and analogues failed to fully eradicate mature biofilms and only the analogous 
GS could achieve 100% eradication of 24 hour old C. albicans biofilms (Table 6.1). Although 
TrcC exhibited lower fungicidal activity and biofilm preventive activity than the other two 
tyrocidines, it was characterised by the highest biofilm eradication activity: at 200 µM, TrcC 
resulted in 74±3 % eradication of the biofilms, whereas TrcA and TrcB treatment of biofilms 
resulted respectively in 64±5 % and 55±7 % eradication. Treatment of the biofilms with 200 µM 
PhcA or TpcC did not induce 50% eradication of the biofilms. 
Compared to the planktonic activity of the tyrocidines, greater variance in the activities of the 
individual peptides was observed with regards to their ability to prevent biofilm formation. It 
seems that, in terms of their biofilm prevention activity, a Phe4 instead of a Trp4 as aromatic 
amino acid residue is preferred. These aromatic amino acid residues have a substantial influence 
on the hydrophobicity of tyrocidines and concurrently contribute to the tyrocidines’ ability for 
membrane partitioning (38). It has been illustrated that Phe has a greater  propensity to insert 
deeper into the membrane (39, 40). The presence of a Tyr7 (as in tyrocidines) instead of for 
example a Phe7 (as in PhcA) or Trp7 (as in TpcC) also appears to be advantageous for the biofilm 
eradication activity of the tyrocidines. As has been proposed in Chapter 5, a higher order 
structure may be the active conformation of the tyrocidines and consequently it could be that the 
more hydrophobic TrcA and TrcB with Phe4 instead of a Trp4 favours the formation of more 
active higher order structures, such as dimers (30, 41).   
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Table 6.1: Summary of activity parameters obtained for tyrocidines against C. albicans. 
Compound 
Inhibition of 
planktonic 
cells ICmax 
(MIC)
a
 
Inhibition of 
planktonic 
cells IC50 
Biofilm  
prevention  
BICmax (BIC)
b
 
Biofilm 
prevention 
BIC50 
Biofilm 
eradication 
BEC50 
% Biofilm 
eradication 
at 200 µM 
Trc mix 
6.0 ± 0.26 
 (6.25) * 
3.7 ± 0.25* 
11.3 ± 0.67 
(12.5) * 
8.3 ± 0.43* 107 ± 20* 81 ± 3.3* 
TrcA 
5.2 ± 0.44  
(6.25) 
3.2 ± 0.31 
8.01 ± 1.77 
(12.5) 
5.7 ± 0.71 145 ± 23 64 ± 4.8 
TrcB 
6.3 ± 0.0  
(6.25) 
4.3 ± 0.03 
10.6 ± 0.32 
(12.5) 
8.3 ± 0.11 164 ± 18 55 ± 7.3 
TrcC 
7.8 ± 0.81  
(6.25) 
4.7 ± 0.05 
24.3 ± 1.44 
(25.0) 
17.4 ± 0.20 133 ± 6.3 74 ± 3.3 
PhcA 
12.5 ± 0.0  
(12.5) 
7.9 ± 0.48 
11.2 ± 1.78 
(25.0) 
12.2 ± 2.5 > 200 41 ± 3.5 
TpcC 
6.0 ± 0.26  
(6.25) 
4.2± 0.42 
18.4 ± 3.33 
(25.0) 
15.5 ± 0.91 > 200 28 ± 5.4 
GS 
6.8 ± 0.52  
(6.25) 
4.4 ± 0.03 
8.55 ± 0.57 
(12.5) 
5.7 ± 0.29 40.9 ± 6.2 100 ± 0.04 
CAS 0.05c 0.03c 0.13c 0.05c 0.35 ± 0.03 - 
AmB 1.73c 0.79c 1.35c 0.37c 0.56 ± 0.02 - 
Each value represents the mean of at least 3 biological repeats, with 2-3 technical repeats per assay. Values are 
given in µM except for µg/mL where indicated with *.  
aMinimal concentration that results in ≥ 95% yeast death; bminimal concentration that prevents ≥ 95% biofilm 
formation;  
cInhibition values supplied by N. Delattin, Centre of Microbial and Plant Genetics, CMPG, KU Leuven, Heverlee, 
Belgium. 
In terms of their biofilm eradication activity it would seem as if the Tyr7 amino acid residue of 
the major tyrocidines is key to higher activity. Sequence wise PhcA and TpcC respectively differ 
from TrcA and TrcC in only one residue, namely a Phe7 or Trp7 instead of a Tyr7 (90% sequence 
identity). Tyr differs from Phe in only an OH-group, but this difference makes Tyr amphipathic, 
dipolar and ionisable (pKa = 10.07). Phe and Trp are more hydrophobic than Tyr 
(Tyr>Trp>>Phe) (42). The three aromatic amino acids also differ in their hydropathies (Phe = 
2.8, Trp = -0.9, Tyr = -1.3) (42). It could be that the Tyr residue has just the right chemical 
properties for target interaction and activity. As was mentioned above it has been hypothesised 
that in order to form amphipathic structures for activity, the tyrocidines require the formation of 
higher order structures such as dimers (30, 41). From our handling of the peptides we found that 
PhcA exhibits a high tendency to aggregate in solution, while TpcC’s tendency to aggregate is 
lower than that of the major tyrocidines, leading either to loss of activity due to solubility or less 
formation of active amphipathic structures. The significantly higher activity of GS (Table 6.1), 
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point out the importance of the VOLfP pentapeptide moiety in terms of biofilm eradication 
activity. This pentapeptide moiety, shared by the tyrocidines relevant to this study, has also been 
linked to an increase in membrane activity (26).  
6.4.3 Tyrocidines disrupt membrane integrity of biofilm cells  
The membrane disruptive activities of TrcA, TrcB and TrcC on in vitro grown C. albicans 
biofilm cells were assessed using the fluorescent membrane impermeable dye propidium iodide 
(Figure 6.2). As GS is known to disrupt microbial membranes, it was included in the study. GS 
induced membrane permeabilisation at concentrations starting from 6.25 µM, whereas the 
tyrocidines induced membrane permeabilisation at two- to fourfold higher concentration (Figure 
6.2). The decrease in peptide-induced propidium iodide fluorescence at higher GS concentrations 
corresponds with the biofilm eradication activity of GS (compare Figure 6.2 and Table 6.1).  
These data indicate that the tyrocidines disrupt the membrane integrity of mature C. albicans 
biofilm cells, albeit not to the same extent as GS. If they also target an internal target subsequent 
to membrane permeabilisation, especially at lower concentrations, remains to be further 
investigated. The significant membrane activity of GS (which contains two VOLfP pentapeptide 
moieties) compared to that of the tyrocidines, again highlights the association between the 
VOLfP sequence and membrane activity (26). 
6.4.4 Induction of endogenous reactive species (ROS) by tyrocidines 
Various antifungal molecules are known to induce accumulation of ROS in susceptible yeast and 
fungal species (2, 34, 35). Significant accumulation of endogenous ROS - indicated by the 
fluorescent dye H2DCFDA - in C. albicans biofilm cells was observed subsequent to 24 hour 
treatment with TrcA, TrcB and TrcC compared to untreated cells (Figure 6.3 A). In order to 
determine if this induction of endogenous ROS in C. albicans biofilm cells is linked to 
tyrocidine activity, the influence of ascorbic acid on the biofilm eradication activity of 100 µM 
TrcA, TrcB and TrcC was determined (35, 43).   
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Figure 6.2: Percentage propidium iodide (PI) fluorescence induced by TrcA, TrcB, TrcC and 
GS on 24 hour C. albicans biofilms with 1% Triton X-100 as reference for 100% 
lysis. Biofilms were incubated for 24 hours with peptide prior to PI staining. 
Fluorescence values were corrected with those obtained from untreated cells. Each 
data point represents the mean of at least 8-10 repeats ±SEM. According to One-
way ANOVA with Bonferroni’s multiple comparison test the fluorescence induced 
by GS is significantly higher than that of TrcA, TrcB and TrcC from concentrations 
of 6.2 µM and up (***P<0.001). There were no significant differences between the 
fluorescence induced by TrcA, TrcB and TrcC. 
Although the addition of 10 mM ascorbic acid significantly decreased the presence of 
endogenous ROS in C. albicans biofilm cells, no significant decrease in the biofilm eradication 
activity of the peptides was observed (Figure 6.3 B). Therefore it would seem as if tyrocidine-
induced ROS is a secondary result of tyrocidine activity and not essential for their antifungal 
activity. A clear correlation can be observed between the propidium iodide and ROS 
fluorescence induced by the tyrocidines (compare Figure 6.2 and Figure 6.3 A) which could 
point to the possibility that the observed ROS induction is a result of the membrane disruptive 
activity of the tyrocidines. However, it must also be kept in mind that ascorbic acid is specific to 
certain ROS species. Although the total ROS is reduced in the presence of 10 mM ascorbic acid, 
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a small percentage of ROS still remains (Figure 6.3 B). It could therefore be that these remaining 
ROS species are responsible for the activity of the tyrocidines. However, surprisingly ascorbic 
acid significantly (P<0.01) enhanced the activity of the two less active peptides TrcA and TrcB. 
The reason for this is unclear, but could point to a difference in activity between TrcC and the 
less bulky and more hydrophobic TrcA and TrcB. It is possible that the formulation of the two 
more hydrophobic cationic tyrocidines with the high concentration ascorbic acid (as possible 
chaotropic agent) lead to less detrimental aggregation and stabilise more active structures.  
 
 
Figure 6.3: A. Dose response curves of ROS induction in 24 hour old C. albicans biofilms 
treated with peptides in relation to untreated cells. Biofilms were incubated for 24 
hours with TrcA, TrcB or TrcC prior to staining with H2DCFDA. Each data point 
represents the mean of triplicate biological repeats ± SEM, with triplicate technical 
repeats per assay. B. ROS induction in mature C. albicans biofilms treated for 24 
hours with 100 µM TrcA, TrcB and TrcC prior to staining with H2DCFDA. The 
influence of 10 mM ascorbic acid (AA) on the tyrocidines’ ability to eradicate 
biofilms and induce endogenous ROS was determined. According to the Student t-
test the ROS induced in the presence of 10 mM ascorbic acid is significantly less 
($$$P<0.001) than in the absence of it. There is significant increase in the biofilm 
eradication activity in the presence of ascorbic acid for TrcA (**P<0.01) and TrcB 
(***P<0.001). The experiment was performed in quadruplicate and citric acid 
served as pH control. 
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6.4.5 Potentiating of antibiofilm activity of caspofungin and amphotericin B by the 
tyrocidines  
Combination drug therapy is currently preferred to limit resistance, therefore we assessed 
combinations of the three major tyrocidines (TrcA, TrcB and TrcC) with commonly used 
antimycotics namely caspofungin (CAS) and amphotericin B (AmB) in biofilm eradication 
assays. In combination TrcA, TrcB and TrcC significantly increased the biofilm eradication 
activity of both CAS (Figure 6.4) and AmB (Figure 6.5).  
The presence of 1.8-6.3 µM of TrcA, TrcB or TrcC decreased the BEC50 of CAS (0.35 µM) and 
AmB (0.56 µM) up to 25- and 16-fold, respectively. Furthermore, our results show that, although 
the tyrocidines alone have only minor biofilm eradicating activity (BEC50 >100 µM, Table 2), 
1.8-6.3 M of TrcA, TrcB or TrcC in combination with CAS or AmB displayed synergistic 
activity with regard to eradication of mature biofilms (Table 6.2). The calculated FICI values of 
both AmB and CAS, in combination with the tyrocidines, were well below 0.5 at values of 0.10-
0.42, pointing toward pronounced synergistic activity (33) (Table 6.2). From the FICI values it is 
also observed that the tyrocidines have a slightly greater effect on the activity of CAS 
(FICI=0.10-0.35) than on the activity of AmB (FICI=0.14-0.42) (Table 6.2). These data indicate 
that combination therapy using co-administration of the tyrocidines and CAS or AmB could be 
effective in curing biofilm-associated infections. The results of the propidium iodide studies 
indicate that the tyrocidines disrupt the membrane integrity of C. albicans biofilm cells. 
Therefore one could hypothesise that the synergistic activity could be the result of increased 
accumulation of the antifungal drug into the cell by the increased membrane permeability.  
Since AmB and the tyrocidines both target the fungal cell membrane (14-16), competition for 
this target could possibly explain why higher synergism was observed for CAS (Figure 6.4) than 
for AmB (Figure 6.5). Nevertheless, further studies will need to be conducted to draw definite 
conclusions regarding the mode of synergism between the tyrocidines and CAS/AmB.  
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Figure 6.4: Dose response curves of CAS biofilm eradication activity (I) and comparison of 
BEC50’s of CAS (II) in the absence and presence of TrcA (A), TrcB (B) and TrcC 
(C). Each data point represents the mean of triplicate biological repeats ± SEM, 
with triplicate technical repeats per assay. According to One-way ANOVA with the 
Bonferroni’s multiple comparison test the BEC50’s of CAS was significantly 
(***P<0.001, **P<0.01) lower in the presence of 1.8, 3.0 and 6.2 µM TrcA, TrcB 
and TrcC. 
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Figure 6.5: Dose response curves of AmB biofilm eradication activity (I) and comparison of 
BEC50’s of AmB (II) in the absence and presence of TrcA (A), TrcB (B) and TrcC 
(C). Each data point represents the mean of triplicate biological repeats ± SEM, 
each with triplicate technical repeats per assay. According to One-way ANOVA 
with the Bonferroni’s multiple comparison test the BEC50’s of CAS was 
significantly (***P<0.001) lower in the presence of 1.8, 3.0 and 6.2 µM TrcA, 
TrcB and TrcC. 
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Table 6.2: Summary of activity parameters for AmB and CAS in combination with TrcA, TrcB and TrcC, against 24 hour old C. albicans 
biofilms. 
[Tyrocidine] 
   TrcA  TrcB  TrcC 
 +AmB  + CAS  +AmB  + CAS  + AmB  + CAS 
  
BEC50 
(µM) 
 
FICI 
 BEC50 
(µM) 
 
FICI 
 
BEC50 
(µM)  
FICI 
 BEC50 
(µM) 
 
FICI 
 BEC50 
(µM)  
FICI 
 BEC50 
(µM)  FICI 
6.2 µM 
  
0.11   0.25  0.04  0.11 
 
0.06 
 
0.14  0.03  0.15  0.21  
 
0.34  0.15   0.12 
3.0 µM 
  
0.12  0.23  0.04  0.10 
 
0.14 
 
0.27  0.04   0.12  0.17  
 
0.28  0.06   0.15 
1.8 µM     0.22   0.41  0.06  0.18   0.22   0.42  0.06   0.19  0.22    0.35  0.13   0.35 
Each value represents the mean of at least 3 biological repeats, with 2-3 technical repeats per assay ± SEM. 
The BEC50 value represents the concentration AmB/CAS at which 50% eradication was achieved in the presence of the tyrocidines. 
The FICI (fractional inhibitory concentration index) was calculated using the BEC50 obtained for combinatorial treatment and the BEC50 values for the individual compounds 
(Table 6.1).   
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6.4.6 In vivo activity of tyrocidine A with caspofungin 
 TrcA and CAS were chosen from their promising FICI values (Table 6.2) to evaluate their 
combined antibiofilm activity in vivo using the C. elegans-C. albicans infection model system as 
described by Breger et al. (36). We performed dose-response experiments with TrcA and CAS to 
determine the TrcA and CAS concentrations ineffective (<10% survival) in curing C. elegans 
infected with C. albicans compared to the control treatment (data not shown). Five days after 
infection with C. albicans, only 4±2 % of the C. albicans infected nematodes survived. The 
survival of nematodes treated with 3.0 µM TrcA (3±1 % survival) or 0.095 µM CAS (10±5 % 
survival) were similar to the survival of untreated nematodes (Figure 6.6).  
 
 
 
 
 
 
 
 
 
 
Figure 6.6: Comparison of C. albicans infected nematode survival 5 days post treatment with 
either 3 µM TrcA, 0.095 µM / 0.19 µM CAS or a combination of 3 µM TrcA and 
0.095/ 0.19 µM µM CAS. Statistical analysis was done using One-way ANOVA 
with Bonferroni’s multiple comparison test. Each bar represents the average of 3-6 
repeats ±SEM. Note: There was no toxicity observed for 6.0 µM TrcA five days 
post treatment and the MC50 (concentration at which 50% of the nematodes died) 
was determined as 25 µM TrcA. 
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A single treatment of infected nematodes with a combination of 3.0 µM TrcA and 0.095 μM 
CAS significantly increased the survival of the nematodes to 23±2 % five days post infection and 
treatment, compared to treatment with 3.0 µM TrcA or 0.095 μM CAS alone or control treatment 
(0.6% DMSO). This combination gave similar nematode survival as treatment with double the 
CAS dose, namely 0.19 µM, CAS which led to 27±3% survival. Although 0.19 µM CAS led to 
significant nematode survival, a single treatment with the combination of 3.0 µM TrcA and 0.19 
µM CAS almost doubled the survival to 42±3% nematodes after five days (Figure 6.6). These 
data indicate that TrcA also enhances the activity of CAS in vivo in the C. elegans infection 
model. Furthermore, there was no toxicity observed for the nematodes for TrcA up to 6 µM. 
These results reveal the potential of tyrocidines to act as candidates for further studies as 
antifungal drugs, especially as potentiating factors to be used in combination with other 
antifungal drugs, such as AmB and CAS. 
6.5 Conclusion 
The significant fungicidal and biofilm prevention activities indicate that the tyrocidines have the 
potential to serve as lead compounds for novel antifungal compounds. Although the tyrocidines 
activity is probably not connected to the induction of ROS, propidium iodide fluorescence as a 
result of tyrocidine activity reveals that the tyrocidines disturb the integrity of C. albicans cell 
membranes in biofilms. If there is an alternative/additional target to the membrane target remains 
to be discovered in future studies. The significant synergistic effect of the tyrocidines on the in 
vitro biofilm eradication activity of AmB and CAS, as well as the potentiating effect of TrcA on 
the in vivo remediating activity of CAS, are promising evidence for the potential of 
combinatorial treatment that will not only decrease the toxicity of the individual compounds, but 
which will also decrease the likelihood of resistance developing against the individual 
compounds.  
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Chapter 7 
Conclusions and recommendations for future studies 
 
7.1 Introduction 
The main goal of this study was to provide novel information and insights regarding the 
antifungal activity of the tyrocidines and their potential to serve as bio-control agents in the 
agricultural sector and therapeutic agents in the medical industry. To realise this goal the major 
tyrocidines and natural analogues had to be purified from the commercial Bacillus 
aneurinolyticus tyrothricin complex and the culture medium of Brevibacillus aneurinolyticus 
ATCC 8185 and subsequently analysed for peptide identity and purity; antifungal activity test 
parameters optimal for fungal growth and peptide activity had to be determined; the biological 
activity of the tyrocidines and any structure-activity parameters had to be elucidated; and the 
potential mode(s) of action investigated.  
This is the first study to give a detailed report on the antifungal activities of the purified 
tyrocidines and their analogues against agronomic important pathogens (Chapter 4-5) and 
medically relevant pathogens (Chapter 6) using the tyrocidines and natural analogues purified 
and analysed in Chapter 2 and the activity test parameters determined in Chapter 3. 
7.2 Experimental conclusions 
7.2.1 Influence of the environment on fungal growth and peptide activity 
In Chapter 3 it was illustrated that the assay medium and peptide solvent composition influences 
the growth of both F. solani and B. cinerea.  F. solani flourished in the nitrogen rich yeast 
supplemented tryptone soy broth (YTSB) while B. cinerea preferred the potato dextrose broth 
(PDB). Both species exhibited improved growth on the gel-based media, yeast supplemented 
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tryptone soy agar (YTSA) and potato dextrose agarose (PDA), compared to the broth media. 
Similar to previous observations made from tyrocidine studies (1), the activities of the 
tyrocidines were also influenced by the environment and solvent conditions. With increasing 
ethanol concentrations in the peptide solvent a concurrent increase in tyrocidine activity was 
observed. The amphipathic tyrocidines have a tendency to aggregate in aqueous environments 
(1-6) and with increased ethanol to water ratio the extent of their initial aggregation is reduced. 
Unfortunately ethanol also influences the growth of fungi which meant a midway ethanol 
concentration (15 %) was chosen for subsequent activity determinations. Compared to their 
activity in broth media, the tyrocidines activity was significantly lower on the agar media 
(Chapter 4). As was mentioned above, the tyrocidines are extremely sensitive to their 
environment and tend to oligomerise which is hypothesised to influence their activity. The 
significant loss in tyrocidine activity on an agar-based assay environment could be the result of 
variation in peptide assembly compared to that in a broth-based environment.  An alternative 
explanation for the loss in activity may be that the altered environment influences the growth of 
the fungal target cell which could lead to adjustments to the target(s) of the tyrocidines in the 
fungal cell. Last mentioned is supported by the observation that the loss in tyrocidine activity is 
much more significant against F. solani than B. cinerea.  
In contrast to the majority of antimicrobial peptides (AMPs) (7-9), the activities of the 
tyrocidines were relatively salt stable and were only negatively influenced by the presence of 
Ca2+ (Chapter 4). The loss of tyrocidine activity in the presence of Ca2+ can either be the result of 
cation-induced peptide aggregation leading to a lowering in the number of available and “active” 
peptides (10) or it can be the result of interference with a specific peptide target that is dependant 
on ionic interactions or ion fluctuations in membranes (11). Because the tyrocidines’ activities 
against B cinerea were in general more stable in the presence of Ca2+ than against F. solani, we 
theorised that the tyrocidines have additional/alternative targets in B. cinerea which are not 
sensitive to the presence of Ca2+. Of all the tyrocidines tested, tyrocidine A (TrcA) was the most 
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successful in maintaining its activity in the presence of Ca2+. These theorised additional target(s) 
may therefore be more effectively targeted by TrcA than the other tyrocidines. 
7.2.2  Biological activity 
The activity of the tyrocidines, a complex of analogous cyclic decapeptides produced by 
Bacillus aneurinolyticus, was determined using broth microdilution assays against a range of 
phytopathogenic fungi, namely F. solani, F. oxysporum, F. verticillioides, Cylindrocarpon 
liriodendri, B. cinerea and Penicillium digitatum, P. glabrum, P. expansum, Talaromyces 
mineoluteus, T. ramulosus, Asperigellus fumigatis and Trichoderma atroviride isolates (Chapter 
4).  The activity of the tyrocidine peptide complex (Trc mixture) was significant, minimum 
inhibition concentrations below 13 µg/mL (~10 µM) were obtained and the Trc mixture’s 
activity was significantly more potent than that of the commercial imidazole fungicide, 
bifonazole. However, the activity of the Trc mixture varied between the different fungal species 
indicating that the fungal target cell a role plays in tyrocidine activity. A significant loss in 
tyrocidine activity was observed on the agar compared to the activity in a broth environment, 
especially against F. solani. The activities of the purified six major tyrocidines and two of their 
natural analogues, phenycidine A (PhcA) and tryptocidine C (TpcC), were investigated against 
F. solani and B. cinerea, in either YTSB or PDB. Each one of the peptides had the ability to 
inhibit both F. solani and B. cinerea in both the broth mediums. However, the activities of the 
individual peptides were influenced by the identity of the target organism and the specific 
medium used. Especially the two tyrocidine analogues, with respectively a Phe and Trp in amino 
acid position 7, were susceptible to changes in the media environment. These results highlight 
the importance of the Tyr7 residue for consistent high activity against different organisms and in 
various environments. It could be that the Tyr residue has the optimal chemical properties for 
target interaction in both PDB and YTSB media or/and the Tyr residue leads to the right amount 
of self-assembly to yield the most active/stable higher-order structure. Surprisingly, in contrast to 
the tyrocidines’ antibacterial (12) and antiplasmodial (13) activity, no other overt structure-
Stellenbosch University http://scholar.sun.ac.za
7-4 
 
activity correlations could be uncovered. The minor differences in the activities of the peptides 
may possibly be the result of minor differences in their propensities to aggregate (3, 4). 
The activities of the Trc mixture, three major tyrocidines, TrcA, TrcB and TrcC, as well as the 
two analogues, PhcA and TpcC, were also determined against the medically relevant pathogen 
Candida albicans and its biofilms (Chapter 6). The selected tyrocidines had significant antiyeast 
activity against planktonic C. albicans cells in the low micromolar range and, except for PhcA, 
their activities were comparable. The tyrocidines were also able to prevent in vitro C. albicans 
biofilm formation, but with more variation in their individual activities. Even though the 
tyrocidines failed to achieve full eradication of mature biofilms, they exhibited pronounced 
synergistic activity with the in vitro biofilm eradication activities of two key antifungal drugs, 
amphotericin B and caspofungin. Using a Caenorhabditis elegans infection model, TrcA was 
also illustrated to have a potentiating effect on the in vivo activity of caspofungin. Tyrocidines 
therefore present promising candidates for further research as antifungal drugs and as agents for 
combinatorial treatment. 
To summarise, the tyrocidines exhibit significant antifungal activity which is 
influenced/determined by the identity of the target cell and which is sensitive to environmental 
conditions. The absence of overt structure-activity relationships, besides the apparent 
significance of the Tyr7 residue, could point to the possibility that higher-order structures are the 
biologically active structures of tyrocidines, a hypothesis that has also been proposed in previous 
studies (1, 2).  
7.2.3 Mode of action studies 
Studies with the membrane impermeable dyes SYTOX green and propidium iodide illustrated 
that the tyrocidines disrupt the integrity of fungal spore membranes (Chapter 4), fungal hyphae 
membranes (Chapter 4 and 5) and the integrity of the membranes of C. albicans biofilm cells 
(Chapter 6). Fluorescence microscopy images revealed that initial membrane permeabilisation 
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takes place at hyphal growth tips and sites of hyphal branching. Therefore it can be concluded 
that at least one of the tyrocidines’ mode(s) of action (MOA) is membrane targeted. However, 
concentrations that resulted in maximum inhibition of filamentous fungi did not lead to complete 
membrane disintegration (compared to 1 % TritonX-100 as 100 % lysis control). Therefore it 
would seem as if membrane interaction is not the only mode of tyrocidine antifungal action, but 
that there are additional target(s) subsequent to membrane interaction, especially at lower 
concentrations of peptide. Furthermore, the membrane disruptive activity of the tyrocidines, in 
terms of their activity parameters, appeared to be much lower against B. cinerea than F. solani 
(Chapter 5). Tyrocidine activity against B. cinerea was also more stable in increasing Ca2+ 
concentrations than against F. solani (Chapter 4). The presence of Ca2+ may therefore influence 
the membrane activity of the tyrocidines and since tyrocidine activity against B. cinerea appears 
to be less dependent on membrane interaction, their activities are more stable against B. cinerea 
in the presence of Ca2+. Similar observations was made in terms of the tyrocidines’ antibacterial 
activity (1, 14). 
Experimental evidence also suggests that tyrocidine interaction with the fungal cell membrane is 
not solely determined by the composition of the cell membrane. Individual tyrocidines that had 
high membrane disruptive action toward fungal model membranes [comprising of 1-palmitoyl-2-
oleoylphosphatidylcholine:ergosterol (70:30) and 1-palmitoyl-2-oleoylphosphatidylcholine: 
glucosylceramide (70:30)] did not necessarily have high biological membrane disruptive activity 
(that results in SYTOX green uptake in F. solani hyphae) and vice versa (Chapter 5). This may 
indicate that the permeabilisation of the fungal hyphae may depend on alternative factors, other 
than membrane permeabilisation, such as self-promoted uptake via lesions in the cell wall (15). 
It has also been hypothesised that even though AMPs may act through membrane 
permeabilisation, additional elements such as their interaction with specific components, for 
instance chitins and phosphomannans of the cell wall, may regulate or enhance their membrane 
activity (16). The observance that the tyrocidines lose activity against F. solani subsequent to 
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treatment with β-glucanase (to remove the cell wall) may indicate that a cell wall related 
component modulates the activity (probably membrane related) of the tyrocidines against F. 
solani (Chapter 5). 
Microscopic analysis revealed that the tyrocidines have a significant impact on the morphology 
of F. solani and B. cinerea which includes retarded germination and hyperbranching of hyphae 
(Chapter 4). Tyrocidine action may therefore target the various processes and regulators believed 
to be involved in spore germination and hyphal branching. These processes include 
establishment of a polar axis (17) which is believed to be regulated by Rho-type GTPases (17) 
and cAMP signalling.(18, 19);  hyphal elongation believed to be controlled by GTPases (17, 20), 
formins and septins (18, 20), the Spitzenkorper, the microtubule cytoskeleton (20, 21), actin 
polymerization (21) and Ca2+ gradient regulated process (22); and subsequent hyphal branching 
which is thought  to be determined by septa location, GTPases activity (20) and localized spikes 
in Ca2+ (23, 24) and ROS (20) and the cell cycle (20, 25). In Chapter 4 it was illustrated that only 
Ca2+ - and none of the other cations - inhibit tyrocidine activity. These results suggests that Ca2+ 
inhibition of tyrocidine activity is not the result of electrostatic interference, but a more specific 
inhibition of tyrocidine-target interaction. Tyrocidine activity could “mimic” the Ca2+ spikes, 
believed to be involved in the regulation of hyphal branching (23, 24), or interfere with Ca2+ 
gradients believed to be involved with hyphal elongation (22), leading to abnormal hyphal 
branching and hyphal growth. The presence of high concentrations Ca2+ may counter/neutralise 
this effect leading to a loss in tyrocidine activity. Tyrocidine activity also induces reactive 
oxygen species (ROS) in C. albicans biofilm cells (Chapter 6). It is therefore possible that 
tyrocidine activity may similarly lead to the formation of ROS in filamentous fungi which could 
induce hyperbarnching. Tyrocidine interference with the cell cycle of Plasmodium falciparum 
has also been hypothesised (13). The tyrocidines may likewise interfere with the cell cycle of 
filamentous fungi leading to retarded germination and hyperbranching. 
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Although tyrocidine activity results in the production of endogenous ROS species in C. albicans 
biofilm cells (which has been linked to the candidacidal activity of antifungal compounds (26-
28)), the addition of the antioxidant ascorbic acid did not decrease tyrocidine activity which 
could indicate that ROS production is not essential for tyrocidine activity. However, since a 
range of ROS species can be produced and the scavenger ascorbic acid acts against specific ROS 
species, this deduction is not absolute and the involvement of ROS in tyrocidine activity remains 
to be further investigated. 
To summarise, the tyrocidines exhibit membrane activity but there are additional MOA(s) which 
results in morphological abnormalities. Ca2+ inhibits at least one of the tyrocidines MOA. The 
tyrocidines induce ROS in C. albicans cells but it still remains to be elucidated if this is linked to 
tyrocidine antifungal effect. 
7.3 Hypothesis 
The tyrocidines have a broad range of antifungal activity which is influenced by the assay 
environment and the properties of the target cell. The strong evidence of tyrocidine 
oligomerisation from the results in Chapter 2, together with the structure-activity results from 
Chapter 3, implies that the biologically active structures of the tyrocidines are most probably 
higher-order structures formed via peptide self-assembly. Munyuki et al. (2) illustrated the 
tendency of TrcA and TrcC to form dimers in aqueous environments through hydrogen bonding 
or hydrophobic interactions. The investigators also hypothesised that the tyrocidines may also 
easily form higher aggregates (2). Investigations by Spathelf (1)  yielded strong evidence of 
tyrocidine self-assembly and it was hypothesised that the tyrocidines form higher-order 
structure(s) for membrane activity (1). However, there is a fine line between the formation of the 
active oligomer(s) and excessive tyrocidine aggregation which leads to a decrease in available 
active peptide structures and a concurrent decrease in peptide activity. The variance in peptide 
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activity in and on different mediums may therefore be the result of variances in tyrocidine self-
assembly in the different media, either not allowing for adequate oligomerisation to form the 
active higher-order structure or promoting excessive aggregation that leads to loss in peptide 
activity.  
The tyrocidines in all probability have more than one mode of action (MOA) of which one is 
undoubtedly fungal membrane disruption. It is most likely that their membrane activity, 
especially at lower concentrations, is regulated by other cellular components and which is 
probably cell wall related for F. solani. In addition to their interaction with the fungal membrane, 
the tyrocidines have an additional effect on fungal spores and hyphae that result in retarded 
germination and hyperbranching. The processes of spore germination, hyphal elongation and 
hyphal branching is complex and not yet fully understood and consequently it is difficult to 
pinpoint what action(s) of AMP action will result in these morphological alterations. 
Nonetheless, some of the processes/regulators proposed to be involved in spore germination and 
hyphal development include Ca2+ concentrations (22-24), ROS production (20), septin 
mislocalisation (18, 20), nuclear division and the cell cycle (20, 25). The inhibition of tyrocidine 
activity by the presence of Ca2+ points to one possible way the tyrocidines can influence these 
cellular processes in fungi. Furthermore, although it appears that the induction of ROS by 
tyrocidine activity is not essential for their antifungal effect, ROS species not affected by the 
antioxidant ascorbic acid may still be involved in tyrocidine action. Interference with the cell 
cycle is another possibility since cellular interference with a target cell’s cell cycle has been 
proposed for the tyrocidines (13). However, these findings do not exclude possible tyrocidine 
interaction with any of the other processes/regulators proposed for fungal germination and 
hyphae development. Furthermore, there is the possibility that the tyrocidines have, to some 
extent, different modes of action to different fungal species. Last mentioned theory is partly 
supported by the results that the influence of assay environment and the presence of Ca2+ have a 
more pronounced effect on tyrocidine activity against F. solani than B. cinerea. Furthermore, in 
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contrast to F. solani, tyrocidine concentrations higher than the minimal inhibition concentration 
were needed to achieve only 70% of the membrane disruption induced by the membrane lytic 
control (1% TritonX-100) in B. cinerea, and tyrocidine action against F. solani was more 
severely influenced by the presence of Ca2+ than their activity against B. cinerea.  
7.4 Recommendations for future studies 
During the course of this study only the in vitro activity of the tyrocidines against 
phytopathogens and the medically relevant C. albicans was investigated. Considering the 
significant activity exhibited by the tyrocidines and their relative stability in various 
environments as well as in the presence of cations, it would be feasible to investigate the in vivo 
activity of the tyrocidines on agricultural crops. Since the activities of the tyrocidines are 
influenced by their solvent composition and environment, it would be advisable to experiment 
with different solvents and treatment conditions. Furthermore, a more in depth study of the 
nature and spectrum of the tyrocidines enhancing effect on caspofungin and amphotericin B can 
be conducted and expanded to include in vivo studies. 
The absence of overt structural-activity relationships implies that the conserved sequence of 
tyrocidines, namely NQYVOLfP, may be important for activity with the aromatic dipeptide unit 
(Ff, Wf or Ww) determining the hydrophobicity and putative active dimer formation (Chapter 2, 
(1, 2)). However, extreme tyrocidine aggregation leads to a decrease in peptide activity. It would 
therefore be of interest to investigate different tyrocidine self-assembly states and how the 
different levels of self-assembly influences tyrocidine antifungal activity, as well as how 
tyrocidine self-assembly is influenced by various environments. 
During the MOA studies differences in peptide activity between the biological and model 
membranes were observed. This may be the result of differences between the activity of a 
particular Trc in a static system such as model membranes and a complex and dynamic 
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biological system, such as growing fungal cells. The model membrane system is limited to 
measuring the peptides direct interaction with the artificial membranes and other factors that may 
complicate peptide activity on biological membranes, such as the fungal cell wall, fungal growth 
and fungal defence mechanisms, in not included in the evaluation of activity.  The biological 
system also has its drawbacks. Peptide activity on fungal target cells is only measured by their 
ability to inhibit fungal growth, while viability of the residual fungi, such as hyper branched 
fungi is not assessed in most assays. Future studies can explore the options on how to overcome 
the drawbacks/pitfalls of these experimental systems. 
The presence of Ca2+ inhibits at least one of the tyrocidines MOA(s).  Greater insight regarding 
the tyrocidines MOA may be gained if a more in depth study is conducted on the effect of Ca2+ 
on tyrocidine activity. Fluorescence microscopy could be utilised to study the effect of Ca2+ on 
the membrane activity of the tyrocidines. Likewise, using light microscopy, the effect of Ca2+ on 
the morphological effect of the tyrocidines could be investigated. Likewise further insight into 
the tyrocidnes’ MOA will be gained by investigating the influence of Ca2+ presence on the 
tyrocidines’ morphogenic effect on target fungi cells.  
The role of ROS in tyrocidine activity against C. albicans may be further investigated. 
Additional ROS stains to that of 2’,7’-dichlorodihydrofluorescein diacetate and additional ROS 
scavengers to that of ascorbic acid can be used to evaluate the effect of ROS production and the 
absence of ROS, on tyrocidine activity. 
Future studies should also include an investigation into the effect the tyrocidines have on fungal 
cells that leads to germination and hyperbranching. ROS stains can be used to see if the 
tyrocidines also induce ROS in filamentous fungi and if this ROS production is limited to certain 
areas in the hyphae. Calcium stains (such as Fura-2) can also be used to assess if the tyrocidines 
influence Ca2+ gradients. Furthermore, stains specific for structural components such as the 
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cytoskeleton network (CellLight Tubulin-GFP) or septa (Solophenyl Flavine 7GFE) of fungi can 
be used to visualize any effect the tyrocidines may have on these structures. 
The tyrothricin complex has been approved for oral use and is the active substance in Tyrozets 
throat lozenges. Preliminary studies conducted in our group showed that the tyrocidines are not 
toxic to bees (personal communication with J.A. Vosloo, BIOPEP peptide group, Biochemistry, 
University of Stellenbosch). However, future studies should include a variety of studies of 
tyrocidine impact on human health and the environment. Furthermore, even though the 
likelihood of AMPs to induce de novo resistance against them is low, considerable care should 
be taken to avoid such a scenario. This can be achieved by limiting the use of tyrocidine-biocide 
and not to encourage widespread use as a broad-spectrum biocide. The tyrocidines can also be 
formulated with other antifungal AMPs of antifungals for combinatorial use, thereby decreasing 
the chance of developing resistance. 
7.5 Last word 
Because of the tyrocidines’ broad spectrum and potent antifungal activity, their membrane 
activity and the possibility of more than one MOA - which reduces the risk of resistance 
developing against them - they are promising candidates for bio-fungicides in the agricultural 
sector and combinatorial treatment in the medical industry. The tyrocidines or derivatives could 
be the answer to resistant fungal pathogens in both the agricultural and medical sector.  
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